








COMPARATIVE EFFECTIVENESS OF LABOR MANAGEMENT IN OBESE, 
NULLIPAROUS WOMEN 
by 
NICOLE SMITH CARLSON 
B.S., Emory University, 1992 
B.S.N., Emory University, 2002 





A thesis submitted to the 
Faculty of the Graduate School of the 
University of Colorado in partial fulfillment  
of the requirements for the degree of 
Doctor of Philosophy 





This thesis for the Doctor of Philosophy degree by  
Nicole Smith Carlson 
has been approved for the 
College of Nursing  
by 
 
Karen Sousa, Chair 
Nancy K. Lowe, Advisor 
Elizabeth Corwin 
Teri L. Hernandez  







           iii 
 
Carlson, Nicole Smith (Ph.D., Nursing) 
Comparative Effectiveness of Labor Management in Obese, Nulliparous Women 
Thesis directed by Professor Nancy K. Lowe. 
ABSTRACT 
 Over thirty percent of childbearing women in the United States are obese (BMI ≥ 
30kg/m2), with disproportionate distribution among racial and ethnic minority groups.  
Obese women are at particular risk to end their full-term pregnancies with unplanned 
cesarean delivery, in large part due to their abnormally slow labors. Gaps exist in our 
understanding of the correct timing and use of technological interventions in the labors of 
obese women.   
Low-risk, nulliparous obese and overweight women (n=718) delivering at the 
University of Colorado Hospital were retrospectively sampled to discover intrapartum 
practices associated with decreased risk of cesarean delivery. Biologic effects of obesity 
on women’s response to synthetic oxytocin augmentation in labor were also examined.  
Propensity score random neighbor matching by the type of intrapartum provider 
(Certified Nurse-Midwife or Obstetrician) was used to create equivalent comparison 
groups of women on perinatal risk factors. 
Maternal delivery BMI was significantly associated with cesarean delivery for the 
indication of slow labor progress, even when included in regression analysis with 
gestational age, baby’s birth weight, maternal age, and maternal height, OR = 1.07, p = 
0.021, 97.5% CI [1.00, 1.13]).  Significant differences existed between the intrapartum 
care provided by CNMs or OBs, but there was no difference by provider type in the 
chances that obese and overweight patients would end labor with cesarean delivery for 
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slow labor progress.  Obese women ending labor with cesarean for slow labor were more 
likely than subjects ending labor with vaginal delivery to receive synthetic oxytocin, OR 
= 9.63, p < 0.001, 97.5% CI [3.19, 41.76], have artificial rupture of membranes or 
synthetic oxytocin infusions initiated at less than 6cm cervical dilation, OR = 3.83, p = 
0.003, 97.5% CI [1.49, 9.41] and OR = 4.67, p <0.001, 97.5% CI [1.96, 11.48] 
respectively, and to have initiation of synthetic oxytocin during times of normal labor 
progression, OR = 5.47, p < 0.001, 97.5% CI [2.25, 14.75].  Maternal BMI explained 
nearly 1/5 of the variance in hourly synthetic oxytocin doses among obese women ending 
labor with vaginal delivery when controlling for both the timing in labor of synthetic 
oxytocin onset and infant birthweight.  
 
The form and content of this abstract are approved. I recommend its publication. 
Approved: Nancy K. Lowe 
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Obese women (BMI ≥ 30kg/m2), who now comprise 36.3% of adult women in the 
United States (Flegal, Carroll, Kit, & Ogden, 2012), are at particular risk for unplanned 
cesarean delivery secondary to their abnormally slow labors, a clinical problem known as 
labor dystocia (ACOG, 2003; Kominiarek et al., 2011; Norman et al., 2012).  Nulliparous 
(first-time laboring) women who are obese have the highest risk for unplanned cesareans, 
with rates nearly 3.5 times that of normal-weight women (Poobalan, Aucott, Gurung, 
Smith, & Bhattacharya, 2009).  Studies on national and international populations show a 
dose-dependent slowing in labor progress with increasing BMI (Kominiarek et al., 2011), 
with the median length of labors among morbidly obese nulliparous women estimated to 
last over two hours longer than labor among similar women with normal BMI.  
 Labor dystocia was last defined by American College of Obstetricians and 
Gynecologists in 2003 as “an abnormal labor that results from …abnormalities of the power, 
the passenger, or the passage” after “women…enter the active phase when cervical dilation is 
between 3 cm and 4 cm” (ACOG, 2003, p. 1445).  Although labor dystocia among obese 
women was initially thought to be caused by soft-tissue obstruction (abnormality of 
“passage”) in late labor and at birth, (S. S. Crane, Wojtowycz, Dye, Aubry, & Artal, 
1997) more recent data suggested that obese women’s labors are slower during the first 
stage, from 4 to 10 centimeters of cervical dilation (Fyfe et al., 2011; Kjaergaard, Olsen, 
Ottesen, Nyberg, & Dykes, 2008; Kominiarek et al., 2010; Vahratian, Zhang, Troendle, 
Savitz, & Siega-Riz, 2004). Once obese women reach the second stage of labor, their 
vaginal birth rate is the same as it is for normal-weight women (Buhimschi, Buhimschi, 
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Malinow, & Weiner, 2004; Robinson et al., 2011).  Obese women are more likely than 
normal-weight women to have slightly larger babies (abnormality of “passenger”), yet in 
studies that controlled for maternal diabetes, the higher fetal weights were not associated 
with additional diagnoses of labor arrest/slowing (Verdiales, Pacheco, & Cohen, 2009; 
Zhang, Bricker, Wray, & Quenby, 2007). Thus, labor dystocia in the obese woman 
appears to be primarily related to abnormalities in “power,” or myometrial dysfunction in 
labor.  Investigators suggest that some obesity-associated physiology in pregnancy causes 
inefficient myometrial cellular contraction compared to normal-weight women 
(Moynihan, Hehir, Glavey, Smith, & Morrison, 2006; Smith, Babiychuk, Noble, Draeger, 
& Wray, 2005; Zhang, Kendrick, Quenby, & Wray, 2007).   
The myometrial dysfunction found among obese women is not completely 
understood and may be the result of several synergistic mechanisms present in some 
pregnant obese women (Moynihan et al., 2006; Smith et al., 2005; Zhang, Kendrick, et 
al., 2007). Both leptin and cholesterol, found at elevated levels in obese women (Domali 
& Messinis, 2002; Gostynski et al., 2004), decrease the contractile force of myometrial 
cells in vitro (Moynihan et al., 2006; Smith et al., 2005).  Synthetic oxytocin, which is 
administered to women in order to induce or augment uterine contractions, does not 
overcome the effects of leptin and cholesterol in these in vitro environments. 
Corroborating this in vitro finding, investigators of clinical studies using standardized oxytocin 
infusion protocols noted that obese women given synthetic oxytocin are more likely to end 
labor with unplanned cesarean delivery when compared to normal-weight women receiving 
oxytocin, an effect that was enhanced in higher obesity categories (Arrowsmith, Wray, & 
Quenby, 2011; Walsh, Foley, & O'Herlihy, 2011).  It is not known if the increased labor 
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slowing observed clinically in obese women could be linked to inefficient myometrial 
contractions and/or unresponsiveness of obese women’s myometrial cells to synthetic oxytocin, 
although this has recently been proposed as a biological mechanism (Lowe & Corwin, 2011). 
 During labor, obese women are typically managed with a technologically driven 
package of interventions including early admission to hospital, augmentation with 
synthetic oxytocin, artificial rupture of membranes, epidural analgesia, and unplanned 
cesarean delivery (Abenhaim & Benjamin, 2011; Carlson & Lowe, 2013; Fyfe et al., 
2011; Green & Shaker, 2011; Vahratian, Siega-Riz, Savitz, & Zhang, 2005).  Obese 
women are more likely than normal-weight women to be admitted to the hospital at earlier 
cervical dilations, and to then have their labors augmented with synthetic oxytocin or artificial 
rupture of membranes (AROM) (Buhimschi et al., 2004; Vahratian et al., 2004).  Early 
admission in labor prior to the onset of active labor contractions and cervical dilation less than 
4cm in nulliparous women was found in a prospective cohort study to be associated with 
increased risk for cesarean delivery (Jackson, 2003) and in a randomized controlled trial to 
increased use of epidural analgesia and synthetic oxytocin (McNiven, Williams, Hodnett, 
Kaufman, & Hannah, 1998). Once obese women are in labor, they are held to a standardized 
expected cervical dilation rate of at least 1cm/hr based on analyses of labor progress in mixed-
weight women performed in the 1950’s (Neal, Lowe, Patrick, Cabbage, & Corwin, 2010).  
This practice exists despite more recent evidence showing that many women who have 
successful vaginal births, including obese women, dilate at a much slower rate (Blackwell, 
Refuerzo, Chadha, & Samson, 2008; Neal, Lowe, Patrick et al., 2010). 
 When obese women proceed more slowly than is standardized, synthetic oxytocin 
augmentation is often employed in their labors.  Synthetic oxytocin augmentation is more 
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likely to fail to result in vaginal delivery in obese women compared to normal-weight women 
(Usha-Kiran, Hemmadi, Bethel, & Evans, 2005).  Standardized synthetic oxytocin 
augmentation dosages corrected for maternal BMI are not currently known, although several 
studies of induction protocols found that obese women required longer administration times 
and larger dosages to achieve vaginal delivery when compared to normal-weight women 
(Pevzner, Powers, Rayburn, Rumney, & Wing, 2009; Walsh et al., 2011).   
 In addition to synthetic oxytocin, AROM is frequently used as an intrapartum 
intervention to speed the labors of obese women.  In a Cochrane systematic review of a mixed-
weight sample of women, AROM was found to carry an independent trend toward increased 
risk of unplanned cesarean delivery with no statistical difference in the length of first stage 
labor (Smyth, Markham, & Dowswell, 2013).  No studies to date have examined the use of 
AROM in the labors of obese women.   
 Higher BMI categories among parturient women also are known to be associated with 
higher epidural use, with unknown effects on the unique labors of obese women.  In contrast to 
earlier studies showing no increased risk of cesarean delivery associated with epidural 
anesthesia, a more recent prospective cohort analysis on a mixed-weight population of 878 
nulliparous women found that epidural use carried a relative risk of 2.5, 95% CI [1.8, 3.4] for 
operative vaginal delivery and a RR of 2.4, 95% CI [0.6, 5.3] for cesarean delivery (Nguyen et 
al., 2009).  However, investigators of this study provided no sub-analysis of this effect by 
maternal BMI.    
 Low-technology interventions in labor such as ambulation, hydrotherapy, continuous 
labor support, and intermittent external fetal monitoring have been associated with lowered 
cesarean delivery rates in mixed-weight populations (Cluett, 2004; McGrath & Kennell, 2008), 
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and all are known to be used more frequently by nurse-midwives when compared to 
obstetricians (Johantgen et al., 2011; Shaw-Battista et al., 2011).  However, no investigators to 
date have described the use of these interventions in the labors of obese women, nor described 
any association between the use of these interventions and outcomes of labor among obese 
women, including unplanned cesarean delivery (Carlson & Lowe, 2013). 
 Increasingly, labor management of nulliparous obese women, including the use of 
early hospital admission, synthetic oxytocin augmentation, AROM, epidural, and 
cesarean delivery is identified as a primary area for study and improvement in the effort 
to decrease the cesarean delivery rate in this population (Abenhaim & Benjamin, 2011; 
Fyfe et al., 2011; Kominiarek et al., 2010; Vahratian et al., 2005).  Although investigators 
have demonstrated that obese, nulliparous women proceed through labor more slowly 
than non-obese women, little is known about the optimum labor management of this 
vulnerable population.  
Significance of Study 
 The combination of an obese woman’s slower labor with her blunted response to 
commonly used medical efforts to speed progress (synthetic oxytocin, AROM) creates 
challenges for the intrapartum provider.  When seen through a technologically driven model of 
intrapartum care wherein providers too often admit women to the hospital in early labor and 
apply stringent guidelines for cervical dilation progress, obese women’s labors can too often 
end in unplanned cesarean delivery for the indication of slow labor progress.  In the absence of 
more complete information about the optimal labor management of obese women, surgical 
delivery will continue to frequently be the outcome of an otherwise normal, full-term 
pregnancy.   
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 As the obesity epidemic in the United States continues, it is vitally important that the 
most effective labor management for obese women is understood and used to prevent 
complications associated with unnecessary cesarean delivery. When obese women give birth 
via cesarean, they are statistically significantly more likely than their normal weight 
counterparts to encounter complications including post-operative infection, clotting disorders, 
postpartum hemorrhage, and prolonged hospitalization, all of which have been linked to 
increased maternal morbidity and mortality, and higher healthcare costs (Grundy, Woodcock, 
& Attwood, 2008; Jarvie & Ramsay, 2010; Myles, Gooch, & Santolaya, 2002; Silver et al., 
2006).  Up to a third of maternal deaths in pregnancy are associated with obesity complications 
(Grundy et al., 2008), many following cesarean delivery.  Obesity is found disproportionately 
among women of U.S. ethnic and racial minorities.  Non-Hispanic White women have a 33.4% 
[95% CI 30.3 - 36.6] rate of obesity, compared to 40.7% [36.7 - 44.8] of Hispanic women and 
58.6% [52.5 - 64.5] of Non-Hispanic Black women (Flegal et al., 2012).  Given this rising and 
increasingly disproportionate rate of obesity found among U.S. ethnic and racial minority 
women, these findings of poor birth outcomes among obese women could contribute to 
worsening perinatal disparities.  Understanding and preventing obesity-related birth 
complications could be one of the key factors in the United States’ efforts to decrease the  
national maternal mortality rate from its current ranking below 40 other countries (Amnesty, 
2010).  
 Gaps exist in our knowledge of the comparative effectiveness of different labor 
management packages and the correct use (timing and dosing) of synthetic oxytocin in healthy 
obese women. In this dissertation research, I used a practical comparative effectiveness 
approach to shed much-needed light on the most effective labor care approaches for the 
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prevention of unplanned cesarean delivery in healthy obese, nulliparous women.  Information 
obtained from this study will inform clinical practice and future research focusing on more 
optimal birth outcomes in this vulnerable population.  
 This study also was significant to the discipline of nursing because it examined 
the effectiveness of the intrapartum management provided by advanced practice nurses, 
including investigation of low-technology labor interventions.  Increasingly, certified 
nurse-midwives are identified as low-cost, high-quality providers of primary and 
women’s health care (Committee on the Robert Wood Johnson Foundation Initiative on 
the Future of Nursing & Medicine, 2011).  However, little is known about the specifics of 
certified nurse-midwives care as it contrasts to care by physicians in this population.  
There is a particular gap in knowledge about the care of certified nurse-midwives for 
higher-risk pregnant populations, such as obese women.  
Purpose of Study 
 This research addressed the problem of labor dystocia in obese, nulliparous 
women by retrospectively investigating labor management approaches in this population. 
This examination used the innovative approach of comparing the processes and outcomes of 
two groups of health care providers who practice in the same environment; yet are known to 
use subtly different management strategies in their intrapartum work with mixed-weight 
women.  The purpose of this study was to examine labor management related to decreased use 
of unplanned cesarean delivery for the indication of labor dystocia and changes in synthetic 
oxytocin dose among healthy obese, nulliparous women at the University of Colorado Hospital 
(UCH).  Specific aims and hypotheses are detailed below.   
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Information from this study will inform future research and clinical practice focused on 
improving birth outcomes in the vulnerable population of obese nulliparous women.  This 
study also was an entry point for the long-term goal of establishing a program of research to 
expand knowledge of the biobehavioral mechanisms involved in the development of labor 
dystocia among nulliparous women.  New knowledge in this area can be used to recommend 
changes in intrapartum management that will reduce numbers of cesarean deliveries performed 
for labor dystocia.   
Rationale 
 A biobehavioral model provided the theoretical framework for this study (Figure 1).  
This biobehavioral framework is built on a conceptual model of factors associated with 
cesarean section in healthy nulliparous women for the diagnosis of labor dystocia 
published by the author’s advisor Dr. Lowe (Lowe, 2007) and extends that model to 
include examination of the interaction among factors from a biobehavioral perspective.  
This new biobehavioral theory links the behavioral determinant of technologically-driven 
package of labor care in these women’s labors to the biological determinant of increased 
risk for labor dystocia in obese women.  This theoretical framework clarifies how 
technologically driven management in this population could lead to the use of unrealistic 
timelines and minimally effective medication usage that worsen a biological tendency for 
decreased uterine contractile efficiency.  Thus, the phenomenon of the increased 
incidence of unplanned cesarean delivery secondary to labor dystocia in healthy obese 
nulliparous women was theorized to be a result of the interplay between biological and 
behavioral determinants.  The biobehavioral theory serves as an ideal lens through which to 
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focus research on these biological and behavioral determinants, thus lending clarity to the 
complex interactions involved in labor.  
 
Figure 1: Conceptual model of labor dystocia leading to unplanned cesarean delivery in 
obese women demonstrating primary phenomenon and both behavioral and biological 
determinants in a biobehavioral framework. 
 
Aims and Hypotheses 
 The overall hypothesis of this study was that the diagnosis of labor dystocia in healthy, 
nulliparous obese women is partially attributable to the strict timelines and early use of labor 
interventions including hospital admission, epidural, synthetic oxytocin augmentation, and 
AROM, and is associated with unplanned cesarean delivery.  Using the comparison of nurse- 
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midwifery care that exists side-by-side, yet contrasts with the more technologically-driven 
model of obstetrician care, the purpose of this study was to examine labor management related 
to use of unplanned cesarean delivery for the indication of labor dystocia and changes in 
synthetic oxytocin dose among healthy obese, nulliparous women.  The study setting was an 
academic medical center in Colorado where certified nurse-midwives manage nearly half of the 
births. 
 The purpose of the study was fulfilled through the following specific aims: 
Aim 1   
 Compare the risk of cesarean delivery for the indication of labor dystocia among 
healthy, nulliparous, overweight or obese women receiving intrapartum care from certified 
nurse-midwives or obstetricians. 
Hypothesis of Aim 1 
 Healthy, nulliparous obese women will be less likely to undergo unplanned cesarean 
delivery for the indication of labor dystocia when managed by certified nurse-midwives 
compared to similar women managed by obstetricians.  This hypothesis is based on data from 
previous studies showing that nurse-midwifery practices tend to have lower rates of labor 
dystocia when compared to obstetrician practices (Leeman & Leeman, 2003). 
Aim 2   
 Among healthy, nulliparous obese women having cesarean delivery for labor dystocia, 
examine how exposure to labor interventions differs when compared to similar women having 
vaginal delivery. 
 Hypothesis 1 of Aim 2. Healthy nulliparous obese women who end labor with 
cesarean delivery for labor dystocia will be more likely than similar women ending labor with 
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vaginal delivery to receive epidural, AROM, foley bulb, misoprostol, and synthetic oxytocin 
augmentation. 
 Hypothesis 2 of Aim 2.  Healthy nulliparous obese women who end labor with 
cesarean delivery for labor dystocia are more likely than similar women ending labor 
with vaginal delivery to receive AROM at < 6cm cervical dilation, synthetic oxytocin 
augmentation at < 6cm, or hospital admission at  < 4 cm cervical dilation.    
 Hypothesis 3 of Aim 2.  Healthy nulliparous obese women who end labor with 
cesarean delivery for the indication of labor dystocia are more likely than similar women 
ending labor with vaginal delivery to experience onset of intrapartum interventions while 
having normal cervical progression.   
Aim 3   
 Characterize use of synthetic oxytocin in labor augmentation by maternal delivery BMI 
in nulliparous, obese women who achieve vaginal birth. 
 Hypothesis 1 of Aim 3.  Healthy nulliparous obese women with higher delivery BMI 
will require larger total doses of synthetic oxytocin and longer oxytocin infusion duration to 
achieve vaginal birth when compared to women with lower delivery BMI.    
Hypothesis 2 of Aim 3.  The hour-to-hour dose of synthetic oxytocin will vary 
over time from hospital admission until birth for each woman, and these hourly dose 
patterns will tend to group depending on the BMI of the women, the woman’s provider, 
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Aim 4  
 Among healthy, nulliparous obese women ending labor with cesarean delivery for 
labor dystocia, examine how exposure to low-technology interventions differs from similar 
women ending labor with vaginal delivery. 
 Hypothesis 1 of Aim 4.  Healthy, nulliparous obese women who end labor with 
vaginal delivery are more likely to make use of low-technology interventions in labor 
compared to similar women who end labor with cesarean delivery for the indication of 
labor dystocia.   
 Hypothesis 2 of Aim 4.  Healthy nulliparous obese women who end labor with 
cesarean delivery for labor dystocia are less likely than similar women ending labor with 
vaginal delivery to engage in ambulation, hydrotherapy, or intermittent fetal monitoring 
at > 6 cm cervical dilation and to engage in these activities for shorter total periods of 
time in labor.  
 Hypothesis 3 of Aim 4.  Healthy nulliparous obese women who end labor with 
cesarean delivery for the indication of labor dystocia are less likely than similar women 
ending labor with vaginal delivery to experience onset of low-technology intrapartum 
interventions while having abnormal cervical progression. 
Design Limitations 
 There are several important limitations in the design of this study.   These limitations 
are reviewed in the following section, and strategies for addressing each are detailed in Chapter 
3.  The first design limitation was the retrospective nature of this study.  I conducted 
retrospective reviews of the Perinatal database and medical records and was therefore unable to 
make causality conclusions.  Further investigation using an experimental prospective design of 
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labor management among obese, nulliparous women would be necessary to establish causality.  
Another limitation of the proposed study design was the medical record data that were used to 
answer study questions.  Medical record data collected during retrospective chart review are a 
low-cost, useful resource for research involving vulnerable populations, such as pregnant 
women (Gregory & Radovinsky, 2012).  However, both the process of collecting data from 
medical records and errors in the information contained within medical records can lead 
researchers to make poor conclusions.  
Another limitation of this study design was selection bias.  There was the potential for 
selection bias in the way subjects were allocated to provider care groups.  For example, if 
subjects were allocated to the obstetrician group based on the involvement of an obstetrician in 
their delivery, all cesarean deliveries would be allocated to the obstetrician group.  This is 
because certified nurse-midwives collaborate with obstetricians when their patients require 
cesarean delivery.  It was therefore important to follow pre-determined protocols and intent-to-
treat subject allocation to comparison groups to decrease selection bias.  Therefore, a nurse-
midwife’s patient who ended labor with a cesarean delivery done by an obstetrician would be 
considered part of the nurse-midwife comparison group for all analyses of labor processes and 
outcomes.  A second way that this study had potential for selection bias was the self-selection 
of women for a particular intrapartum provider.  For example, if anxious women were more 
likely to self-select for the care of nurse-midwives at UCH, findings regarding the processes or 
outcomes of nurse-midwifery care may actually correlate to patient anxiety, rather than the care 
of nurse-midwives.  Propensity score matching of subjects was used in subject allocation to 
decrease this threat.  In addition, this study was limited to only two types of intrapartum 
providers:  University certified nurse-midwives or obstetricians.   Women who received care 
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from other types of obstetric providers such as maternal-fetal medicine doctors (specializing in 
high-risk obstetric patients) and family practice physicians or another practice of certified 
nurse-midwives with a self-selecting clientele were excluded from this study to decrease self-
selection bias of some subjects for these specialized providers.   
Finally, this study was limited by confounding factors that may have affected both the 
exposure and outcome variables.  For example, obese nulliparous women with insulin-
dependent gestational diabetes are more likely to receive obstetrician care during labor 
(exposure) and be more likely to experience labor dystocia leading to unplanned cesarean 
delivery (outcome).  Therefore, insulin-dependent gestational diabetes is one example of a 
confounding factor that was considered in the exclusions for this study.  
           15 
CHAPTER II 
LITERATURE REVIEW 
 This study of the comparative effectiveness of labor management of nulliparous, 
healthy obese women was based upon a biobehavioral theoretical framework linking both 
biological and behavioral determinants to the phenomenon of unplanned cesarean 
delivery secondary to labor dystocia, as shown in Figure 1 in the previous chapter.  When 
comparing groups of obese women to normal-weight women, research findings suggest 
that there are multiple mechanisms acting in concert to bring about an increased risk of 
unplanned surgical birth (Lowe & Corwin, 2011). A biobehavioral framework was 
chosen for the proposed study because this framework provides a focus on both 
biological and behavioral factors, both highlighted by recent research as two of the most 
important mechanisms in obese women’s tendency to end pregnancy with unplanned 
cesarean delivery (Abenhaim & Benjamin, 2011; Cedergren, 2009; Walsh et al., 2011; 
Zhang, Bricker, et al., 2007). The biological determinant in this study’s theoretical 
framework is the increased risk for labor dystocia among obese women.  The behavioral 
determinant is a technologically driven package of labor management used with obese 
women. A biobehavioral framework also served this proposed research well in the clarity 
it lended to structure research that questions how behavioral interventions affect 
biological outcomes, and how biological interventions affect behavioral outcomes 
(Grady, 2006).   In the following review of the literature, both the biological and 
behavioral determinants of unplanned cesarean delivery for the indication of labor 
dystocia in the nulliparous, healthy obese woman are detailed. 
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Biological Determinant:  Increased Risk for Labor Dystocia in Obese Women 
 This review of the biological literature first summarizes the metabolic and 
endocrine changes caused by obesity on the human body, and then describes ways that 
these changes might alter labor processes in the obese woman.   
Metabolic and Endocrine Changes Caused by Obesity   
 Our understanding of the metabolic and endocrine changes caused by obesity has 
changed significantly in the past 10 years (Stehno-Bittel, 2008).  New research benefited 
from improved technologies for inquiry and the growing scientific and larger societal 
realization of the epidemic of obesity. When individuals combine high-fat dietary intake 
with decreased energy expenditure, the body’s storage capacity for free fatty acids (FFA) 
in adipocytes is eventually overwhelmed (Frayn, 2010). Initially, cells adapt to excess 
FFA by sequestering them as triglyceride in new adipose cells or in fat droplets created in 
non-adipose tissues (ectopic fat) (Frayn, 2010).  In response to excess fat consumption, 
the peroxisome proliferator-activated receptor (PPAR) system is activated (Frayn, 2010).  
This system of transcription factors contains three isoforms, and works to both increase 
storage and increase oxidation of free fatty acids (FFA).  In addition, PPAR ligands 
reduce the recruitment of immune cells and inhibit inflammation.  To increase storage of 
FFA, the PPAR proteins regulate the differentiation and proliferation of new adipose 
cells from fat cell precursors called preadipocytes (Frayn, 2010; Jiang, Strand, Franco, 
Clark, & Hayward, 2011).  These new adipose cells are more active than large, older 
adipose cells in collecting excess FFA from the circulation.  In fact, thiazolidinedione 
(TZD) drug therapy to treat patients with insulin resistance is thought to work because 
these drugs activate the PPAR system, creating new adipose cells that effectively “trap” 
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FFA and allow better utilization of glucose as an energy source for cellular processes and 
increase insulin sensitivity (Frayn, 2010).    
New adipose cells are set up with adequate perfusion, and effectively sequester 
harmful FFA from the other body tissues (Unger & Scherer, 2010). However, continued 
metabolic imbalance with overeating and under-exercising leads to adipose tissue 
deposits around the body becoming swollen with accumulated fat.  When the body 
exceeds normal adipose storage and oxidative abilities, FFA levels rise again (Stehno-
Bittel, 2008).  In the effort to control the effects of FFA, the body stores fatty acids as 
triglycerides (TAG) in ectopic sites, including the skeletal muscle, liver, heart muscle, 
pancreatic islet cells, and vascular tissue (Sørensen, Virtue, & Vidal-Puig, 2010).  In 
addition to the intra-organ ectopic fat deposits, ectopic fat is also created throughout the 
abdominal cavity in visceral fat deposits (Unger & Scherer, 2010).  Visceral fat deposits 
tend to have sub-optimal vascularization when compared to healthy adipose tissue, 
leaving these new sites of fat storage to exist on the edge of viability, releasing 
inflammatory cytokines into the body (Stehno-Bittel, 2008).  Like all cells caught up in 
an inflammatory process, visceral fat deposits become insulin resistant so as to retain 
cellular energy for the purposes of dealing with the threat to the cell (stress) (Gregor & 
Hotamisligil, 2011).  Unfortunately, with insulin resistance these ectopic sites lose the 
ability to effectively sequester FFA into TAG and switch instead into fat mobilization 
mode and start releasing FFA into the body (Frayn, 2010).   
Some tissues are able to remain functional despite moderate amounts of ectopic 
fat accumulation.  For example, liver cells can tolerate moderate amount of ectopic fat 
deposits before becoming overwhelmed and insulin resistant (Stehno-Bittel, 2008).  Other 
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tissues are less tolerant to ectopic fat deposits. In the pancreas, ectopic fat accumulation 
harms the beta cells, causing the organ to secrete less insulin than normal in response to 
fatty acid or glucose loads (Frayn, 2010).  In the heart, ectopic fat causes necrosis leading 
to functional cardiomyopathy (Stehno-Bittel, 2008).  When tissues exceed their ability to 
tolerate ectopic fat deposits, inflammation, cell dysfunction, and cell death result (Bluher, 
2009). 
 Inflammation:  The role of adipose tissue dysfunction.  As mentioned above, 
visceral and ectopic fat deposits exist on the edge of viability and are especially prone to 
dysfunction.  Macrophages infiltrate adipose cells in the situation of chronic over-
nutrition, becoming as much as 50% of tissue weight (Stehno-Bittel, 2008).  In contrast, 
macrophages normally exist as only 10% of adipose tissue mass in lean persons with 
minimal visceral adiposity.  Macrophages are summoned to infiltrate this dysfunctional 
adipose tissue (Gregor & Hotamisligil, 2011).  These macrophages release TNF-α and 
other cytokines, which alert surrounding tissues and immune cells to the adipose tissue’s 
state of chronic inflammation.  Now in stress, the adipose cell blocks insulin signaling 
molecules, thus switching its metabolism from a focus on storage to a focus on energy 
expenditure in the aid of defense.  Paracrine effects of the inflammation signals released 
by dysfunctional adipose tissue causes other tissues to become inflamed and develop 
insulin resistance, thus causing lipotoxicity throughout the body.   
Inflammation also plays a role in lipotoxicity by increasing the reactive oxygen 
species (ROS) in adipocytes (Curtis et al., 2012).  TNF-α, released by macrophages that 
are recruited to unhealthy adipose tissue, increases ROS production (for a full description 
of ROS and protein carbonylation production as a result of FFA overload, see section on 
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Lipotoxicity).  This ROS production leads to damage to internal cellular proteins, which 
can in turn cause myriad cellular dysfunctions, including the change of the adipocyte to 
bind less FFA from the surrounding tissue.  In the presence of increased levels of FFA, 
the muscle and liver cells become insulin resistant.  
 Insulin resistance.  Insulin resistance plays an integral part in the spiral of 
dysfunction caused by excess FFA.  Visceral adipose deposits have less insulin receptors 
than subcutaneous adipose tissue, leaving this tissue ill equipped to protect the body by 
absorbing FFA (Bluher, 2009).  Visceral adipose tissue is also insulin resistant secondary 
to the pro-inflammatory cytokines released by macrophages that circulate around this 
dysfunctional tissue (Iyer, Fairlie, Prins, Hammock, & Brown, 2010).  Visceral adipose 
tissue releases a stream of FFA into the circulation as a result of insulin resistance.  
Visceral adipose tissue’s location in the abdomen creates the situation that the liver is the 
first organ to be exposed to the free flow of FFA from visceral adipose tissue through the 
portal circulation.  In response to FFA exposure, the liver initiates gluconeogenesis and 
becomes insulin resistant.  Although an appropriate response to short-term increases in 
FFA, this action by the liver only contributes to physiologic dysregulation with long-term 
FFA exposure.   
Insulin resistance also occurs in the muscle cells in response to excess FFA 
(Schrauwen, Schrauwen-Hinderling, Hoeks, & Hesselink, 2010).  There, glucose is the 
metabolite of choice for energy needs.  However, in situations of surplus dietary fat, high 
plasma FFA, and ectopic fat deposits, the striated muscle cells switch to using lipids for 
metabolic needs.  Within the muscle cell’s mitochondria, the metabolism of lipids 
through lipid peroxidation creates ROS that damage the cell.  As a result, the muscle cell 
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becomes insulin resistant, contributing to the risk of Type 2 Diabetes Mellitus.  This ROS 
damage is the key dysfunction of lipotoxicity.   
 In the situation of defective insulin secretion and resistance, glucose intolerance 
develops and fasting and postprandial TAG levels rise in the plasma (Frayn, 2010).  
However, without insulin sensitivity, the adipose cells lose their ability to create new 
adipocytes to sequester TAG (Unger & Scherer, 2010).  As a result, excess insulin, TAG, 
and glucose cause endothelial damage that results in hypertension, increased risk of blood 
clots, and increased blood uric acid (metabolic syndrome) (Frayn, 2010).  Unrestrained 
release of FFA from adipose tissue also causes hyperlipidemia, another component of 
metabolic syndrome, when the liver responds to high levels of circulating FFA by 
increasing cholesterol transport to the tissues.   
 Leptin—the coordinator of metabolic syndrome?  Some researchers now 
theorize that leptin is a central player in both the protection afforded by adipose tissue 
and in the pathway toward metabolic syndrome when this protection is lost (Unger, 
Clark, Scherer, & Orci, 2010; Unger & Scherer, 2010).  Leptin is a hormone secreted by 
adipose cells that protects the body from FFA exposure by limiting over nutrition 
(increases satiety via the hypothalamus) and increasing the oxidation of FFA in 
peripheral organs.  When over nutrition occurs despite leptin’s satiety signals, leptin also 
can signal for the expansion of adipose cells to accommodate additional storage needs.     
Although leptin promotes oxidation of FFA in peripheral tissues, it cannot have 
the same effect in an autocrine fashion if adipose cells are to function normally.  Leptin 
resistance, initially used by healthy adipose cells to prevent fatty acid oxidation in favor 
of fatty acid ⇒ TAG storage, spreads beyond the adipose cells in the situation of long-
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term over nutrition to the peripheral organs (Unger & Scherer, 2010).  Once immune to 
the effects of leptin, the peripheral organs switch from fatty acid oxidation to fatty acid 
accumulation (Unger et al., 2010).  Ectopic fat deposits are then created in various organs 
as the body attempts to manage the continuing influx of FFA (Stehno-Bittel, 2008; Unger 
& Scherer, 2010).  Polygenic variation causes some individuals to become leptin resistant 
at lower body fat levels than others, helping to explain how some individuals exhibit 
symptoms of metabolic syndrome and lipotoxicity without obesity (Frayn, 2010, p. 336). 
 Lipotoxicity.  Lipotoxicity is the process by which excess FFA and TAG create 
widespread cellular damage involved in metabolic syndrome.  As discussed above, 
excess FFA and TAG cause the body to eventually deposit fat in ectopic locations.  This 
ectopic fat accumulation causes widespread cellular damage in a variety of ways (Wende, 
Symons, & Abel, 2012).   
The first way that excess FFA creates cellular damage is through the 
accumulation of ROS (Stehno-Bittel, 2008).  With increased FFA, mitochondria use FFA 
for the cell’s energy needs.  ROS are produced as a result of FFA oxidation.  Cells 
contain native antioxidants to handle ROS from normal cellular function.  For example, 
in the case of endurance athletes who use FFA for energy, antioxidant capacity of the 
cells is heightened by exercise (Schrauwen et al., 2010).  However, with long-term FFA 
exposure in sedentary individuals, the cell’s normal antioxidant capacity is exhausted, 
and ROS induce insulin resistance, RNA/DNA damage, and protein damage in the cells 
(Demozay, Mas, Rocchi, & Van Obberghen, 2008).  Protein carbonylation is a product of 
oxidative stress, where reactive lipid aldehydes bind to cysteine, histidine, or lysine 
residues, resulting in a loss of protein function (Curtis et al., 2012).  The amount of 
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protein carbonylation is directly related to the extent to which the cellular antioxidant 
capacity is exhausted.  ROS can also change cellular functioning by acting to change 
gene expression (Al-Gubory, Fowler, & Garrel, 2010).  Eventually, cell death can occur 
(Curtis et al., 2012).  Especially in cells with limited capacity to use lipids for fuel, a 
lipid-rich environment leads to cell death from ROS.  For example, organs with high 
mitochondrial oxidative capacity, like the liver, can tolerate more ectopic fat than organs 
with lower oxidative capacity, like the pancreatic islet cells.   
The second way that excess FFA cause cellular damage involved in lipotoxicity is 
through endoplasmic reticulum dysfunction (Carobbio, Rodriguez-Cuenca, & Vidal-Puig, 
2011).  The endoplasmic reticulum is made up of folded layers of phospholipid 
membrane and synthesizes proteins, lipids, membranes, and other key exports of the cell.  
When the cell is exposed to increased levels of FFA, especially saturated fatty acids, the 
endoplasmic reticulum attempts to use some of this FFA to make new membranes for its 
functioning.  These new membranes, stiff secondary to their type of fat composition, do 
not function as fluidly as normal.  Decreased functionality leads the ER to form a stress 
response, signaling the cell to release pro-inflammatory cytokines (Bluher, 2009).  
Eventually, the unfolded protein response is activated, whereby the ER ceases to be 
functional and causes cell death (Carobbio et al., 2011).   
Finally, FFA cause cellular damage through membrane physiochemical alteration 
(Carobbio et al., 2011).  With excess FFA, the cell remodels exterior lipid membranes 
with more fatty acid.  In a cholesterol rich diet, this means that the bilayers are made less 
elastic and therefore have less ion channel functionality as a result of the cell using more 
saturated forms of lipids as a building material.  This decreases the functioning of 
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embedded proteins in the cell membrane, thus causes difficulty for the cell in signal 
transduction and transport of solutes.  ROS produced by the mitochondria attempting to 
oxidize excess FFA can also change cellular membranes by creating lipid peroxidation 
products that are used with ill effect in the plasma membrane.   
To summarize, lipotoxicity sits at the center of the chain of events starting at over 
nutrition and leading to ectopic fat deposition and eventual widespread metabolic 
dysfunction.  “Lipotoxicity results from the cellular uptake of lipid outpacing the ability 
of mitochondria to use lipid, resulting in the accumulation of lipid droplets, eventually 
mitochondrial dysfunction, and even apoptosis and alterations in cell phenotype” (Hardin, 
Kleiber, & Roberts, 2003, p. 2065) (Figure 2).   
Smooth Muscle Lipotoxicity  
 Uterine myometrial tissue is one type of smooth muscle, and is the tissue of 
interest in the overall research focus of myometrial dysfunction in obese women. Much 
of the research concerning lipotoxicity in smooth muscle is focused on bladder and 
vascular smooth muscle.  In vascular smooth muscle, excess FFA and lipid utilization 
disrupts cellular homeostasis (Wende et al., 2012).  Hyperglycemia, oxidative stress, 
proinflammatory cytokines decrease the bioavailability of nitric oxide (NO), thus 
harming not only the vascular smooth muscle, but also the individual’s ability to maintain 
normal blood pressures and cardiovascular functioning.   
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 Bladder smooth muscle (BSM) is also very susceptible to metabolic syndrome 
because it is not designed to utilize FFA for metabolic needs (Hardin et al., 2003).  When 
BSM cells are exposed to different nutrient mixtures in vitro, they show a preference for 
glucose.  If deprived of glucose nutrient mixtures, BSM cells will use short-chain fatty 
acids.  However, mitochondria in BSM tend quickly to become overwhelmed by the ROS 
produced from the use of lipids for metabolic processes, and cell damage/dysfunction 
quickly results.   
Some individuals are less prone to BSM damage in response to excess FFA.  In 
these individuals, it appears that tolerance for FFA metabolic utilization is increased 
through the action of PPARs (Mattern, Lloyd, Sturek, & Hardin, 2007).  To review, 
PPARs are transcription factors that control the expression of specific genes regulating 
metabolic processes.  PPARs are activated by increased levels of FFA.  Some individuals 
have genotypes with PPAR mixtures that lead to decreased fatty acid oxidation and 
increased fatty acid storage, leading to decreased dysfunction of bladder smooth muscle.  
Experimental increase of dietary fatty acids seems to have little effect on individuals with 
this genotype in animal models. Decreased PPAR function is also suggested as a key to 
the known interaction between obesity/metabolic syndrome and benign prostatic 
hyperplasia/lower urinary tract symptoms in men (Jiang et al., 2011).  Prostate volume 
increases directly with obesity and diabetes.  However, these effects can be reversed with 
thiazolidinedione (TZD) medications, which are known to activate PPAR systems.   
Biological Models of Obesity Effects in Labor 
 The manuscript following summarizes mechanisms by which obesity may change 
labor processes and create labor dystocia resulting in unplanned cesarean delivery.  This 
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manuscript was written as part of independent studies completed with Drs. Teri 
Hernandez and K. Joseph Hurt.  The manuscript is planned for submission in the Journal 
of Reproductive Biology and Endocrinology.1  
Biological Basis of a Labor Dysfunction in Obesity 
 
Introduction: The Clinical Phenotype of Obesity in Labor 
 
Over thirty percent of childbearing women in the United States are obese (BMI ≥ 
30kg/m2), with disproportionate distribution among racial and ethnic minority groups 
(31.9% overall, 34.4% among Hispanic and 58.5% among Non-Hispanic Black women) 
(Flegal et al., 2012).  Obesity has profound effects in pregnancy, carrying increased risks 
for gestational diabetes (OR = 2.83, [95% CI: 2.74-2.92]), gestational hypertension/pre-
eclampsia (OR 2.68, [95% CI 2.59-2.77]) (Chung et al., 2012), and maternal depression 
(OR 1.43 [95% CI: 1.27-1.61]) (Molyneaux, Poston, Ashurst-Williams, & Howard, 
2014).  Babies born to obese women are at increased risk for congenital anomalies 
(O'Reilly & Reynolds, 2013), macrosomia (birth weight > 4,500g) (OR 2.15 [95% CI: 
2.03-2.29]) (Ovesen, Rasmussen, & Kesmodel, 2011), and lifetime incidence of diabetes, 
heart disease, and obesity (O'Reilly & Reynolds, 2013).   
Labor in obese women is altered.  Although obese women are more likely to 
deliver prematurely, many of these early births result from labors that are medically 
induced in response to common obesity-associated pregnancy complications, including 
hypertension (Suidan, Apuzzio, & Williams, 2012).  When not induced, obese women are 
more likely than normal weight women to have prolonged pregnancy (≥ 41 weeks or 290 
                                                
1 This section is planned for submission to the Journal of Reproductive Biology and 
Endocrinology, N. Carlson, T. Hernandez, & K. Joseph Hurt. Biological basis of a Labor 
dysfunction in obesity, Journal of Reproductive Biology and Endocrinology. Manuscript 
submitted for publication. 
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days gestation before onset of spontaneous labor) (22.3% risk in normal weight women 
or 30.0% risk in obese and 39.4% risk in morbidly obese women) (Arrowsmith, Wray, & 
Quenby, 2012).  This tendency for prolonged pregnancy is especially concerning because 
the babies of obese women are more likely to die in utero during the third trimester (OR 
2.07 compared to normal weight referent [95% CI 1.59-2.74]) (Chu, Kim, Lau et al., 
2007).  
Once they go into labor, obese women are more likely than normal weight women 
to have abnormally slow progress of cervical dilation (Arrowsmith et al., 2011; Dietz, 
Callaghan, Morrow, & Cogswell, 2005; Fyfe et al., 2011; Poobalan et al., 2009), a 
complication known as labor dystocia (ACOG, 2003). In a multi-site sample of 118,978 
women who labored and had normal outcomes, increasing maternal BMI resulted in a 
dose-dependent slowing of labor (p < .001) (Table 1) (Kominiarek et al., 2011).  Among 
first-time mothers in this study, the median time in labor was 1.2 hours longer between 
the lowest and highest BMI groupings, with morbidly obese women (BMI ≥ 40kg/m2) 
taking more than 7 hours longer than normal weight women to achieve full cervical 
dilation. 
Because they have slow labors, obese women are more likely than normal-weight 
women to be admitted to the hospital at earlier cervical dilations, and to have interventions like 
synthetic oxytocin administration and artificial rupture of membranes (AROM) used by their 
health care providers in the attempt to hasten labor progress (Buhimschi et al., 2004; Carlson & 
Lowe, 2014; Vahratian et al., 2004).  Synthetic oxytocin is the most commonly used clinical 
tool for strengthening and speeding labor. Typically, obese women are given the same 
dosages of synthetic oxytocin as normal-weight women, and expected to make cervical  
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Table 1: Adjusted Duration of Labor in Hours and (95th percentile duration) Between 4-











35.0 - 39.9 
 






birth                                
5.4 (18.2) 5.7 
(18.8) 
 




4.6 (17.5) 4.5 
(17.4) 
4.7 (17.9) 5.0 (19.0) 5.4 (20.6) < .0001 
Note. Adjusted for age, height, race, gestational age, diabetes, induction, augmentation, 
epidural (first stage), operative vaginal delivery, and birthweight. Adapted from 
“Contemporary Labor Patterns: The Impact of Maternal Body Mass Index,” by M. A. 
Kominiarek et al., 2011, American Journal of Obstetrics and Gynecology, 205, p. 
244.e.1-244.e8. 
 
progress in response to these dosages within the same time period as women with normal 
BMI (Arrowsmith et al., 2011).  However, in a prospective clinical trial, obese women 
required higher median doses and duration of synthetic oxytocin (3.5 units over 7.7 hours 
in obese vs. 2.6 units in 6.5 hours in lean women, p < .001) over the course of labor 
(Pevzner et al., 2009).  Even with these higher doses, they were still less likely to achieve 
progressive labor (OR 0.43, 95% CI 0.24-0.78, p = .004).  
Despite exposure to clinical interventions to speed their slow labors, obese women are 
2-3 times more likely than normal weight women to end labor with an unplanned cesarean 
delivery (Chu, Kim, Schmid et al., 2007; Poobalan et al., 2009).  This relationship between 
obesity and unplanned cesarean delivery is true even in studies controlling for co-morbid 
conditions found more frequently among obese women like diabetes, hypertension, and 
macrosomia (Fyfe et al., 2011; Poobalan et al., 2009).  When obese women experience 
cesarean delivery, they are more likely than normal weight women with cesarean to have 
poor maternal outcomes.  Post-operative infection (OR 1.88, [95% CI: 1.09-1.88]) (Leth, 
Uldbjerg, Norgaard, Moller, & Thomsen, 2011), postpartum hemorrhage (32.6% morbidly 
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obese vs. 4.9% normal weight comparison, p = .002), and prolonged hospitalization (34.9% 
morbidly obese vs. 2.3% comparison, p = .0003) are all seen more frequently among women 
having cesarean who are obese (Perlow & Morgan, 1994).  
Targeted intervention strategies are needed to reduce poor birth outcomes among 
obese women. Currently, health care providers of obese women in labor use the same 
medication dosages and protocols used with normal-weight women, despite the fact that 
labor interventions and labor timing are known to be different in the unique systems of 
obese women (Hill, Reed, & Cohen, 2014; Pevzner et al., 2009; Walsh et al., 2011). 
There is a critical need to better understand the biologic mechanisms underlying 
clinically observed effects of obesity on labor. This systematic review explored maternal 
obesity as a mechanism of labor dysfunction, integrating the results of studies from both 
animal and human models showing the effects of obesity on the onset, synchronization, 
and progression of labor.  Discussion is framed within overviews of both human 
parturition biology and obesity pathophysiology.  
Methods 
 In order to explore the primary question of this review: “What biologic 
mechanisms are involved in parturition dysfunction (alterations in labor onset, 
synchronization, and progression) in obesity?” we performed a systematic review of the 
literature (Khan, Kunz, Kleijnen, & Antes, 2003).  The aim of the review was to 
summarize basic science literature on mechanisms of parturition dysfunction in obesity.  
We selected studies for this review on the basis of both content and methodologic quality, 
locating studies via a literature search performed in December, 2014 of electronic 
databases PubMed, Google Scholar, Web of Science, and MEDLINE using the primary 
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medical subject heading (MeSH) search terms: obesity and parturition.  Additional search 
terms included: BMI (or body mass index), uterus, myometrium, dystocia, mechanism 
and dysfunction.  We limited searches to original research with no year limitations in 
order to capture all basic science research in this area.  We also searched reference lists 
from included articles to locate all relevant studies in the area.  After initial screening of 
abstracts, we obtained full-text articles for second-stage screening of content and study 
quality.  Studies located in this systematic review are included in Table 2.   
Overview of Obesity Pathophysiology 
 Our understanding of the metabolic and endocrine changes caused by obesity 
changed significantly in the past 10 years (Stehno-Bittel, 2008). Although obesity was 
once considered a universally unhealthy condition, it is now recognized that 32% of 
obese people appear to be metabolically healthy (Karelis, St-Pierre, Conus, Rabasa-
Lhoret & Poehlman, 2004). In these individuals, and in many other people who are 
simply overweight, adipose tissue protects against the development of harmful 
cardiovascular and endocrine effects (Unger & Scherer, 2010).  Adipose tissue functions 
protectively in two primary ways.  First, adipose tissue acts as a storage reservoir for free 
fatty acids (FFA) (Frayn, 2010), which cause inflammation and cell damage throughout 
the body when allowed to circulate freely (Frayn, 2010).  Second, healthy adipose tissue 
secretes compounds known as adipokines that regulate glucose and lipid metabolism, 
feelings of satiety, adipose storage, and immune regulation (Gualillo, Gonzalez-Juanatey, 
& Lago, 2007; Unger & Scherer, 2010).  The pathophysiology of obesity involves 
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alterations of both FFA storage and levels of circulating molecules, including adipokines, 
insulin and cholesterol.  
FFA storage and metainflammation. When individuals combine high-fat 
dietary intake with decreased energy expenditure, the body’s storage capacity for free 
fatty acids (FFA) in adipocytes is eventually overwhelmed (Frayn, 2010). Initially, cells 
adapt to excess FFA by sequestering it as triglyceride in new adipose cells or in fat 
droplets created in non-adipose tissues (ectopic fat) (Frayn, 2010).  When the body can 
no longer sequester FFA, they circulate freely and are used instead of glucose for cells’ 
metabolic needs (Schrauwen et al., 2010). Within the cell’s mitochondria, metabolism of 
lipids through lipid peroxidation creates reactive oxygen species (ROS) that damage 
cellular components. As increasing amounts of fatty acids are used instead of glucose for 
muscle cells’ metabolic needs, insulin resistance rises, and ROS damage in the cells 
worsens in a process known as lipotoxicity.  Normally, cells can neutralize these ROS 
with cellular antioxidants. When FFAs are too numerous, however, the cell’s native 
antioxidant capacity is overwhelmed and ROS bind to intracellular components leading 
to RNA/DNA damage, protein damage to myofilaments via protein carbonylation, and 
eventual apoptosis (programmed cell death) (Curtis et al., 2012; Demozay et al., 2008). 
There is evidence from work with bladder smooth muscle cells that some individuals 
have genetic variations allowing them to utilize FFA without producing high levels of 
ROS (Mattern et al., 2007). These genetic variations involve forms of peroxisome 
proliferator-activated receptors (PPARs) that are especially able to safely store FFA 
(Jiang et al., 2011). 
           42 
When damaged by FFA, cells release pro-inflammatory mediators, which sets up 
a chronic, low-grade inflammatory response throughout the body known as 
metainflammation (Hotamisligil, 2006; Segovia, Vickers, Gray, & Reynolds, 2014).  
During metainflammation, cells exist in a state of stress, causing them to increase their 
ROS production (Curtis et al., 2012).  Physiologic functioning degrades once 
metainflammation is established in a spiraling process that ultimately results in a cluster 
of symptoms known as metabolic syndrome, including dyslipidemia (increased LDL 
cholesterol, decreased HDL cholesterol, increased triglycerides), atherosclerotic 
cardiovascular disease, liver disease, Type 2 diabetes, raised blood pressure, and 
prothrombotic state (Ervin, 2009; Jung & Choi, 2014).  
Changes in circulating molecules.  Obesity causes profound changes in the 
levels and function of circulating molecules, including adipokines, insulin and 
cholesterol, which contributes to the eventual metabolic dysregulation observed in many 
obese people.   Leptin is an adipokine hormone primarily secreted by white adipose tissue 
that normally increases appetite suppression, adipocyte expansion, and free fatty acid 
oxidation in peripheral organs, along with a host of other effects (Tsai, Davis, & Bryant-
Greenwood, 2014; Unger et al., 2010).  In obesity, lower levels of leptin’s soluble 
receptor are present, resulting in increased secretion of leptin from the hypothalamus 
satiety center and causing abnormally elevated free leptin levels in a situation of “leptin 
resistance” (Tessier, Ferraro, & Gruslin, 2013; Tsai et al., 2014).  Free leptin levels rise in 
a dose-dependent fashion with increases in body mass index (BMI) (Hamed, Zakary, 
Ahmed, & Gamal, 2011), but are unable to exert their normal feedback functions on 
satiety (Tsai et al., 2014).  During pregnancy, leptin is also secreted by the placenta and is 
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thought to be important for fetal growth and development (Tessier et al., 2013; Tsai et al., 
2014).  Leptin serum levels rise to a peak in the 2nd trimester of all women, along with a 
rise in the soluble leptin receptor (Domali & Messinis, 2002).  In the obese pregnant 
woman, leptin serum levels rise to significantly higher levels than in normal weight 
pregnant women (n = 84 women, p = .001), while their levels of soluble leptin receptors 
decrease linearly with BMI (p < .001) (Tsai et al., 2014).  Thus, many obese pregnant 
women develop especially profound levels of leptin resistance. 
Insulin stimulates the uptake of FFA into adipose tissue, thus preventing harm to 
body tissues (Jung & Choi, 2014).  Insulin is also integral for glucose transport, glycogen 
synthesis, and lipogenesis.  Insulin regulates cell growth and survival, promoting the 
differentiation of healthy adipose cells when needed to safely store excess FFA.  In 
muscle cells, glucose is the metabolite of choice for energy needs (Schrauwen et al., 
2010).  However, with a surplus of dietary fat, high plasma FFA, and ectopic fat deposits, 
muscle cells switch to using some lipids for metabolic needs with resulting excessive 
production of ROS.  Widespread cellular damage caused by excess ROS creates insulin 
resistance.  As a result, the muscle cell is unable to efficiently absorb glucose and the 
body is less able to create new adipose storage sights for FFA. 
Insulin resistance is a normal state in pregnancy; levels of observed insulin 
resistance achieved by late pregnancy are comparable to those of a person at the time of 
Type 2 diabetes diagnosis (Catalano, 1994).  Because they start pregnancy with some 
degree of insulin resistance already in place, most obese women are more likely to 
experience the poor downstream effects of insulin resistance like metabolic syndrome 
during pregnancy.  Metabolic syndrome in pregnancy is characterized by whole-body 
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deconditioning and maternal vasculature degradation that increases the risk for 
preeclampsia, gestational diabetes, and other poor maternal outcomes (Horvath, Bodecs, 
Boncz, & Bodis, 2013; Stekkinger et al., 2013). 
Cholesterol is also altered in obesity.  Cholesterol is carried through the body via 
lipoproteins which range in size (Miller, Choi, Fang, & Tsimikas, 2010).  Low-density 
lipoproteins (LDL) transport cholesterol and triglycerides from the liver to cells 
expressing the LDL-receptor.  LDL can also infiltrate the walls of arteries, depositing fats 
there and causing the wall to become thickened and infiltrated with macrophages, leading 
to atherosclerosis (Hansson, 2005).  The size of LDL particles varies, with higher plasma 
levels of triglyceride causing LDL particles to become smaller and denser (LDL-III), thus 
better able to infiltrate artery walls and cause atherosclerotic changes (Watson et al., 
1994).  In obesity, hypercholesterolemia rises with increasing BMI (p < .001), especially 
among females ages 25-39 years (Gostynski et al., 2004).  Perhaps more importantly, 
obese people with higher levels of insulin resistance and plasma triglycerides (i.e. more 
metabolically dysfunctional obesity) show a shift among their LDL molecules to more 
small, dense LDLs (Selby et al., 1993).   
In pregnancy, plasma lipids and lipoproteins increase through each trimester to 
supply necessary nutrients to the fetus.  Obese pregnant women start pregnancy with 
higher plasma triglycerides and LDL than normal weight women, but have equal levels of 
total LDL and total triglycerides by the end of pregnancy (Meyer et al., 2013).  However, 
obese pregnant women exhibit a very different profile of LDLs by their third trimester 
when compared to normal weight women.  In one study of 55 women followed 
longitudinally through pregnancy, the proportion of small, dense LDL was twice as high 
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in obese compared to normal weight women (40.7% of obese women vs. 21.9% of 
normal weight women, p = .014).  Higher proportion of small, dense LDLs in pregnancy 
is associated with gestational diabetes (Rizzo et al., 2008) and ectopic fat deposition 
(Mackay et al., 2012).   
Biology of Parturition 
Human parturition is traditionally understood to have four phases: quiescence, 
preparation, labor, and recovery (Cunningham & Williams, 2010).  Ninety-five percent of 
pregnancy is spent in the first phase of parturition, quiescence.  During the last 6-8 weeks 
of pregnancy, the second phase of parturition begins, during which the cervix and 
myometrial tissues prepare for the onset of labor.  Phase three of parturition includes 
active labor, when uterine contractions synchronize and progressively dilate the cervix 
allowing for delivery of the fetus.  In the fourth and final phase, the uterus and cervix 
remodel themselves in preparation for the return of fertility.  For this review of human 
parturition dysfunction in obesity, we focus on important processes in phases 2 (labor 
preparation) and 3 (labor synchronization and labor progression).  
Labor preparation. Corticotrophin releasing hormone (CRH), normally released 
by the hypothalamus, is also synthesized by the placenta (pCRH) during pregnancy and 
controls the timing and functioning of labor preparation (Cunningham & Williams, 
2010).  Maternal pCRH values rise precipitously during the final 12 weeks of pregnancy, 
preparing the uterine myometrial cells to exhibit increased contractility and response to 
oxytocin, a hormone, which causes stronger and more frequent uterine contractions in 
labor.  Inside the fetal pituitary, pCRH stimulates the release of adrenocorticotropic 
hormone (ACTH), prompting the fetus to secrete cortisol from the adrenal glands.  Fetal 
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cortisol stimulates the release of prostaglandins, hormones that prepare the maternal body 
for labor via cervical ripening and myometrial activation.  Fetal cortisol is also cycled 
back to the placenta, leading to the release of more pCRH (positive feedback loop) and 
estrogen into the maternal system.  Estrogen is an important regulator of labor 
preparation, shifting the balance from uterine quiescence to contractility by increasing the 
ability of myometrial cells to contract in response to key agents of the labor process (i.e. 
oxytocin, prostaglandins) and stimulating the release of oxytocin from the chorio-
decidual tissues (Chibbar, Miller, & Mitchell, 1993).  Thus, pCRH sits at the center of the 
complex coordination between the placenta and fetus required for normal labor 
preparation. 
Before labor can begin, the cervix must remodel to become pliable and ready to 
open when labor pushes the fetal head downward (Cunningham & Williams, 2010).  
Prostaglandins, released by the fetal membranes in response to fetal cortisol, activate the 
cervical tissue to ripen.  Cervical ripening takes place over several weeks prior to labor 
onset, and involves degradation and dispersion of the cervical extracellular collagen 
structure.  Matrix metalloproteases (MMPs) are proteases that assist in this process by 
destroying proteoglycan connectors that bind collagen into tightly-packed bundles (Canty 
& Kadler, 2005). In addition, some cervical cells undergo programmed death, or 
apoptosis, to ripen in preparation for normal labor (Hassan et al., 2006). 
While the cervix prepares for labor by becoming softer and shorter, the amnion 
and chorion fetal membranes directly overlying the maternal cervix also undergo 
morphologic changes in preparation for labor (Reti et al., 2007).  The fused amnion and 
chorion membranes contain the sterile amniotic fluid compartment, which protects the 
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fetus during pregnancy.  Spontaneous rupture of these membranes, causing release of 
amniotic fluid into the vagina, is a normal part of labor.  In late gestation, a series of both 
biochemical and physical events weaken the membranes directly overlying the cervix.  
When compared to other areas of the amniotic sac, these membranes near the cervix 
exhibit increased cellular apoptosis near the time of labor, resulting in degeneration of the 
tissue layers in preparation for easier rupture (Reti et al., 2007). 
Labor synchronization.  Labor is characterized by phasic contractions of the 
uterine smooth muscle myocytes, causing progressive cervical dilation and fetal descent.  
During normal labor, individual myocytes synchronize, creating strong, wave-like 
contractions that start in the fundus (top of the uterus) and move longitudinally down the 
body of the uterus, increasing intra-cavity pressure and resulting in cervical dilation and 
fetal descent (Aslanidi et al., 2011; Buhimschi, 2009).  Myocyte contractions occur when 
actin and phosphorylated myosin interact via cross-bridge cycling (Wray, 2007).  The 
phosphorylation of myosin is initiated by an influx of calcium ions (Ca2+) into the 
intracellular space, primarily via L-type Ca2+ channels, triggered by action potential 
depolarization.  A reversal of these events causes relaxation of the myocyte: Ca2+ efflux 
mechanisms lead to movement of K+ to the extracellular space, and the myocyte is 
subsequently repolarized following a contraction.  Other mechanisms and ions are 
involved in myocyte contractions, and may be reviewed in more detail elsewhere 
(Cunningham & Williams, 2010; Wray, 2007).   
 The synchronization of action potentials between neighboring myocytes for 
rhythmic contractions occurs via several mechanisms.  First, myometrial cells insert 
intercellular pores, or gap junctions, in their plasma membranes during the time period 
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immediately preceding labor (Bru-Mercier, Gullam, Thornton, Blanks, & Shmygol, 
2012).  These low-resistance junctions allow action potentials to move quickly from one 
myocyte cell to the next.  Connexin-43 is the primary intercellular communication pore 
used by myometrial cells (Cluff et al., 2006).  Second, the organization of myocytes into 
bundles synchronizes action potentials for normal uterine contractions.  Myocytes 
contained in a bundle, or fasciculus, are depolarized nearly simultaneously if a strong 
action potential is transmitted nearby. Neighboring fasciculae depolarize only after the 
relatively slow spread of action potentials between bundles of myocytes.  The stronger 
the originating action potential, the more fasciculae are recruited at once, resulting in a 
uterine contraction of higher force and better synchronization (Burdyga, Borisova, 
Burdyga, & Wray, 2009).  Finally, the third mechanism of labor synchronization is the 
oxytocin receptor (OTR).  Oxytocin promotes more frequent and forceful contractions in 
uterine myocytes (Garfield & Beier, 1989).  It is released in a pulsitile manner from the 
posterior pituitary during labor (Fuchs et al., 1991), and exogenous oxytocin 
administration is the current leading treatment for poor labor progress.  Myocytes express 
the OTR at very different levels depending on the stage of labor progression 
(Cunningham & Williams, 2010).  In active phase labor, widespread OTR expression 
allows myocytes to respond synchronously, creating contractions that are forceful and 
frequent.   
 Labor progression.  Once labor begins and synchronizes, successful vaginal 
birth depends on uterine cells having the endurance to continue the work of contraction 
and synchronization until the baby is born and postpartum recovery complete.  The 
squeezing force of contractions periodically occludes blood supply through the uterine 
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wall, thus exposing myometrial cells to intermittent periods of hypoxia (Khan, Matharoo-
Ball, & Shaw, 2010; Wray, 2007).  While contracting, myocytes produce acid and ROS 
(Wray, 2007).  Measurements of myocyte intracellular pH demonstrate waves of 
acidification lagging each uterine contraction during labor (Taggart & Wray, 1993).  
More frequent or strong contractions create more intense intracellular myocyte 
acidifications.  Myocytes contain native pH and ROS regulatory mechanisms to buffer 
these changes, thus maintaining their endurance and allowing them to contract strongly 
and frequently throughout labor.   
Obesity in Pregnancy: Biologic Mechanisms Underlying Dysfunctional Labor 
 Obesity-related changes in biologic mechanisms of labor onset.  Coordination 
between the maternal and fetal systems via the placenta and corticotrophin-releasing 
hormones is integral for labor preparation. We located no studies where investigators 
examined changes in pCRH in obese women or animals.  However, it is logical that even 
small changes in placental function, vascular communication between the placenta and 
the fetus, or the fetal response to pCRH could have dramatic effects on myometrial 
contractility, myometrial response to oxytocin, and maternal/fetal tissue preparation for 
labor via prostaglandin stimulation.  Investigators of several studies found evidence of 
obesity-related alterations in placenta morphology and function (Table 2).  In a 
retrospective analysis of 55,105 pregnant women, placenta weight was positively 
correlated with BMI, as was placental hypertrophy (OR 2.34 [95% CI 2.098-2.63] in 
morbidly obese group) (Wallace, Horgan, & Bhattacharya, 2012).  By contrast, placental 
efficiency in overweight and obese women was reduced (fetal/placental weight ratio 
lower among overweight, obese, and morbidly obese women compared to normal weight 
           50 
and underweight women, p < .001).  In a non-human primate model, animals eating a 
high-fat diet had decreased uterine blood flow through the placenta in the third trimester 
(Frias et al., 2011).  In another study, placentas from obese women (mean BMI = 31.5) 
had decreased nutrient transport (amino acids) compared to normal weight women (mean 
BMI = 22.4) (p =.005) (Farley et al., 2010). Given these widespread changes in placental 
structure and function demonstrated in both human and non-human models of obesity, 
alterations in pCRH and other key regulators of labor preparation and progression are a 
key area for future study. 
 Cervical ripening is another integral process in labor preparation. High levels of 
leptin circulating in the 2nd trimester, such as those found in obese pregnant women, may 
prevent cervical ripening and uterine activation in preparation for labor.  There are two 
mechanisms by which leptin is thought to alter the processes underlying normal cervical 
ripening.  First, leptin disrupts programmed cell death in myometrial cells, a key process 
for both cervical ripening and uterine activation (Wendremaire et al., 2011) (Table 2).  In 
myometrial samples taken from term women having cesarean delivery, exposure to 
different physiologic concentrations of leptin in vitro significantly diminished 
lipopolysaccharide-induced apoptosis (p <.05 to p <.001, dose-dependent with increased 
concentration of leptin).  This finding is important in light of evidence from an earlier 
study where investigators found that samples of cervical tissue taken from term women 
with spontaneous labor had markedly increased expression from genes coding for 
apoptosis processes compared to cervical samples taken from controls who were not in 
labor (Hassan et al., 2006).  Thus, high levels of leptin may delay spontaneous labor by 
suppressing normal apoptosis in the uterine cervix and myometrium. Spontaneous rupture 
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of membranes is another process involved in labor preparation that appears to be 
biologically altered in obesity. As discussed above, leptin suppresses normal apoptosis in 
the uterine cervix and myometrium (Wendremaire et al., 2011).  These anti-apoptosis 
effects may also extent to the amnion/chorion membranes, therefore slowing another 
mechanism of normal labor preparation. 
 Leptin also interferes with labor onset by preventing normal uterine extracellular 
collagen degradation.  In myometrial biopsies taken from term women, leptin blocked the 
action of matrix metalloproteinase (MMP) to degrade collagen (p < .001) (Wendremaire 
et al., 2012; Wendremaire et al., 2013).  As a result, myometrial tissue exposed to leptin 
did not show normal decreases in collagen content, and this effect was more pronounced 
with increased concentrations of leptin. Furthermore, leptin appeared to stimulate 
collagen synthesis, which is normally down regulated in preparation for labor 
(Wendremaire et al., 2012).  Thus, high levels of leptin maintain pre-labor collagen 
amount and formations in pregnant women. Figures 3 and 4 summarize these 
mechanisms of obesity changes in labor onset.  
 Obesity-related changes in biologic mechanisms of labor synchronization.  
In addition to interfering with labor preparation, leptin may also alter labor progression 
by decreasing both spontaneous and synthetic oxytocin-induced uterine contractions.  
Investigators using myometrial strips taken from women having elective cesarean 
delivery who were not in labor showed that leptin exerted a cumulative inhibitory effect 
on the ability of the myometrial tissue to contract spontaneously (contractions inhibited 
by 46.794% ± 5.133%, p < .001) or in response to synthetic oxytocin (42.323% inhibition  
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Figure 3: Conceptualization of pathophysiology leading to labor dystocia in obese 
women, highlighting interaction of demands caused by labor and by lipotoxicity in 
myometrial dysfunction.  GSHPx = Glutatione Peroxidase, one of the myometrial cell’s 
native antioxidants.  FFA = Free Fatty Acids.  ROS = Reactive Oxygen Species.   
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Figure 4: Proposed obesity-related changes in biologic mechanisms of labor onset. 
 
of contractions ± 3.692%, p < .001) (Moynihan et al., 2006) (Table 2).  By contrast, 
Higgins and colleagues found no change in contractility among myometrial cells taken 
from obese women compared to those from normal weight women in a similarly 
conducted in vitro investigation (Higgins et al., 2009). Higgins and colleagues did not 
expose myometrial strips to leptin.  They also did not measure levels of leptin among 
women who provided myometrial samples.  It is possible that these myometrial samples 
came from obese women without high leptin levels, or the cells contracted normally in 
vitro because they were separated from their in vivo environments with loss of circulating 
leptin effect. 
In addition to leptin, cholesterol also has an inhibitory effect on myometrial  
contractility. Exposure to cholesterol and LDL in experiments similar to the leptin 
investigations described above was shown to diminish contractile force and frequency in 
myometrial cells taken from late pregnancy rats, effects that were not alleviated by the 
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subsequent addition of synthetic oxytocin (Smith et al., 2005) (Table 2). When added to 
the perfusate surrounding myometrial cells, cholesterol altered normal contractions by 
decreasing Ca2+ influx, contraction force, amplitude, and frequency in both rat (Smith et 
al., 2005) and human (Zhang, Kendrick et al., 2007) models.  All of these effects reversed 
with the addition of methyl-ß-cyclodextrin (MCD), an agent that removes cholesterol 
from cellular membranes (Shmygol, Noble, & Wray, 2007; Smith et al., 2005; Zhang, 
Kendrick et al., 2007). 
Evidence from cellular communication studies helps explain the etiology of 
altered myocyte contractions seen after exposure to cholesterol.  Cholesterol serves as an 
integral molecule in many cellular biologic reactions, especially those involving plasma 
membrane channels (Dopico, Bukiya, & Singh, 2012).  In eukaryotic cells, cholesterol-
enriched areas of the plasma membrane known as lipid rafts are associated with a 
collection of membrane-spanning channels that facilitate the transfer of numerous 
substances into and out of the cell.  Smooth muscle cells, including myocytes, are rich in 
a particular type of lipid raft, the caveolae, which are altered by cholesterol enrichment 
(Noble, Zhang, & Wray, 2006).  Large-conductance, calcium activated K+ channels 
known as Maxi-K channels tend to cluster on these caveolae, and may be more active 
under conditions of hypercholesterolemia.  When more uterine Maxi-K channels are 
active, myocyte hyperpolarization occurs and new action potentials are more difficult to 
generate, with subsequent decreased propagation to other myocytes (Shmygol et al., 
2007).  Under conditions of hyperpolarization, the myoctye has difficulty triggering the 
massive Ca2+ influx necessary for actin/myosin coupling and subsequent myocyte 
contraction.  Myocyte membrane caveolae are also thought to be associated with both 
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estrogen (Turi, Kiss, & Mullner, 2001) and oxytocin receptors (Klein, Gimpl, & 
Fahrenholz, 1995), but it is unknown if high maternal cholesterol may cause caveolae 
changes leading to decreased levels of these receptors.  
Another biologic mechanism by which obesity may impair labor synchronization 
is through decreased formation of gap junctions between myometrial cells. Research 
performed in a rat model found evidence that animals eating a high fat, high cholesterol 
diet during pregnancy showed a decrease in connexin-43 expression (p = .059) when 
compared to animals eating a regular chow diet (Elmes, Tan, Cheng, Wathes, & 
McMullen, 2011) (Table 2).  Rats were not monitored through labor in this study, so 
uterine contractile implications of the HFHC rats’ decreased connexin-43 expression was 
not measured.  However, in another investigation complimenting this work, uterine 
biopsies taken from women with prolonged labor (n = 7) showed decreased expression of 
connexin-43 mRNAs when compared to women in normal labor (n = 7) (p < .005) (Cluff 
et al., 2006). We did not locate studies for this review comparing connexin-43 expression 
in obese vs. non-obese women, either with and without labor dystocia.  However, if 
women consuming a HFHC diet express fewer Connexin-43 gap junctions near the time 
of labor, their phenotype would match that of women with labor dystocia.   
A final biologic mechanism theoretically causing difficulties in obese women’s 
labor synchronization involves the oxytocin receptor (OTR).  Garabedian and colleagues 
demonstrated decreased OTR mRNA expression in myometrial biopsies taken from term 
women with higher delivery BMIs, (p = .004) (Garabedian, Hansen, Manning, McCord, 
& Curry, 2011) (Table 2).  However, later research by Grotegut and colleagues with 
human myometrial biopsies examining both protein and gene expression of the OTR did 
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not find an association of either with BMI (Grotegut, Gunatilake, Feng, Heine, & Murtha, 
2013).  The Grotegut study was an improvement over the Garabedian study in the 
measurement of both OTR mRNA expression and OTR protein.  However, the Grotegut 
study contrasted from the Garabedian study by including myometrial samples from 
laboring women (over 1/3 of samples) unlike the Garabedian study, which only included 
samples from non-laboring women.  The laboring process is known to up-regulate 
myometrial responsiveness to oxytocin (Garfield & Beier, 1989).  Thus, it is possible that 
laboring obese women in the Grotegut study had already up-regulated their levels of 
OTR, thereby masking associations between maternal obesity and OTR expression in the 
immediate pre-labor time when differences in the expression of OTR could have changed 
labor preparation and/or early labor contractility.  In another investigation, women with 
slow labor progress and later transition to progressive labor exhibited inefficient 
genotypes of OTR when compared to similar women with more efficient labors (Terkawi 
et al., 2012).  It therefore appears that labor progress is demonstrably sensitive to OTR 
expression.  Possibly, obese women who express fewer OTR exhibit slower labor 
progress for this reason.   
How might changes in myometrial contractility observed at the cellular level 
translate to the organ level?  Leptin and cholesterol enrichment of the obese maternal 
environment is postulated to cause relative hyperpolarization of myocytes, thereby 
leading to smaller spontaneous action potentials with insufficient amplitude to recruit 
multiple fasciculae at once.  In an investigation using a mouse model with dysfunctional 
liver X receptor transcription factor (LXRß), which is normally involved in the clearance 
of cholesterol from uterine myocytes, researchers observed the organ-level effects of high 
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myometrial cholesterol (Mouzat et al., 2007) (Table 2).  Mice with non-functional LXRß 
accumulated cholesterol in their myometrial cells and exhibited reduced response to 
synthetic oxytocin (p < .001), and abnormal labors ending in pups stuck in their mothers’ 
uteri.  Uterine contractions can be completely diffused by even small areas of myometrial 
cells engaged in non-synchronous contractile behavior (Aslanidi et al., 2011).  In three-
dimensional computational models of a human late-pregnancy uterus constructed using 
algorithms for known uterine muscle cell excitation, geometry, and cell to cell coupling 
characteristics, researchers demonstrated the complete dispersal of wave-like contractions 
by even small changes in action potential diffusion coefficients.  It is possible that in 
obese women, similar patterns of labor asynchronization are set off by shifts in myocyte 
action potential diffusion characteristics.  These shifts could be caused by the isolated 
action of myocyte hyperpolarization following exposure to high maternal cholesterol or 
leptin, the lowered ability of myocytes in an obese environment to express OTR, or 
decreased myocyte-myocyte linkages via gap junctions like Connexin-43.  Labor 
asynchronization in the obese woman could also result from the synergistic effect of all 
or some of these mechanisms.  Figure 5 summarizes these mechanisms of obesity 
changes in labor synchronization. 
 Obesity-related changes in biologic mechanisms of labor progression. Normal 
labor progression requires myometrial cells to balance the metabolic demands of their 
contractile action in labor (lower intracellular pH, increased ROS production) with 
intermittent hypoxia created when uterine contractions occlude capillary blood flow to 
the myocytes (Taggart & Wray, 1993; Wray, 2007).  No studies to date have investigated 
the effects of dysfunctional obesity on myometrial cellular respiration or endurance in 
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Figure 5: Proposed obesity-related changes in biologic mechanisms of labor 
synchronization. 
 
labor.  However, some research exists on bladder smooth muscle susceptibility to 
lipotoxicity (Hardin et al., 2003).  Investigators using pig bladder in culture demonstrated 
that smooth muscle cells had limited ability to increase their consumption of lipids for 
cellular metabolism.  When exposed to tissue media mimicking an anaerobic physiologic 
environment, these cells could metabolize intracellular lipids, but showed signs of 
switching from a contractile to a proliferative phenotype in response.  
How would myometrial cells perform once they experienced cellular damage 
consistent with lipotoxicity?  Investigators examining the effects of high ROS and low 
pH on in vitro myometrial performance provide clues to this question.  In myometrial 
strips taken at cesarean from laboring women of mixed weights that were exposed in 
vitro to lower pH perfusate (pH shifted from 7.5 to 7.3), contractions became more 
irregular, with reduced amplitude (Quenby, Pierce, Brigham, & Wray, 2004).  In a 
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similarly designed study, investigators showed that myocytes exposed to hydrogen 
peroxide, mimicking the cellular circumstance of high ROS exposure, also exhibited 
reduced contractility (maximal reduction of 27.2 ± 4.2% compared to control), even 
when stimulated with synthetic oxytocin (Warren, Matharoo-Ball, Shaw, & Khan, 2005).  
These myometrial cells were later exposed to an enzymatic scavenging antioxidant, 
catalase (CAT), causing contractions to return.  Authors of this study concluded that 
human myometrial cells are susceptible to the effects of ROS, likely through ROS 
damage to their lipid bilayers resulting in disrupted signaling networks.  
Myometrial mitochondria sit at the center of mechanisms influencing labor 
progression through myocyte endurance.  When mitochondria work to provide energy for 
the myocyte, pH lowers and ROS is produced.  Interfering with mitochondrial function 
via a variety of agents decreases contractile frequency (Gravina et al., 2010).  The ROS 
produced by normally contracting myocyte mitochondria is neutralized by Glutatione 
Peroxidase (GSHPx), one of the myometrial cell’s native antioxidants (Khan et al., 2010).  
Although normally reduced in labor, most women retain enough GSHPx function to 
balance ROS levels in their myocytes.  Possibly, obese women exhibit slow labor 
progression because their myocyte mitochondria, already burdened by lipotoxicity-
related excess ROS, create additional ROS during labor, causing damage of the lipid 
bilayers and myofilaments, thus reducing the cell’s ability to contract.  Two recent 
studies examined the effect of obesity on mitochondrial function in human placentas and 
rat myometrium.  In the study using human tissue, placentas taken from women with 
higher pre-pregnancy BMIs showed evidence of higher ROS levels, lower mitochondrial 
ATP generation, reduced mitochondrial respiration, and abnormal metabolic flexibility 
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(Mele, Muralimanoharan, Maloyan, & Myatt, 2014) (Table 2).  By contrast, mitochondria 
in myometrial tissue of pregnant rats fed a high-fat, low-carbohydrate diet or a low-fat, 
high-carbohydrate diet did not differ in maximal oxygen consumption, phosphate/oxygen 
ratio, or the amount of mitochondria per gram of myometrial tissue compared to matched 
control rats fed a regular chow diet (Gam, Mortensen, Qvortrup, Damm, & Quistorff, 
2014).  It is unknown how human myometrial tissue taken from obese women might 
differ from that taken from normal weight women in mitochondrial performance.  
At the organ level, poor contractile performance is associated with an 
accumulation of cellular metabolites.  In one of the first studies to shed light on the 
pathophysiology of labor dystocia, Quenby and colleagues demonstrated that women 
experiencing slow labor had reduced oxygen saturation, reduced capillary pH (pH 7.35 in 
dysfunctional labor vs. 7.48 normal spontaneously laboring, p < .001), and increased 
lactate in their myometrium when compared to normally laboring controls (Quenby et al., 
2004).  The investigators theorized that lower pH and increased ROS in these women 
caused their contractions to become unorganized and weak, and that individual women’s 
differing abilities to buffer pH and neutralize ROS damage might predict their risk for 
labor dystocia. Figure 6 summarizes the above findings in a combined model of obese 
pathophysiology in labor progression.  
Therapeutic Targets 
Changes in the biologic functioning of labor onset, synchronization and 
progression reviewed here suggest avenues for future therapeutic targets with obese 
women.  Obese women in labor might benefit from additional time to labor:  intrapartum 
management allowing for more time in labor decreased the risk of unplanned cesarean for  
           61 
 
Figure 6.  Proposed biologic effects of obesity on labor progression. 
 
the indication of labor dystocia among obese women when compared to national average 
cesarean rates (Kaiser & Kirby, 2001).  Obese women might also benefit from different 
dosing schedules for synthetic oxytocin.  Two studies comparing the synthetic  
oxytocin infusions of obese and normal weight women showed that obese women 
required 50% more synthetic oxytocin to achieve the same cervical progression (Hill et 
al., 2014; Nuthalapaty, Rouse, & Owen, 2004).  
Statin drugs have been used to lower cholesterol levels in non-pregnant 
populations for years, but traditionally have not been used among pregnant women for 
fear of causing congenital anomalies (Morton & Thangaratinam, 2013).  However, a 
recent meta-analysis did not find an increased rate of major congenital anomalies among 
pregnant women exposed to statins during their pregnancy.  No studies have been done to 
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examine the effect of statin use on the labor progress in either obese or non-obese women 
with hypercholesterolemia.  It is also unknown if other medications used to decrease 
cholesterol like niacin and bile acid sequestrants might have effects on labor progression.   
Vitamin D is one example of an anti-oxidant that has been shown in clinical trials 
to significantly decrease biomarkers of oxidative stress (Asemi, Samimi, Tabassi, 
Shakeri, & Esmaillzadeh, 2013). Interestingly, levels of serum vitamin D are inversely 
related to both visceral and subcutaneous fat and insulin resistance; thus, obese women 
have decreased vitamin D bioavailability when compared to normal BMI women (Cheng 
et al., 2010). Supplementation of vitamin D during pregnancy is controversial, but may 
be especially indicated in an environment of decreased bioavailability, as in many obese 
women.  Supplementation with other anti-oxidants in obese women’s pregnancy like 
Vitamin C, E, and DHA/EPAs, are also targets for future investigations.  
Peroxisome proliferator-activated receptors (PPARs) allow for the safe storage of 
FFA and resulting decrease in insulin resistance and cellular ROS damage (Jiang et al., 
2011).  Thiazolidinedione drug therapy (TZD) is known to activate PPAR systems, thus 
increasing insulin sensitivity and helping cells to trap FFA and better utilize glucose for 
cellular energy needs. It is unknown if TZD treatment during pregnancy in obese women 
may improve labor function by decreasing myometrial ROS damage.  TZD drugs are 
classified pregnancy category C, are known to cross the placenta, and little data are 
available on their safety in pregnancy. Finally, metainflammation may be another target 
for intervention in pregnant obese women.  Aspirin is an anti-inflammatory medication, 
and was recently shown in a 2012 meta-analysis of five randomized controlled trials 
(total N = 556 women) to be effective in pregnancy for reducing severe preeclampsia by 
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78%  (RR 0.22 [95% CI: 0.08-0.57]) if started prior to 16 weeks (Roberge et al.).  Early 
use of aspirin in obese women for the prevention labor dysfunction is another area for 
future study. 
Conclusions 
 In this review, we summarized evidence of changes in labor onset, progression, 
and synchronization with maternal obesity. In a theoretical model of successful human 
parturition, the Modular Accumulation of Physical Systems (MAPS), labor occurs as a 
result of “integrative and synergistic coordination” of separate biological processes or 
modules, occurring across a diverse range of tissues (Mitchell & Taggart, 2009).  The 
MAPS model suggests that the degree of labor dysfunction in any woman depends on the 
number of modules malfunctioning during a particular pregnancy. In the obese woman, 
labor dystocia could be the accumulated result of multiple malfunctioning parturition 
modules including: dysfunctional cervical ripening and amnion/chorion weakening, 
placental alterations, decreased action potential creation and propagation, decreased 
myometrial gap junction and oxytocin receptor expression, and myometrial ROS damage. 
With better information on the multiple mechanisms at work in lipotoxicity of 
myometrial smooth muscle cells and the larger organ systems of obese women, new 
techniques and medications for optimizing myometrial performance might be developed, 
thereby reducing the risk of poor obstetric outcomes in this population. 
Behavioral Determinants:  Technologic-Driven Package of Labor Management in 
Obese Women 
 Recent studies on the phenomenon of unplanned cesarean delivery among obese 
women reveal that although there does appear to be some biological slowing of labor 
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among these women, the behavioral determinant of intrapartum provider decision-making 
is also implicated in the outcomes of obese women’s labors (Abenhaim & Benjamin, 
2011; Ehrenberg, 2011; Fyfe et al., 2011).  Investigators have found substantial regional 
variation in the use of unplanned cesarean delivery among similar populations of women, 
with labor dystocia rates being the cause of most of this variation (Hanley, Janssen, & 
Greyson, 2010; Olatunbosun, Ravichander, Turnell, & Edouard, 2002).  In a chart review 
done by a panel of providers examining 290 primary cesarean deliveries during a 12 
month period in Canada, 23% were deemed preventable, and over half of those 
preventable cesareans were done for the indication of labor dystocia (Olatunbosun et al., 
2002).   
 In another study out of Canada, analysis of 116,839 women’s labors revealed 
substantial regional variation in the use of unplanned cesarean delivery, with the labor 
dystocia rate varying nearly five-fold across different regions (Hanley et al., 2010).  
When medical co-morbidities including diabetes, preeclampsia, and gestational diabetes 
were controlled for in a group of obese women, differences in the use of intrapartum 
interventions like synthetic oxytocin administration, epidural anesthesia, and early 
hospital admission were found to explain much of the association between obesity and 
unplanned cesarean delivery (Abenhaim & Benjamin, 2011).  Much of the recent 
literature on unplanned cesarean delivery in obese women calls for the investigation of 
intrapartum provider decision-making patterns that might influence labor progression and 
increase the chance for unplanned cesarean delivery (Ehrenberg, 2011; Fyfe et al., 2011; 
Sheiner et al., 2004; Vahratian et al., 2005).  Authors of these investigations cite a lack of 
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studies in the area of management factors, despite association of specific labor 
interventions with increased risk of labor dystocia and unplanned cesarean delivery.    
  The labor management of women in the United States typically includes many 
technologic interventions.  In the most recent Listening to Mothers survey of 2,400 U.S. 
women, synthetic oxytocin was used in 50% of women’s labors, AROM was performed 
in 36% of the women’s labors, epidural anesthesia was used in 67% of women’s labors, 
and induction in 41% of women’s labors (Declercq, Sakala, Corry, Applebaum, & 
Herrlich, 2013). Once obese women are in labor, they are held to a standardized expectation 
of regular cervical dilation at a rate of at least 1cm/hr based on analyses of labor progress in 
mixed-weight women performed in the 1950’s (Friedman, 1954).  This practice exists despite 
the fact that more recent evidence shows that many women, including obese women, dilate 
much more slowly.  In a sample of mixed-weight nulliparous women, over 40 percent were 
found to have cervical dilations in active labor that were slower than 1 cm/hr (Blackwell et al., 
2008).  In an integrative review of the literature on cervical dilation rates in mixed-weight 
nulliparous women, the slowest-yet-normal rate of cervical dilation was identified as 0.5 cm/hr 
(Neal, Lowe, Ahijevych et al., 2010).  Strict labor progression timelines have been found, even 
in mixed-weight groups of women, to be associated with higher rates of technologic labor 
intervention and unplanned cesarean (Lavender, Hart, & Smyth, 2012; Leeman & Leeman, 
2003).   
 Because they have labors that proceed more slowly than normal-weight women, obese 
women are more likely to be admitted to the hospital at earlier cervical dilations, and then to 
have their labors augmented with synthetic oxytocin or AROM (Buhimschi et al., 2004; 
Vahratian et al., 2004).  It is unclear if these earlier hospital admissions among obese women 
           66 
are the result of contractions that are painful despite the fact that they do not efficiently change 
cervical dilations or if the management of laboring women involves hospital admission in early 
labor irrespective of woman’s perceived pain with early contractions.  Early admission in labor 
(admission prior to the onset of active labor contractions and cervical dilation to at least 4cm in 
nulliparous women) was found in a prospective cohort study to be associated with increased 
risk for cesarean delivery (Jackson, 2003) and in a randomized controlled trial to increased use 
of epidural analgesia and synthetic oxytocin (McNiven et al., 1998).   
 As mentioned above, synthetic oxytocin augmentation is more likely to fail in obese 
women when compared to normal-weight women who are augmented (Usha-Kiran et al., 
2005).  Standardized synthetic oxytocin augmentation dosages corrected for maternal BMI are 
not currently known, although several studies have found that obese women required longer 
administration times and larger dosages when compared to normal-weight women 
(Nuthalapaty et al., 2004; Pevzner et al., 2009; Walsh et al., 2011). In a labor induction study 
by Pevzner and colleagues, obese women who achieved vaginal birth required a median 0.9 
additional units of synthetic oxytocin when compared to normal weight women, infused over 
an additional 1.2 hours.  Morbidly obese women required even more time and higher total 
doses before achieving vaginal delivery (+2.5 units, +2 hours when compared to normal-weight 
women) (Pevzner et al., 2009).  
 AROM is frequently used as an intrapartum intervention to speed the labors of laboring 
women.  In a Cochrane systematic review of the literature analyzing 5,583 women’s labors, 
AROM was found to carry a trend toward increased risk of cesarean delivery (RR 1.27, 95% CI 
[0.99-1.63]) with no statistical difference in the length of first stage labor on a mixed-weight 
sample of women (Mean Difference -20.43 min, 95% CI [-95.93 to 55.06]), even in cases of 
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prolonged labor (Smyth et al., 2013).  No studies to date have examined the use of AROM in 
the labors of obese women.   
 Higher BMI categories are also known to be associated with higher epidural use 
(Abenhaim & Benjamin, 2011), with unknown effect on the unique labor of an obese woman.  
In contrast to earlier studies showing no increased risk of cesarean delivery associated with 
epidural anesthesia, a more recent analysis of a multi-site, prospective cohort study on a mixed-
weight sample of 2,052 women found that epidural use carried a RR of 2.5, 95% CI [1.8, 3.4] 
for operative vaginal delivery and a RR of 2.4, 95% CI [0.6, 5.3] for cesarean delivery in 
nulliparous women (Nguyen et al., 2009), although there was no sub-analysis of this effect by 
BMI.   
 The proposed research will focus on intrapartum management of obese women, as 
demonstrated by the timing and choices of technologic interventions used in the labors of 
obese women, including admission to the hospital, epidural, synthetic oxytocin 
augmentation, AROM, and unplanned cesarean delivery.  The following manuscript, co-
authored by myself and Dr. Nancy Lowe, was published in January 2014 by the Journal 
of Midwifery and Women’s Health, and summarizes the findings of a systematic review 
of the literature on the use of intrapartum interventions in healthy, nulliparous obese 
women.2    
Intrapartum Management Associated with Obesity in Nulliparous Women 
The United States is in the midst of an obesity epidemic, with nearly two-thirds of 
U.S. women of childbearing age being either overweight (Body Mass Index [BMI] = 25-
                                                
2 This section was published with permission from the Journal of Midwifery & Women’s 
Health. N. Carlson & N. K. Lowe, 2014, Intrapartum management associated with 
obesity in nulliparous women, Journal of Midwifery & Women’s Health 59, 43-53. doi: 
10.111/jmwh.12073. 
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29.9kg/m2) or obese (BMI ≥ 30kg/m2) (Vahratian, 2008). This obesity epidemic has 
developed quickly over the past twenty years, resulting in a very different BMI mix of 
women becoming pregnant now than in the near past (CDC, 2012). The purpose of this 
systematic review was to examine evidence on the use of intrapartum interventions in 
healthy, nulliparous, obese women.   
 Clinical investigators have shown that obese women are at increased risk for 
unplanned cesarean delivery when compared to normal-weight women, thus contributing 
disproportionately to the nationwide cesarean rate (Barau et al., 2006; Briese, Voigt, 
Wisser, Borchardt, & Straube, 2010; J. Crane, White, Hutchens, Burrage, & Murphy, 
2007; S. S. Crane et al., 1997; Dietz et al., 2005; Kominiarek et al., 2010; Poobalan et al., 
2009). The United States has seen a dramatic increase of over 60% in the nation’s 
cesarean delivery rate since 1996 (Menacker & Hamilton, 2010). Currently, the United 
States’ cesarean rate is at an all-time high of 32.8% (Hamilton, Martin, & Ventura, 2011). 
When obese women have cesarean delivery, they are more likely than their normal-weight 
counterparts to experience significant morbidity and mortality following birth (Grundy et al., 
2008; Myles et al., 2002; Sebire et al., 2001; Silver et al., 2006). Post-operative infection, 
clotting disorders, postpartum hemorrhage, and prolonged hospitalization have all been found 
to occur more frequently after cesarean delivery among obese women when compared to 
normal weight women. Up to a third of maternal deaths in pregnancy are associated with 
obesity complications, (Grundy et al., 2008) a statistic that is of key importance in the United 
States, where the national maternity mortality rate is on the rise and currently ranks 48th in the 
world (WHO, 2012). 
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 Nulliparous obese women are at the highest risk for unplanned cesarean delivery. 
In a 2008 meta-analysis of 11 studies, Poobalan et al found that nulliparous obese 
women’s risk of unplanned cesarean delivery was more than double that of normal 
weight women (OR 2.26, 95% CI 2.04 to 2.51) while morbidly obese (BMI > 35 kg/m2) 
women’s risk was more than triple that of normal weight women (OR 3.38 95% CI 2.49 
to 4.57) (Poobalan et al., 2009). Nulliparous obese women are at highest risk for 
unplanned cesarean delivery in part because they are induced more frequently than 
multiparous obese women (Kominiarek et al., 2011), and are more likely to fail induction 
(Wolfe, Rossi, & Warshak, 2011).  However, the primary reason that obese, nulliparous 
women are at highest risk for unplanned cesarean delivery and intrapartum interventions 
to speed labor is slow labor progress.  In a large, multicenter study of contemporary labor 
practices from 2011, nulliparous women with BMI < 25 kg/m2 completed labor 2 hours 
faster than obese women and nearly 4 hours faster than morbidly obese women (BMI > 
40 kg/m2) (Kominiarek et al., 2011).  Moreover, obese nulliparous women were found to 
lack an acceleration of cervical progress in the active phase of labor (Cedergren, 2009).   
 Abnormally slow progress in labor is known as labor dystocia (Gifford et al., 2000). 
Labor dystocia was last defined by American College of Obstetricians and Gynecologists in 
2003 as “an abnormal labor that results from …abnormalities of the power, the passenger, or 
the passage” after “women…enter the active phase when cervical dilation is between 3 cm and 
4cm” (ACOG, 2003, p. 1445).  Although labor dystocia among obese women was initially 
thought to be caused by soft-tissue obstruction (abnormality of “passage”) in late labor 
and at birth, (S. S. Crane et al., 1997) recent studies have found that obese women’s 
labors are slower during the first stage, from 4 to 10 centimeters of cervical dilation (Fyfe 
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et al., 2011; Kjaergaard et al., 2008; Kominiarek et al., 2011; Vahratian et al., 2004). 
Once obese women reach the second stage of labor, the vaginal birth rate for them is the 
same as it is for normal-weight women (Buhimschi et al., 2004; Robinson et al., 2011).  
Obese women are more likely than normal-weight women to have slightly larger babies 
(abnormality of “passenger”), yet in studies that have controlled for maternal diabetes, 
the higher fetal weights were not associated with additional diagnoses of labor 
arrest/slowing (Verdiales et al., 2009; Zhang, Bricker et al., 2007). Thus, labor dystocia 
in the obese woman appears to be primarily related to abnormalities in “power,” or 
myometrial dysfunction, in the active phase of labor.  Investigators suggest that some 
physiology in the pregnant obese women’s system causes her myometrial cells to contract 
with less efficiency than is found in normal-weight women, during the active phase of 
labor (Moynihan et al., 2006; Smith et al., 2005; Zhang, Kendrick et al., 2007). 
 Standard intrapartum management practices may compound the problem of 
slower labors.  In a recent Canadian retrospective cohort study (n = 11,922) by Abenhaim 
et al that controlled for co-morbidities including diabetes, preeclampsia, and gestational 
diabetes, increased use of intrapartum interventions such as induction of labor, early labor 
hospital admission, synthetic oxytocin administration, epidural anesthesia, and decreased 
use of assisted vaginal delivery were found to explain much of the association between 
obesity and unplanned cesarean delivery (Abenhaim & Benjamin, 2011). Recent 
literature on the problem of unplanned cesarean delivery among obese women includes 
calls by investigators for future studies of intrapartum provider decision-making patterns 
that might influence labor progression and increase the likelihood of cesarean delivery 
(Ehrenberg, 2011; Fyfe et al., 2011; Sheiner et al., 2004; Vahratian et al., 2005). 
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 However, investigations of intrapartum intervention use in obese women have had 
conflicting results. Two prospective cohort studies conducted prior to the Abenhaim 
study did not find evidence of increased epidural usage by obese women (Sarkar et al., 
2007; Vahratian et al., 2004) and investigators of several studies have not found 
decreased use of assisted vaginal delivery among obese women (Beyer, Amari, Lüdders, 
Diedrich, & Weichert, 2011; Bhattacharya, Campbell, Liston, & Bhattacharya, 2007; 
Buhimschi et al., 2004; Jensen, Agger, & Rasmussen, 1999; Vahratian et al., 2005; 
Vahratian et al., 2004; Voldner, Frøslie, Haakstad, Bø, & Henriksen, 2009; J. Walsh et 
al., 2011). 
 Complicating the interpretation of findings from these and other studies on 
intrapartum management in obese women are differing study methods, sampling 
exclusions, and analyses. Both gestational diabetes and preeclampsia are found more 
frequently in obese women, in a dose-dependent relationship with maternal BMI 
(Abenhaim & Benjamin, 2011; Bhattacharya et al., 2007; Vahratian et al., 2005). When 
obese women have preeclampsia, they are significantly more likely to undergo induction 
of labor compared to other obese women without preeclampsia (Suidan et al., 2012). 
While co-morbidities, such as gestational diabetes and preeclampsia, were controlled in 
some studies, in others they were not. 
 Induction of labor is more likely to fail when used with obese women, and is used 
more often among obese women (Arrowsmith et al., 2011; Gauthier et al., 2011; Wolfe et 
al., 2011).  In a 2011 retrospective analysis of cervical ripening success, 53.7% of obese 
women failed cervical prostaglandin ripening compared to 34.2% (p = 0.0018) of normal 
weight women following the initial attempt at cervical ripening (Gauthier et al., 2011). In 
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a retrospective population cohort study of 80,887 women, women with BMI ≥ 40 kg/m2 
had a 29% risk of failed induction compared to a 13% rate among normal weight women 
(OR 2.73, 95% CI 2.53-2.96) (Wolfe et al., 2011).  Therefore, if obese women are more 
likely to be induced, they are also more likely to have unplanned cesarean delivery 
secondary to failed induction.   
 Maternal obesity was an independent risk factor for unplanned cesarean delivery 
in a study that excluded all women with diabetic and hypertensive complications (Sheiner 
et al., 2004) and in a meta-analysis of 11 studies on unplanned cesarean delivery in obese 
women that adjusted for preeclampsia and diabetes (Poobalan et al., 2009).  However, we 
found no systematic review of studies examining the association between obesity and 
other intrapartum interventions that controlled for medical co-morbidities.  Findings of  
studies focusing on the use of intrapartum interventions in obese women also are 
confounded by the lack of standardized sampling exclusions.  Some studies included both 
nulliparous and multiparous women, others limited to nulliparous women, and others 
controlled for parity via statistical analysis.  The purpose of this article is to report the 
findings of a systematic review of studies that had similar exclusions and control of 
confounding factors, which investigated intrapartum management in healthy, obese 
nulliparous women.   
Methods 
We focused this systematic review on the question: “What intrapartum 
management is associated with maternal obesity in healthy, nulliparous women?”  
Specifically, we were interested in intrapartum interventions performed prior to birth 
among these women.  Intrapartum management includes medical and surgical 
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interventions performed in the intrapartum period (from onset of labor or initiation of 
induction until birth via cesarean or vaginal delivery).  Although comfort measures (i.e. 
massage, hydrotherapy, repositioning, warm/ice packs, etc.) are also part of intrapartum 
management, no studies were found examining the use of these measures in healthy 
nulliparous obese women.  We also found no studies with data on intrapartum 
psychological support measures in obese women.  We excluded studies that only 
analyzed cesarean delivery because several meta-analyses of cesarean’s use in obese 
women have been published (Chu, Kim, Schmid et al., 2007; Poobalan et al., 2009). 
Although included studies may have examined the use of cesarean delivery, they also 
analyzed either the use of unplanned cesarean for different indications (Cedergren, 2009) 
or the use of other intrapartum interventions in addition to cesarean delivery.  Further, if 
the study included analysis of cesarean delivery in obese women, the analysis was limited 
to unplanned cesarean delivery (i.e. cesarean delivery done after trial of labor).  
Therefore, inclusion criteria for this review were:  investigations on the use of 
intrapartum interventions, including but not limited to unplanned cesarean, in healthy, 
nulliparous obese women compared to a normal weight referent. If included studies did 
not limit their sample to nulliparous women, they had to either provide a separate 
analysis for nulliparous women or adjust for parity in the analysis.   
Health in a nulliparous obese woman was defined as a lack of preeclampsia.  
Ideally, a sample of healthy nulliparous obese women would also exclude women with 
gestational diabetes, pre-existing diabetes and pre-existing hypertension, or control for 
these co-morbidities in an adjusted analysis.  However, gestational diabetes, pre-existing 
diabetes, and pre-existing hypertension were allowed in the studies included in this 
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review with the rationale that in the Suidan et al. (2012) study of obesity and co-
morbidities, while preeclampsia accounted for 44.7% of the indications for induction of 
labor in the group of obese women with co-morbidities, other co-morbidities each 
accounted for significantly less of the indications for induction of labor (gestational 
diabetes 2.6% of the indications, chronic hypertension 2.6%) (Suidan et al., 2012).  If a 
study did not include controls for preeclampsia, either in subject exclusion or in adjusted 
analysis, the study could only be included in this review if it instead controlled for 
induction of labor statistically.  Controlling for induction of labor would have the effect 
of excluding many of the more severe cases of preeclampsia (Suidan et al., 2012). 
A literature search was conducted using Pubmed, CINAHL, EBSCO, Google 
Scholar and MEDLINE databases in August 2012.  A university research librarian 
conducted a second literature search for comparison, and the results of the two 
independent searches were combined.  Pubmed, CINAHL, EBSCO and MEDLINE 
databases were chosen to capture relevant nursing and medical literature.  Google Scholar 
was used to help locate dissertation, conference proceedings, and book entries.  Primary 
MeSH search terms included: obese, obesity, BMI, body mass index, body weight, 
nulliparous, parity.  Primary search terms were cross-searched against secondary MESH 
search terms including: management, intrapartum management, cesarean birth, cesarean 
section, and unplanned cesarean.  In addition, some publications were identified from the 
reference lists of pertinent articles.     
Due to substantive changes in practice and the scope of obesity among 
childbearing women, publications prior to 1995 were excluded because of limited 
relevance to today’s clinical environment.  Searches were limited to human subjects, 
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original research, and English language.  Maternal age and the study’s country were not 
restricted. Although publications from peer-reviewed journals were acceptable for 
inclusion, none were located that met other search criteria.   
Our initial search produced 266 articles (Figure 7).  These articles were reviewed 
in abstract form against inclusion criteria and culled to 98 articles.  Articles were 
excluded for being off-topic, including articles that contained no information on 
intrapartum management, did not include obese samples, were on non-human 
populations, were not English language, or were not original research.  Full-text copies of 
the remaining 98 articles were obtained through online proxies or library reserve and 
analyzed again for eligibility.  We eliminated 90 articles because they did not include 
intrapartum management (n = 33), did not include obese populations (n = 12), were not 
available in full-text (n = 5), did not control for either preeclampsia or induction (n = 8), 
did not provide separate analysis for nulliparous women (n = 7) or were off-topic (n = 
25).  The remaining 8 publications were included in the review.  
All studies were assessed for methodological quality using the Newcastle-Ottawa 
Scale (NOS) (Wells et al., 2012).  This scale was developed to assess the quality of non-
randomized studies, and involves the use of a star system to judge each study for the 
selection of study groups, the comparability of groups, and the method for assessing 
outcome of interest.  The NOS has well supported content validity and inter-rater 
reliability, and has been used in many analyses of non-randomized studies.  The NOS has  
a maximum score of 9 stars.  For the purposes of this review, studies scoring ≥ 6 stars 
were assessed as high quality. 
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Figure 7:  Flow chart describing literature extraction process for Behavioral Review of 
Intrapartum Managements Associated with Obesity. Adapted from “Intrapartum 
management associated with obesity in nulliparous women,” by N. Carlson, and N. K. 
Lowe, 2014, Journal of Midwifery & Women’s Health, 59, p. 46. Copyright 2013 by The 
Journal of Midwifery & Women’s Health. 
 
Results 
Among the eight studies, four were conducted in the United States with the 
remaining studies conducted in Canada, Australia, the United Kingdom, and Sweden. 
Investigators examined a variety of medical and surgical interventions used in the labors 
of nulliparous obese women but none included psychological support interventions or 
199 records identied 
through database 
searching
67 additional records 
identied through other 
sources
266 records after duplicates removed
266 records 
screened
168 records excluded as 
off-topic
98 full-text articles assessed for 
eligibility
90 full-text articles 
excluded:
n=25 off topic
n=33 no intrapartum info
n=5 no full text
n=12 no obese women
n=8 included PIH or IOL
n=7 no info on nulliparous





















From:  Moher D, Liberati A, Altman DG, The PRISMA Group (2009).  Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses:  The PRISMA Statement.  PLoS Med 6(6): e1000097, doi:
10.1371/journal.pmed1000097
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comfort measures for obese women in labor.  Although investigators of five of the 
included studies limited their study population to nulliparous women, results in the 
remaining three studies either presented results separately for nulliparous women (Jensen 
et al., 1999) or the results were adjusted for parity (Abenhaim & Benjamin, 2011; 
Sukalich, Mingione & Glantz, 2006).  Among the included studies, a total of 364,771 
women were included for analyses.   
All of the studies included in this review scored 6-8 stars on the NOS (high 
quality).  All except one (Vahratian et al., 2005) were retrospective cohort or case-control 
studies.  The remaining study was a secondary analysis of a prospective study performed 
in North Carolina (Vahratian et al., 2005).  All but one (Jensen et al., 1999) of the studies 
were published since 2005, and all but two (Abenhaim & Benjamin, 2011; Bhattacharya 
et al., 2007) included data from women who delivered over the course of 4-5 years.  The 
Abenhaim et al study included data from Canadian women who birthed over a 10-year 
period at one regional hospital (Abenhaim & Benjamin, 2011), and the Bhattacharya et al 
study included data from over a 29-year period (Bhattacharya et al., 2007).  Results on 
the use of intrapartum interventions in the Bhattacharya et al study were adjusted for year  
of delivery to control for changes in intrapartum practice that may have taken place over 
this period.   
Investigators in the included studies operationalized obesity somewhat differently 
(Table 3).  In three studies (Abenhaim & Benjamin, 2011; Cedergren, 2009; Garabedian, 
Williams, Pearce, Lain, & Hansen, 2011), investigators classified normal BMI as 20-24.9 
kg/m2, obesity as a BMI 30-39.9 kg/m2, and morbid obesity as BMI ≥ 40 in keeping with 
World Health Organization criteria (Gostynski et al., 2004).  In other studies, 
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investigators collapsed these categories to include morbidly obese women (Jensen et al., 
1999; Sukalich et al., 2006; Vahratian et al., 2005) and some overweight women 
(Sukalich et al., 2006) with the group of obese women, or counted some obese women as 
morbidly obese (Bhattacharya et al., 2007). Normal BMI categories of women were also 
different from study to study, with four studies including underweight women in the 
group of women with ‘normal’ BMIs (Garabedian, Williams et al., 2011; Green & 
Shaker, 2011; Sukalich et al., 2006; Vahratian et al., 2005).  This confusion of obesity 
categories made comparisons of results from these studies problematic.  Odds ratios of 
intrapartum intervention use in obese groups of women were computed using the normal 
BMI group of women as the referent.  
Complicating the issue of participant grouping was the calculation of BMI at 
different times (Table 4) (Abenhaim & Benjamin, 2011).  In 7 of the 8 studies, pre-
pregnancy or initial booking weight and height were used to calculate BMI (Table 4).  
Pre-pregnant weight came from prenatal records at first prenatal visit or from women’s 
recall of their pre-conception weight, a method that is cited by several investigators as 
consistent with actual measurements of pre-pregnant weight (Lederman & Paxton, 1998). 
Maternal height and weight at the time of birth were used for BMI calculations in the 
remaining study (Abenhaim & Benjamin, 2011), thereby including both pre-pregnancy 
and gestational weight gain/loss in BMI calculations.  Only two studies controlled for 
maternal height in their analyses of intrapartum intervention use in healthy, nulliparous 
obese women (Bhattacharya et al., 2007; Vahratian et al., 2005). 
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Table 3: Studies Included in the Behavioral Review of Intrapartum Interventions 



















N = 224 nullips 
 
Retro cohort BMI @ 
booking 
Normal = 18.5-25 
Obese > 35 











Normal = 18.5-24.9 
Overweight = 25.0-
29.9 
Obese I = 30.0-34.9 
Obese II = 35.0-39.9 
Obese III = 40.0-49.9 







Gestational age @ 
delivery 









N = 11,922* 
Retro cohort BMI @ birth Normal = 20-24.9 
Overweight = 25-
29.9 
Obese = 30-39.9 





DM or GDM 
IOL (in CD calc) 
Birth weight 









BMI @ first 
booking 
Normal = 20-24.9 
Overweight = 25-
29.9 
Obese I = 30-34.9 
Obese II = 35-39.9 














Normal = 20.24.9 
Overweight = 25-
29.9 
Obese = 30-34.9 
Morbid Obese ≥ 35 
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Normal = 18.5-24.9 
Obese ≥ 25 
TWG 

















Normal = 19.8-26.0 
Overweight = 26.1-
29.0 

















Normal = 20.0-24.9 
Overweight = 25.0-
29.9 




Note. *Although sample included multiparous women, results are reported adjusting for 
parity. **Although sample included multiparous women, separate analysis provided for 
nulliparous participants. BMI = Body Mass Index. IOL = Induction of Labor. TWG = 
Total gestational Weight Gain. DM = Diabetes Mellitus. PET = Preeclampsia. HTM = 
Hypertension. CD = Cesarean Delivery. Adapted from “Intrapartum management 
associated with obesity in nulliparous women,” by N. Carlson, and N. K. Lowe, 2014, 
Journal of Midwifery & Women’s Health, 59, p. 47. Copyright 2014 by The Journal of 
Midwifery & Women’s Health. 
 
Summary of Evidence   
A summary of the main findings for intrapartum care associated with maternal 
obesity in healthy, nulliparous women is in Table 5.  Induction of labor, AROM prior to 6 
cm cervical dilation, augmentation of labor, epidural in labor, early hospital admission 
for labor, and unplanned cesarean delivery were all found in one or more of the reviewed 
studies to be positively associated with maternal obesity.   
Induction of labor was shown in the Garabedian et al study (2011) to increase in a 
dose-dependent manner with maternal BMI when controlling for diabetic and   
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Table 4: Methodology for Obesity Classification from Manuscript: Behavioral Review of 
Intrapartum Managements Associated with Obesity 
 BMI pre-
pregnancy 
BMI @ booking, 
or in 1st 
trimester 
























Voldner et al, 
2009 
 
Green & Shaker, 
2011 
 




Wray & Quenby, 
2011 
 





















Note. Adapted from “Intrapartum management associated with obesity in nulliparous 
women,” by N. Carlson, and N. K. Lowe, 2014, Journal of Midwifery & Women’s 
Health, 59, p. 48. Copyright 2013 by The Journal of Midwifery & Women’s Health.   
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Table 5: Intrapartum Intervention Use by BMI Category in Healthy, Nulliparous Women 
(normal BMI women as referent), Behavioral Review of Intrapartum Managements 
Associated with Obesity 
Intrapartum 
Intervention 
Study BMI Category Findings 
Odds Ratio &  
95% CI 







BMI ≥ 50 
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Obese Not significant c 
           83 
Table 5 cont. 
Intrapartum 
Intervention 
Study BMI Category Findings 










in both categories c 
Green & Shaker, 
2011 
BMI >35 No sig difference 
once adjusted results 
for IOL c 
























































Obese 1.07 (1.05-1.09)f 
Vahratian, 2005 Overweight 
Obese 









1.69 (1.06-2.68)f, b 
1.91 (0.94-3.86) b 
Note. a Significance not computed, as confidence intervals overlap. b OR and CIs calculated from 
frequency tables provided in manuscript. c OR and CI not provided d Not significant when 
adjusted for known confounders (maternal age, parity, prev c/s, DM, GDM, HTN, PET, cervix on 
admit, IOL, birthweight, gestational age) and for labor management differences (use of epidural 
analgesia, oxytocin, forceps, vacuum). e Adjusted Risk Ratio reported, not Odds Ratio, with 
rationale that OR tend to overestimate effect when likelihood of outcome is > 10%. f Significant at 
p < .05. g Significant at p < .001. Adapted from “Intrapartum management associated with obesity 
in nulliparous women,” by N. Carlson, and N. K. Lowe, 2014, Journal of Midwifery & Women’s 
Health, 59, p. 49-50. Copyright 2013 by The Journal of Midwifery & Women’s Health.  
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hypertensive disorders and using WHO BMI classifications.  Although also showing a 
significantly increased use of induction, Bhattacharya (Bhattacharya et al., 2007) did not 
find the odds ratio for induction as high as the Garabedian study, especially for morbidly 
obese women.  Geographic population differences may explain the discrepancies in 
findings of these two studies.  Also, the Garabedian et al study defined morbid obesity as 
BMI ≥ 50, while the Bhattacharya et al study defined this same category as BMI ≥ 35.   
The use of AROM prior to 6 cm of cervical dilation was significantly associated 
with maternal obesity when compared to normal weight women in the Jensen 
investigation (Jensen et al., 1999).  Other studies included in this review did not analyze 
the use of AROM. 
Synthetic oxytocin augmentation of labor was used significantly more frequently 
among healthy nulliparous obese women in four studies (Abenhaim & Benjamin, 2011; 
Garabedian, Williams et al., 2011; Jensen et al., 1999; Vahratian et al., 2005). Both the 
Garabedian et al (2011) and Abenhaim et al (2011) studies showed similar BMI dose-
dependent increases in the use of augmentation, with levels of augmentation in morbidly 
obese women reaching three times the use in normal-weight women.  Jensen et al also 
found an increased use of augmentation in obese women, which was almost twice the rate 
of augmentation use in normal weight women (OR 1.98, 95% CI 1.28 to 3.05) (Jensen et 
al., 1999). This result was similar to the reported odds ratio in the Garabedian and 
Abenhaim et al. studies.  
Only one study (Abenhaim & Benjamin, 2011) provided information about the 
use of epidurals.  Similar to augmentation and induction of labor, epidurals were used 
with increasing frequency in a dose-dependent relationship to maternal BMI (Table 5).   
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In two studies, the incidence of assisted vaginal delivery was lower among obese 
women when compared to a normal weight cohort (Abenhaim & Benjamin, 2011; Jensen 
et al., 1999). Abenhaim et al found both that vacuum and forceps-assisted delivery 
occurred less frequently among obese women (Abenhaim & Benjamin, 2011).  In 
contrast, Sukalich et al (Sukalich et al., 2006) found no difference in the use of assisted 
vaginal delivery among obese women compared to normal weight women.   
Vahratian et al found increased use of early labor hospital admission among both 
overweight and obese women compared to women with normal BMI (Vahratian et al., 
2005). Other studies included in this analysis did not report on the use of early hospital 
admission in obese women.  
All of the investigations included in this review analyzed the use of unplanned 
cesarean delivery in the labors of obese women.  The findings consistently demonstrated 
a step-wise increase in the risk of cesarean as BMI increased from overweight through 
obese to morbid obesity.  In the only study to detail the indications for cesarean, 
Cedergren found that there was a highly significant increase in cesarean risk for the 
indication of ineffective uterine contractility with increasing BMI but no increase in 
cesareans done for obstructed labor (Cedergren, 2009).  Included studies that examined 
the odds ratios for unplanned cesarean in obese women varied from a low of 1.07 [95% 
CI 0.80-1.43] in the Abenhaim et al study (Abenhaim & Benjamin, 2011) to a high of 2.0 
[95% CI 1.8-2.3] in the Bhattacharya et al study (Bhattacharya et al., 2007).  This large 
spread in the ORs from included studies is likely due in part to differences in sample 
selection and analysis.  Abenhaim et al reported a nonsignificant odds ratio for unplanned 
cesarean use among obese women after controlling for co-morbidities and various 
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management differences, while the significant odds ratio results from Bhattacharya et al 
were obtained after controlling for only hypertensive disorders and gestational diabetes.  
Green et al also reported a nonsignificant odds ratio for unplanned cesarean among obese 
women (Green & Shaker, 2011).  Those investigators adjusted their analysis for induction 
of labor.   
Discussion 
Results of the review of these 8 studies indicate that healthy, nulliparous obese 
women were more likely to receive a variety of medical and surgical interventions during 
labor when compared to women with normal BMIs.  Intrapartum interventions used 
significantly more frequently among healthy, nulliparous obese women are induction of 
labor, augmentation of labor, and unplanned cesarean delivery.  It is unclear if assisted 
vaginal delivery is used differently, and early hospital admission, epidural, and AROM 
prior to 6 cm cervical dilation were used more often among these women only in isolated 
studies.  All of the studies examining the use of intrapartum interventions in healthy 
nulliparous obese women focused on the use of unplanned cesarean delivery, while other 
intrapartum interventions like early hospital admission, epidural, and AROM were rarely 
considered.  With the exception of two studies that used data from prospective cohorts 
(Cedergren, 2009; Vahratian et al., 2005), other studies used data from large hospital 
system databases or birth certificate records. Therefore, it is possible that data on the 
processes of intrapartum care were not available.  
The practice of early labor hospital admission has been associated with an 
increased risk for cesarean delivery (Jackson, 2003), epidural anesthesia (McNiven et al., 
1998), and augmentation of labor in studies that have not controlled for BMI. Once 
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women are admitted to the hospital, they are more likely to receive interventions, and 
their progress through labor is tracked and timed (Downe & Dykes, 2009).  If progress is 
found slow or lacking, women are more likely to receive interventions intended to speed 
labor (Lavender et al., 2012).  Especially in the setting of a healthy nulliparous obese 
woman’s slower labor progress, the first intrapartum intervention of hospital admission 
may increase her risk of other interventions.  However, without more precise information 
on the use of early hospital admission in obese women, we are unable to comment on the 
relationship between early hospital admission and other interventions in this population.    
Augmentation of labor occurred significantly more often among healthy 
nulliparous obese women in the studies of this review.  Augmentation with synthetic 
oxytocin has been found to fail more frequently in obese women when compared to 
normal-weight women in some studies (Usha-Kiran et al., 2005; J. Walsh et al., 2011), 
but in the Garabedian et al study it was found to have a unplanned cesarean delivery 
protective effect among obese women with BMI ≥ 35 kg/m2 (Garabedian, Williams et al., 
2011).  The dose of synthetic oxytocin received by obese women in the Garabedian et al 
study was not reported.  Evidence from a 2009 prospective trial of 1,273 women 
suggested that obese women require higher median dosages and duration of synthetic 
oxytocin during induction when compared to normal weight women (Pevzner et al., 
2009).  Moreover, increased levels of cholesterol and leptin, which are more common in 
obese women, are associated with decreased myometrial contractility response to 
synthetic oxytocin in in-vitro studies (Lowe & Corwin, 2011; Zhang, Kendrick et al., 
2007).  Currently, optimal synthetic oxytocin doses for obese women are not known.  The 
studies included in this review do not provide information on obese women’s risk for 
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unplanned cesarean delivery after augmentation.  Prospective trials are needed to 
examine the dose, duration, and results of synthetic oxytocin augmentation in obese 
women to understand how use of oxytocin augmentation might change the course or 
outcome of obese women’s labors.   
Two important issues revealed in our review are that subject selection and the 
method of BMI calculation are crucial areas for standardization in future investigations.  
Nulliparous women proceed through labor differently than parous women, and this is 
especially true for women with higher BMIs (Kominiarek et al., 2011).  Therefore, 
investigations of intrapartum interventions must limit subject selection by parity or 
control for parity in the analysis.  Many investigations were excluded for this review 
because they did not limit their sample by parity or analyze the confounding effect of 
parity.  Maternal height is another important factor in women’s risk for unplanned 
cesarean delivery and other interventions in labor (Prasad & Al-Taher, 2002).  However, 
only two studies (Bhattacharya et al., 2007; Vahratian et al., 2005) we reviewed 
controlled for maternal height when analyzing use of intrapartum interventions among 
obese women.   
The method of BMI calculation is another important area for standardization in 
future investigations.  Abenhaim et al argued that BMI calculations made at the time of 
delivery are preferable to pre-pregnancy BMI for the purpose of evaluating the role of 
labor interventions on obese women’s risk for unplanned cesarean delivery.  For the 
purpose of statistical analysis, confounding factors are traditionally located in time before 
both the exposure and the outcome of investigation.  Most intrapartum investigations of 
obese women instead consider factors like preeclampsia as confounders that are located 
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in time between the exposure (prepregnant BMI) and the outcome (cesarean delivery) 
(Bhattacharya et al., 2007; Garabedian, Williams et al., 2011; Sukalich et al., 2006).  By 
using delivery BMI as the exposure in their analysis, Abenhaim et al restored the 
traditional statistical orientation of confounder (preeclampsia) being present prior to 
exposure (delivery BMI), which then affects the outcome (cesarean delivery).  Future 
investigations that seek to control for co-morbidities through statistical analysis may want 
to consider using delivery BMI rather than pre-pregnancy BMI.   
Delivery BMI includes both pre-pregnancy weight and the total weight gain 
during pregnancy. Overweight and obese women are more likely to gain gestational 
weight in excess of Institute of Medicine recommendations than normal or underweight 
women (Ferraro et al., 2012), and are more likely to have newborns that are macrosomic 
(Di Benedetto et al., 2012). Although it is known that women who are obese have a 
higher risk for slow labor and unplanned cesarean delivery independent of their 
gestational weight gain and fetal weight, it is unknown if higher gestational weight gain 
among obese women puts them at increased risk for intrapartum interventions like 
induction, augmentation, epidural, etc.  Future investigations of intrapartum intervention 
use for obese women may best capture the decisions made by providers if both total 
weight gain and pre-pregnancy BMI are considered in analyses.   
Even in this small group of studies with the most stringent controls for co-
morbidities and parity, there remain large methodological differences in subject selection 
and analysis that limit the comparison of findings across studies.  Future studies should 
use the IOM BMI categories so that groups of women and study results can be compared 
across studies.  In order to focus on healthy obese women, women with preeclampsia, 
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gestational diabetes, and other serious co-morbidities should be analyzed separately from 
low-risk obese women.  
This review is limited by the non-standardized categorization of obese women in 
the included studies.  Underweight and morbidly obese women have significantly 
different lengths of labor (Kominiarek et al., 2011; Verdiales et al., 2009) and risk for 
unplanned cesarean delivery (Bhattacharya et al., 2007) when compared to obese women.  
Therefore, investigations that blur the lines between these groups run the risk of reporting 
intervention rates and odds ratios that are difficult to compare to other investigations 
using standardized BMI groupings.  In addition, this review is limited by the fact that all 
but one of the included investigations was retrospective in design.  Therefore, only 
correlations between BMI and the use of intrapartum interventions can be made.  
Causality conclusions about the effect of a particular intervention on the outcomes of 
obese women’s labors will require prospective, randomized trials.   
Given that intrapartum interventions like early admission in labor (Jackson, 
2003), epidural anesthesia (Nguyen et al., 2009), and AROM (Smyth et al., 2013) have 
been found in unselected groups of women to be associated with unplanned cesarean 
delivery, the results of this systematic review indicate that future studies are needed to 
evaluate changes in maternal and neonatal outcomes when intrapartum interventions are 
not used or are used at different times in labor.  For example, would unplanned cesarean 
delivery be less likely in obese women if hospital admission or AROM were delayed in 
labor?  Does this relationship change in nulliparous vs. multiparous women?  Does this 
relationship change in obese women with and without co-morbidities, with or without 
excessive gestational weight gain?  What is the optimal timing and dosage of synthetic 
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oxytocin augmentation, if used in nulliparous obese women, to decrease cesarean rates?  
These and other questions have yet to be answered.  We do know that cesarean delivery 
in obese women results in increased morbidity and mortality (Grundy et al., 2008; Myles 
et al., 2002; Sebire et al., 2001).  Therefore, these and other questions relating to the 
intrapartum management of obese women are important to consider as new investigations 
are designed.  
Implications for Clinical Practice 
Implications for clinical practice from this systematic review are that healthy, 
nulliparous obese women are exposed to the common intrapartum interventions more 
often than normal weight women.  There was broad consistency in the findings that 
healthy, nulliparous obese women are significantly more likely to experience unplanned 
cesarean delivery, and their risk for this intervention increases in a dose-dependent 
manner with maternal BMI.   
Providers should monitor their use of intrapartum interventions like induction of 
labor, early hospital admission in labor, AROM, and augmentation of labor, as these 
interventions are used more frequently among obese, nulliparous women and all have 
been shown in other studies to be associated with unplanned cesarean delivery.  It is 
unclear if these interventions are used more frequently in the labors of women who had 
some increased risk for cesarean before the first intervention was applied, or if the use of 
the intervention caused the obese woman to be more likely to end her labor with 
cesarean.   
With their slower rates of cervical dilation, obese women are more likely to fall 
outside the action line of standardized tools for labor progression (Kominiarek et al., 
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2011) (i.e. partogram with 2-hour action line); however, no studies have specifically 
examined the use of partograms with different action lines among obese women.  
Although augmentation of labor with synthetic oxytocin occurs more frequently in obese 
women’s labors, correct dosages for this population are unknown.  Until new studies are 
completed that compare birth outcomes in matched groups of obese women who are 
exposed to different intrapartum interventions, more liberal labor timing, and a range of 
synthetic oxytocin dosages, providers will have limited evidence to guide their practice 
with these women. 
Conclusions 
Findings from the studies included in this review of intrapartum management of 
obese, nulliparous women demonstrate that these women often experience a labor 
characterized by frequent technologic interventions and unplanned cesarean delivery.  
Although pregnant obese women are more likely to have coexisting medical 
complications like diabetes and hypertension when compared to normal-weight pregnant 
women, obese women’s risk for unplanned cesarean delivery persists even when these 
conditions are controlled in analyses (Abenhaim & Benjamin, 2011; Sheiner et al., 2004; 
Sukalich et al., 2006). 
Future studies examining the intrapartum management of obese, nulliparous 
women are needed with: (a) samples defined by standardized obesity classifications, 
parity, and medical co-morbidities; (b) analysis of intrapartum interventions like 
psychological/physical comfort measures, early hospital admission, early epidural 
anesthesia, AROM, and partogram use; (c) quantification of synthetic oxytocin dose 
requirements by maternal BMI; and (d) use of prospective, randomized designs to allow 
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for causality conclusions about links among intrapartum interventions and a woman’s 
risk for unplanned cesarean delivery.   
Obstetrician or Certified Nurse-Midwife Model of Intrapartal Management 
Obstetricians managed the intrapartum course of over 90% of U.S. women in 
2010, the most recent year for which data are available (Hamilton et al., 2012). 
Obstetrician-management of labor relies heavily on technological interventions that 
standardize labor management (Reime et al., 2004).  In contrast, nurse-midwife 
management of labor tends to emphasize physiologic processes (Johantgen et al., 2011) 
and is associated with reduced use of procedures during labor (Sutcliffe et al., 2012).  
Certified nurse-midwives were the intrapartum provider for 7.8% of U.S. women in 2010 
(Hamilton et al., 2012).  Little is understood about the full content and context of care 
provided during labor by certified nurse-midwives (Johantgen et al., 2011), although a 
recent meta-synthesis of qualitative studies on midwifery-led care found that the 
decreased rates of intrapartum procedures may be linked to an increased sense of agency 
felt by women who are patients of midwives (D. Walsh & Devane, 2012).   
Certified nurse-midwives are known to use early hospital admission, epidural 
anesthesia, synthetic oxytocin augmentation, and AROM less frequently than obstetricians in 
matched samples of patients (Davis, Riedmann, Sapiro, Minogue, & Kazer, 1994; Hatem, 
Sandall, Devane, Soltani, & Gates, 2009; Johantgen et al., 2011; Shaw-Battista et al., 2011).  
Nurse-midwives tend to have cesarean delivery rates that are significantly lower than 
obstetricians, even when samples are matched for medical risk factors for cesarean (Davis et 
al., 1994; Hatem et al., 2009; Jackson, 2003).  Nurse-midwives are known to encourage 
ambulation (Albers et al., 1997) and continuous support in labor (McGrath & Kennell, 2008), 
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and to use hydrotherapy (immersion in warm water) during labor (Davis et al., 1994).  All of 
these midwifery practices are associated with decreased risk of cesarean birth (Cluett, 2004; 
McGrath & Kennell, 2008; McNiven et al., 1998), although not all have been found in 
randomized controlled trials to be individually associated with decreased rates of surgical birth 
(Bloom et al., 1998; Gagnon, Waghorn & Covell, 1997; McNiven et al., 1998). 
Although certified nurse-midwives in the U.S. have traditionally cared for underserved, 
mixed-risk populations, few studies have been published on certified nurse-midwife care of 
obese women.  In a 2003 study reporting on outcomes of a 1,132 medically high-risk Native-
American community cared for by a group of certified nurse-midwives and family physicians, 
the cesarean delivery rate was lower than average (7.3%), largely due to a decreased use of 
cesarean for the indication of labor dystocia (Leeman & Leeman, 2003).  These providers used 
a liberal timeline for labor (lowest expected cervical dilation 0.5 cm/hr), continuous labor 
support, and strict limits on induction of labor to help achieve these outcomes.  Another study 
profiling midwifery care of 1,881 high-risk women showed an increased rate of cesarean for 
obese women (BMI ≥ 29.0) compared to normal-weight women in the same practice (OR 2.02, 
95% CI [1.26, 3.25]), yet an overall cesarean rate for obese women that was well below 
national averages for even a mixed-weight population (7.7%) (Kaiser & Kirby, 2001). 
Certified nurse-midwives offer a model of labor management that exists side-by-
side, yet contrasts with a technologically driven model of labor management used more 
frequently by obstetricians.  Both the biological determinant of slow labor progress and 
the behavioral determinant of intrapartum use of technologic-driven interventions have 
been shown to contribute to the outcome of unplanned cesarean delivery for the 
indication of labor dystocia among obese women.  However, direct comparison of the 
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processes and outcomes of labor in obese women managed by providers using different 
levels of technologic intervention has not yet been performed.   This study compared 
certified nurse-midwife and obstetrician intrapartal care of obese women within the same 
institution to investigate the intervention choices associated with lowered rates of 
unplanned cesarean delivery for the indication of labor dystocia.   
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CHAPTER III 
METHODS 
A comparative effectiveness (CER) approach was used to examine different systems of 
management (certified nurse-midwife or obstetrician) within the labor care (intrapartum 
management) of obese, nulliparous women in a single institution for this study.  When 
examined under the lens of the randomized controlled trial, it is difficult to appreciate the effect 
of individual intrapartal interventions after isolation and use in a complicated environment of 
care.  When examined in this way, many interventions shown to be associated as part of a low-
technology model of care with lowered cesarean delivery rates do not reach significance 
individually.  CER provides a framework for examining different models of intrapartal care of 
healthy obese, nulliparous women.  In this study, in addition to examining the association of 
individual intrapartum interventions on the risk of obese women for the outcome of cesarean 
delivery for labor dystocia, the first aim will also utilize a CER approach by examining the 
association of a nurse-midwife or obstetric model of intrapartum care on the risk of obese 
women for the outcome of cesarean delivery for labor dystocia.  Furthermore, national and 
healthcare agencies like the Institute of Medicine identify CER as a critical methodology for 
filling the knowledge gap of what works in healthcare services, thereby benefitting patients, 
providers, and communities (2009). 
Design 
A retrospective cohort analysis of existing data contained in the University of 
Colorado’s Perinatal Database (UCPD) and a case-control analysis of existing data contained in 
the University of Colorado Hospital (UCH) medical records were performed.  These analyses 
compared the frequency of unplanned cesarean delivery and labor interventions in matched 
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samples of healthy, term obese and overweight nulliparous women entering labor 
spontaneously and with a plan for vaginal birth who were cared for by obstetricians or certified 
nurse-midwives at UCH between October 2005-January 2013 (n = 718, Aim 1).  Logistic 
regression analysis was also used in a sub-set of obese women from this first analysis, using 
information from their medical record plus information in the UCPD, to examine the 
differences in the timing of interventions for obese women who ended labor with a primary 
cesarean delivery and those who did not (n = 348, Aim 2 & 4).  These second and fourth Aims 
used a case-control study design.  Finally, total synthetic oxytocin dose and duration was 
compared in a sample of women who received oxytocin augmentation and achieved vaginal 
birth by delivery BMI (n = 136, Aim 3).  Women who ended labor with cesarean delivery were 
excluded from this Aim 3 analysis so only women achieving a common end point (vaginal 
delivery) could be compared on their synthetic oxytocin dosing characteristics.  Matched 
samples of obese women were created for all analyses via propensity score analysis based on 
perinatal risk factors.   
Setting and Sample 
University of Colorado Hospital   
The UCH is an academic medical center on the Anschutz Medical campus of the 
University of Colorado in Aurora. UCH and its affiliated clinics provide health care 
services to a diverse population of ethnic backgrounds located in the Rocky Mountain 
region. The Hospital is involved in the education of health professionals and technical 
personnel at all service levels and serves as an educational site for the nearly 1,800 
nursing and medical students, residents, fellows, and allied health students at the 
University. UCH is a state-designated provider of indigent care in Colorado. The UCH 
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includes an acute care general hospital licensed for 370 general beds staffed by over 
1,600 personnel, plus a wide range of adjacent outpatient clinics and additional clinics at 
other locations. Each year UCH provides over 18,000 inpatient stays and 200,000 
outpatient visits. Many providers at UCH are also faculty members at one of the schools 
or colleges on the Anschutz Medical Campus, which require them to keep up with, and 
often lead, the latest in research and medical treatments.  
Obstetrician-gynecologists, certified nurse-midwives, family practice physicians, and 
Maternal-Fetal Medicine specialists (high-risk OB-GYN) provide care on the UCH birth unit.  
Neonatal Intensive Care and emergency surgical care are both available around the clock.  
Certified nurse-midwives manage approximately 40% of the births at UCH, with the remainder 
managed by obstetricians.  The University Nurse Midwifery Faculty Practice (UNM) is a 
comprehensive inpatient and outpatient service located at UCH. The nurse-midwifery 
faculty practice, started in 1983, expanded several years ago to include the Center for 
Midwifery, a primarily private practice in which nurse-midwives provide personalized 
holistic care to women and their families. The UNM have a combined FTE of 9.0 and 
manage over 1,000 births per year (Nacht, personal communication, 2014). Prenatal care 
is provided at the Anschutz Outpatient Pavilion (3rd floor) where nurse midwifery and 
obstetrical care is provided. Births occur at the Anschutz Inpatient Pavilion Birth Center 
adjacent to the Outpatient Pavilion. Graduate nursing students, among other health 
professional students, use the midwifery practices for clinical practice opportunities. An 
exchange of service agreement facilitates provision of prenatal care at a second clinical 
site, the Metropolitan Community Provider Network Clinic in Aurora, Colorado. This 
community health clinic provides additional learning opportunities for students, as well 
           99 
as enabling low-income and underinsured patient’s access to certified nurse-midwifery 
services at UCH. Medical consulting arrangements are with the Department of Obstetrics 
and Gynecology, School of Medicine when certified nurse-midwifery patients need 
operative birth or evaluation and treatment of other high-risk medical conditions. 
Preliminary Study:  Obese Women at UCH  
In 2009/10, Dr. Lowe conducted a retrospective analysis of nulliparous women who 
delivered at UCH between 2005-2009 (personal communication, Lowe).  This analysis 
revealed that nulliparous obese women delivering at UCH had a significant and progressive 
increased cesarean delivery rate with each increase in BMI category (cesarean rates: 31.3% 
Obese 1, 32.5% Obese II, 35.2% Obese III), in agreement with multiple studies from the 
national and international literature.  Birth outcomes by provider type were not collected in this 
pilot study.  A total of 374 obese, nulliparous women labored at UCH during the time period 
for the study (BMI ≥ 30.0).  An additional 708 overweight women (BMI 25.0-29.0) labored 
during the same time period, and had an unplanned cesarean delivery rate (25.4%) that was also 
elevated above normal-weight women (cesarean rate 17.0%).   
Preliminary Study:  Intrapartum Care at UCH  
A preliminary exploration of the UCH birthing unit was conducted in September 2012 
and July 2014 to collect background information on the birth unit and the patients cared for by 
certified nurse-midwives and physicians at UCH in preparation for this study. This preliminary 
exploration revealed that most pregnant women come to UCH via a system of prenatal care 
clinics spread around the metro Denver area. These women are assigned to obstetrician or 
certified nurse-midwife provider group by their prenatal clinic catchment area and do not self-
select their intrapartum provider. Although obstetricians care for all women with extreme 
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complications of pregnancy from any prenatal clinic, healthy obese women, such as the 
subjects of this study, are cared for by either certified nurse-midwives or physicians, typically 
on separate floors of the UCH birth center.  A group of privately insured women who self-
select for midwifery care are seen by a separate group of certified nurse-midwives at The 
Center for Midwifery.  The Center for Midwifery clients are very different in age, socio-
economic, and educational backgrounds from women attending the UCH clinics; thus these 
women were excluded in the sampling descriptions below.  In addition, family practice 
physicians at UCH manage a small number of births/year and tend to manage differently than 
the group of UCH obstetricians. Family-practice physician patients were also excluded from 
this study. 
Planned Sample  
Samples for database and chart-review analysis for this study were collected from the 
UCPD, the UNM database, and UCH medical records following Colorado Multiple 
Institutional Review Board (COMIRB) approval.  See Figure 8 for detail of planned sample 
sizes and types of analyses.  Data were collected from the records of women who delivered at 
UCH over a period of approximately seven years (2005-2012). The health history, provider, 
social, pregnancy, birth, and neonatal variables contained in both the UCPD and in 
medical records from hospital admissions of women giving birth at the UCH between 
January, 2005-January 2013 were used.  Women and their neonates who meet the 
following criteria were included in this study: 
• Obese (BMI ≥ 30kg/m2) at time of delivery (except for Aim 1 analysis, which 
included both overweight and obese women, BMI ≥ 25.00 kg/m2).   
• Nulliparous (first-time mothers with no previous viable pregnancies beyond 
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24 weeks gestation) 
• Delivered at term gestation (37 0/7-41 0/7 weeks gestation from first day of 
last menstrual period) (Abenhaim & Benjamin, 2011; Kominiarek et al., 2011; 
Norman et al., 2012) (Arrowsmith, Quenby, Weeks, Burdyga, & Wray, 2012) 
• Delivered a singleton fetus 
• Fetus was in a head-down position at the start of labor 
• Healthy at the onset of labor (no hypertension or diabetes, either pre-
gestational or gestational) 
• No medical indication for cesarean delivery prior to the onset of labor 
• No major congenital anomalies diagnosed on fetus at onset of labor 
• Spontaneous onset of labor with no premature rupture of membranes  
• Had some period of labor in the hospital (defined as ≥ 2 vaginal exam results 
in the woman’s medical record) 
• Cared for by either a certified nurse-midwife from the University Nurse 
Midwives group or by a UCH obstetrician 
• Outcome of either vaginal delivery (spontaneous or operative) or cesarean 
delivery for the indication of labor dystocia 
Obesity in sample.  The exposure variable of obesity was important for sample 
inclusion.  Although both pre-delivery BMI and delivery BMI have been used by investigators 
of labor dystocia in obese women, delivery BMI was used for this study.  This decision was 
made for two reasons.  First, delivery BMI reflects the physiologic state of the woman at the 
time of labor and delivery, the time period of interest in this study.  Delivery BMI includes both 
pre-pregnancy BMI and the total weight gain (TWG) of the woman in pregnancy.  Both TWG 
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Figure 8:  Flowchart describing the aims, research questions and planned data collection 
for the proposed dissertation project.  
 
 
Aim 2:  Examine differences in the use 
and timing of intrapartum interventions 
during the labors of healthy, 
nulliparous obese women with 
different delivery outcomes
Aim 1:  Examine differences in the rate of 
cesarean delivery for the indication of labor 
dystocia among healthy, nulliparous obese 
women of similar perinatal risk by the 
professional affiliation of their intrapartum 
care provider
Aim 3:  Characterize response to synthetic 
oxytocin by maternal delivery BMI in 
nulliparous, obese women who achieved 
vaginal birth
University of Colorado 
Hospital Pernatal Database
Nulliparous, obese (>=30 BMI) singleton, cephalic, 37 0/7-41 0/7 weeks @ 
admit, maternal age <=40 y, no diabetes, no hypertension, plan for vaginal 
birth, spontaneous labor and no premature rupture of membranes
CNM intrapartum management OB intrapartum management
Perinatal Background Index 
score assigned Propensity score matching
Nearest neighbor random 
allocation
n=325n=325
Rate of: cesarean section for 
indication of labor dystocia
Rate of: cesarean section for the 
indication of labor dystocia
Database Analysis 




Had cesarean delivery for 
indication of labor dystocia Had vaginal birth
Combined group of OB and CNM patients from Aim 1 Analysis, identified by 
those who had cesarean following labor dystocia vs. those who had vaginal 
birth
Rate of:  epidural, AROM, pitocin 
augmentation, low-technology 
interventions
Rate of:  epidural, AROM, pitocin 
augmentation, low-technology 
interventions
Rate of: AROM, pitocin, or epidural 
<6cm, admission to hospital @ 
<4cm
Rate of low-technology 
interventions > 6cm
Rate of: AROM, pitocin, or epidural 
<6cm, admission to hospital @ <4cm
Rate of low-technology interventions > 
6cm
Plot cervical exams and interventions on partogram.  Designate intervention as 
'red zone' if took place during time of normal progression and 'green zone' if took 
place in a time of abnormally slow cervical progression.
Rate of red zone:
AROM, pitocin start, 
epidural start, low-tech 
intervention
Had cesarean delivery for 
indication of labor dystocia Had vaginal birth
Rate of red zone: 
AROM, pitocin start, 
epidural start, low-tech 
intervention
Combined group of OB and CNM patients from Aim 2, identified by those 
who had vaginal delivery and pitocin augmentation
Chart Review
Aim 4:  Explore use of low-technology 
interventions including ambulation, 
hydrotherapy, continuous labor support and 
intermittent external fetal monitoring in the 
labors of healthy, nulliparous obese women
n=150
Chart Review
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and pre-pregnancy BMI are known be associated with labor dystocia, and women crossing into 
obesity (BMI ≥ 30kg/m2) over the course of pregnancy were shown by Kominiarek et al. 
(2010) to have a 30% increased risk of unplanned cesarean delivery when compared to 
women with similar pre-pregnancy BMIs who did not cross into obesity during their 
pregnancy.  Therefore, delivery BMI more accurately reflects the exposure variable of 
obesity at the time of intrapartum management decisions.   
The second reason that delivery BMI was used in this study is that this exposure 
definition allowed for correct statistical adjustment of confounding variables occuring 
during pregnancy as a result of higher TWG.  For example, regression analysis of the 
association between delivery BMI and synthetic oxytocin augmentation dose involves 
statistical adjustment by the variable of baby’s birth weight.  Birth weight is a potential 
confounder of the relationship between delivery BMI and synthetic oxytocin duration 
because it occurs prior to both delivery BMI and onset of synthetic oxytocin 
augmentation in that woman’s labor (baby’s birth weight ! delivery BMI ! dose of 
oxytocin).  If this study had used pre-pregnancy BMI instead of delivery BMI, it is 
possible that the “confounder” of birth weight would actually occur after the exposure 
variable (pre-pregnancy BMI ! baby’s weight ! dose of oxytocin) (Abenhaim & 
Benjamin, 2011, p. 446).  Delivery BMI was used instead of pre-pregnancy BMI by 
investigators of previous studies examining labor management and outcomes in obese 
women for these reasons (Abenhaim & Benjamin, 2011; Kominiarek et al., 2010; 
Kominiarek et al., 2011; Norman et al., 2012; Pevzner et al., 2009).   
Intrapartum management was determined for each woman by examining the type of 
provider (certified nurse-midwife or obstetrician) who was responsible for her hospital 
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admission immediately preceding labor and delivery (Intent to Treat Analysis).  Patients of The 
Center for Midwifery and the family-practice physicians at UCH were excluded from analysis 
to eliminate the related self-selection bias. 
As the UCPD does not include identifiers of provider type for each woman, medical 
record numbers for samples of women found in the UCPD were cross-referenced against 
records of certified nurse-midwife clients as recorded in a separate database maintained by 
UNM to identify women birthing at UCH during the included years who were admitted to the 
hospital as certified nurse-midwife patients.  A group of women, also meeting inclusion 
criteria, who were cared for by obstetricians at UCH were then identified from the remaining 
UCPD sample.   
Perinatal Background Index.  To control for confounding factors in groups of 
women cared for by certified nurse-midwives or obstetricians, a composite perinatal risk score 
was used to allocate subjects to comparison groups via propensity score matching.   Perinatal 
risk variables for this propensity matching were identified from an existing instrument, the 
Perinatal Background Index (PBI).  The PBI is one part of a larger index used to evaluate birth 
processes and outcome, the Optimality Index-US (OI-US) (Murphy & Fullerton, 2001).  
Within the OI-US, the PBI “depict(s) pre-existing medical and social conditions that may 
influence processes of care or outcomes of care” (Cragin & Kennedy, 2006, p. 780).  The PBI 
for nulliparous women consists of eight socio-demographic and health status items.  For each 
PBI item, women are scored one point for the presence of the risk factor.  An example of the 
original PBI data abstraction tool from the University of Michigan can be found in Figure 9. 
For this study focusing on the labor care of obese women, the PBI instrument was 
altered slightly to better capture the complex comorbidities often present in obese women.   
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Optimality Index Case Report Form – UM version 
GENERAL CODES:  0 = No/not true  1 = Yes/true 
7 = Not Applicable (N/A) 8 – General missing (data that are not collected in this setting) 
9 = Missing data (data that should be present, but are missing from this specific chart)  
THE PERINATAL BACKGROUND INDEX 
Parity First continued/viable 
pregnancy 
Not first continued/viable 
pregnancy 
1.  married or partnered   
2.  non-minority     
3.  smoke-free since conception   
4.  alcohol-free since conception   
5.  no drugs or OTCs since conception    
6.  normal weight (BMI 18.5-24.9)  





7.  age 18-40 during pregnancy   
8.  no preexisting, major, chronic, disease:  
Hypertension, chronic renal disease, 
diabetes (nongestational), heart disease 
class II-IV, HIV+, major psychosocial 
history (treated with drugs or inpatient 
therapy), prior pregnancy complications 
EXCEPT C/S or VBAC 
  
9.  Child spacing >=18 months   
10.  no preterm infant (<37 weeks)   
11.  no previous intrauterine death   
12.  no previous cesarean birth   
13.  no previous birth weight infant <2500 
or >4000 gm (5 1/2 – 8 1/2 lbs) 
  
14.  no HISTORY of other serious 
antepartum complications:  gestational 
diabetes, praevia, abruption, severe 
PIH/eclampsia, pyelonephritis, Rh 
sensitization   
   
PBI DENOMINATOR 8 14 




/ ___ ___ 
PBI %  ___ ___ ___ % 
Figure 9: The Perinatal Background Index, to be used in planned dissertation project’s propensity 
scoring of subjects.  Adapted from “Linking Obstetric and Midwifery Practice With Optimal 
Outcomes,” by L E. Cragin and H. P. Kennedy, 2006, Journal of Obstetric, Gynecologic, & 
Neonatal Nursing, 35, p. 779-785. Copyright 2006 by the Association of Women’s Health, 
Obstetric and Neonatal Nurses. 
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First, two items of the original PBI were deleted: 
• Age of mother > 40 or < 18 years. 
• Pre-pregnancy BMI outside normal range (18.5-24.9 kg/m2) 
These items were deleted because the inclusion criteria for this study limited subjects to those 
between 18-40 years of age, and Aim 2 and Aim 3 analyses were limited to women with 
obesity at the time of delivery.  Ultimately, Aim 1 of this project did include overweight 
women.  However, assessment of perinatal risk via an item indicating normal vs. obese pre-
pregnant BMI was not added back into the propensity score matching for this Aim because 
there were a large number of cases in the UCPD that had missing values on pre-pregnant BMI.  
Analysis was done for the Aim 1 samples to determine if there were differences in delivery 
BMI between groups.  This analysis revealed that the creation of these groups via propensity 
score matching on the remaining PBI measures was sufficient to result in a non-significant 
difference on mean delivery BMI, as will be discussed in Chapter 4.   
In place of the two deleted PBI items, two new perinatal risk variables were created: 
• Major Psychosocial Complications History 
• Miscellaneous Chronic Disease History 
Obese women are known to be at higher risk for psychiatric conditions than normal 
weight women (Molyneaux et al., 2014).  Among the original PBI items, only one included 
history of psychosocial difficulty, and this item lumped psychosocial risk together with 
pregnancy risk secondary to a host of other, non-psychiatric chronic diseases.  In the new 
perinatal risk item, women with a history of major psychiatric disease (schizophrenia, bipolar, 
psychosis, major depression, panic attacks, PTSD, autism, history of suicide attempt or  
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psychiatric hospitalization) or trauma history (woman was threatened at home, physical assault 
in pregnancy) were scored one point for the Major Psychosocial Risk variable.   
 Obese women are also known to have a greater risk for various chronic diseases 
(Suidan et al., 2012).  Although history of chronic disease of the heart or kidney was included 
as an original PBI measure, women with a history of other chronic diseases were not scored for 
these risks in the original PBI.  To resolve this problem, an additional perinatal risk item was 
created, the Miscellaneous Chronic Disease Risk variable.  This variable includes one point 
assessed for women with a history of pulmonary disease, clotting or bleeding disorders, liver 
disease, neurological disease, stroke, multiple sclerosis, myasthenia gravis, autoimmune 
disease, epilepsy, HIV+, or sickle cell disease.  A side-by-side comparison of the original and 
altered perinatal risk items is provided in Table 6.   
 Propensity score matching produces samples with balanced baseline covariates, thus 
reducing confounding of the relationship between group allocation and a measured outcome 
(Austin, 2011).  Traditionally, the randomized controlled trial has been held as the gold 
standard for evaluating the effects of treatments because random allocation was thought to 
prevent confounding by a host of baseline characteristics that may or may not have been 
measured.  By matching subjects using propensity scores, a similar balance of potentially 
confounding characteristics (both named and unnamed) can be achieved in observational 
studies.  In this study, propensity score matching was used to create two samples of women 
who were “treated” with different intrapartum provider types (CNM or OB) and yet had the  
same distribution of observed baseline perinatal risk covariates.  
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 Propensity score matching for this study was performed using the program 
“psmatching,” which is an R-Plugin to SPSS (Thoemmes, 2012).  As recommended by the 
designer of this propensity score matching tool, the following steps were completed for this 
study: 
1. A set of pre-test perinatal risk covariates was identified and used for the propensity 
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score.  The choice of these risk covariates was informed by their theoretical importance 
to treatment selection and studied outcome.  The modified PBI covariates met these 
criteria and were thus used with some modification for this study (Murphy & Fullerton, 
2001).   
2. Propensity score was estimated using logistic regression, with treatment assignment 
(CNM or OB) used as the outcome variable, and the selected covariates (6 modified 
PBI variables) used as predictors.   
3. Once propensity score was estimated, matching was performed with a 1:1 nearest 
neighbor method, utilizing a caliper to define the maximum distance between matching 
cases.  Caliper for this study was set at 0.15, which was calculated as 0.2 of the 
standard deviation of the propensity score logit (0.2 x 0.796 = 0.15) (Austin, 2011).  At 
this caliper level, it was estimated that propensity score matching would ‘eliminate 
approximately 99% of the bias due to the measured confounders” (p. 407). 
4. After matching, model adequacy checks were performed to confirm that covariate 
balance was achieved by bringing the standardized mean difference of covariates close 
to 0 and balancing the distribution of the covariates in the matched sets (Figures 10, 11, 
12).  
For Aim 1, a dataset of n = 1,119 women of BMI ≥ 25 kg/m2 matching exclusion 
criteria was matched by type of provider in labor using propensity scores to produce a sample 
of 794 cases (397 CNM patients and 397 OB patients).  It was originally planned that the Aim 
1 analysis would include only obese women by delivery BMI.  However, overweight women 
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Figure 10.  Propensity Score Matching Results for Aim 1 sample: Distribution of 
Propensity Scores in both matched and unmatched samples. 
 
had to be included in this analysis to meet power calculations.  Multivariate imbalance was 
reduced via propensity matching (Multivariate imbalance measure L1 reduced from 0.359 to 
0.087 after matching).  Figures 10-12 provide graphical views of the distribution of propensity 
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Figure 11. Propensity Score Matching results for Aim 1 sample: Absolute Standardized 
Difference in Mean scores on PBI items in unmatched vs. matched samples. 
 
 
 scores among unmatched and matched sets (Figure 10), change in the absolute standardized 
difference in means of PBI covariates in matched vs. unmatched datasets (Figure 11), and 
distributions of propensity score density in matched vs. unmatched datasets (Figure 12).   
For Aim 2 and 4, another propensity-matched dataset was created in a similar manner 
to the procedure described above (nearest neighbor 1:1 propensity score matching via logistic 
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Figure 12.  Propensity Score Matching results for Aim 1 sample: Density of Propensity 
Scores for individual PBI items in matched vs. unmatched samples.  Samples matched on 
type of provider caring for subject during labor (Certified Nurse Midwife or 
Obstetrician).   
 
regression of propensity score calculated from the modified PBI covariates, caliper set at 0.15).  
For this dataset, all exclusion criteria were applied.  Starting with a dataset of N = 542 cases of 
obese women (287 OB patients, 255 CNM patients), a propensity matched dataset was 
created which included n = 400 cases (200 OB patients, 200 CNM patients).  After 
matching, this Aim 2 & 4 dataset had a reduced imbalance measure (Relative multivariate 
imbalance L1 lowered from 0.347 to 0.145).  Figures 13 and 14 provide similar graphical 
views of the PBI covariates variance for the Aim 2/4 sample as was presented on the 
dataset matched for Aim 1.  Aim’s 3 dataset was created from the Aim 2/4 sample by 
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selecting only women with vaginal delivery and synthetic oxytocin augmentation.  The 
Aim 3 sample included 136 women.     
 
Figure 13. Propensity Score Matching results for Aim 2 & 4 sample: Absolute 
Standardized Difference in Mean scores on PBI items in unmatched vs. matched samples. 
 
Data Collection  
  Data were collected from three sources:  1) the UCPD, 2) the UNM practice dataset 3) 
the UCH medical records.  Following approval by COMIRB and the UCH Research Support 
Services in 5/2014, the UCPD was received and data cleaning was performed. After project 
exclusions were applied and propensity matching was performed to obtain the final samples,  
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Figure 14. Propensity Score Matching results for Aim 2 and 4 sample: Density of 
Propensity Scores for individual PBI items in matched vs. unmatched samples. 
 
data were collected from the UCH medical records during an on-site stay at the Anschutz 
medical campus 10/2014-12/2014. 
  The UCPD was created in 2005.  Data contained in the UCPD were collected on a 
continuing basis until December 2012, entered into the database, and maintained in the 
de-identified state for research purposes by the UCH Department of OBGYN.  The 
UCPD is stored on a password-protected, secured Data Coordinating Center (DCC) 
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server at National Jewish Medical and Research Center (NJMRC), a collaborating 
institution with University of Colorado.  Each person associated with the UCPD has their 
own password.  I received a deidentified UCPD dataset and a separate database with links 
between UCPD identifier numbers and UCH medical record numbers after acceptance by 
the Department of OBGYN of my COMIRB-approved study.  
Data from the medical records were collected in REDCap, a secure web-based 
application designed to support data capture for research studies (Harris et al., 2009).  
REDCap is underwritten by the University of Colorado’s CCTSI for all studies approved 
by the COMIRB, and is HIPAA compliant.  I completed training in Fall 2013 on using 
REDCap from the Vanderbilt University team who designed the program.  I also 
completed REDCap training through CCTSI.  Support for the use of REDCap in this 
project was provided by CCTSI (NIH/NCRR Colorado CTSI Grant Number UL1 
TR001082).  All information was completely de-identified when exported out of 
REDCap.  Once data capture was completed in REDCap of the medical record 
information, this data were combined with data from the UCPD and imported into SPSS 
or R for data analysis.  Data was only reported in the aggregate for this study.  
Project testing.  Prior to collecting data, the data collection instrument and chart 
abstraction process were thoroughly tested.  First, the data dictionary (including all 
variables, with corresponding values and format) was created and sent to both Dr. Oliwer 
Dziadkowiec, the UCH College of Nursing statistician, and the REDCap database 
specialist at the University of Colorado for feedback.  Second, test data from ten subjects 
in the UCPD who did not match this project’s inclusion specifications were collected into 
the REDCap database to test the instrument’s performance.  All fields in all sub-domains 
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of the REDCap instrument were used to test the functioning of event definition, 
branching logic, validated data ranges, and calculated fields during this test.  These data 
were then de-identified and exported to SPSS to test for correct export functioning.  All 
processes for this project’s REDCap instrument were found to function correctly during 
this test, and the project was then moved into production mode.  Test data were erased 
automatically in REDCap when the project was moved to production mode.   
  Intra-rater reliability of chart abstraction process.  Intra-rater reliability (IRR) of 
the chart abstraction process was tested using REDCap’s double data entry functionality.  
During chart abstraction, some charts were abstracted on two separate occasions and results 
were then compared for accuracy.  REDCap’s IRR functionality randomly selected the cases 
which were abstracted twice, and calculated percentage accuracy scores after repeat abstraction 
was completed.  Although there was only one rater for these abstractions, the abstractions were 
conducted on randomly selected charts, during episodes that were spaced apart by at least two 
weeks.  This double data entry process was completed for 20 charts (10 charts from women 
cared for by certified nurse-midwives, 10 charts from women cared for by obstetricians), 
representing 5.7% of the 348 medical record reviews performed in this study, as recommended 
in protocols for chart abstraction reliability estimates (To, Estrabillo, Wang, & Cicutto, 2008).  
IRR was estimated with intra-rater percent agreement for each area of data collection, and for 
the overall data form.  The IRR was measured at 95.14%, which meets recommendations that 
IRR be greater than 95% (Mi, Collins, Lerner, Losina, & Katz, 2013).   No one area of the 
REDCap collection instrument showed levels of chart abstraction error greater than 95%.  
Although calculation of intra-rater reliability of this study’s chart abstraction process did 
establish the accuracy of chart abstraction, it did not diminish the possibility of observer bias 
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because the same reviewer abstracted all charts.  Ideally, two or more separate reviewers would 
be compared using inter-rater reliability testing to decrease the possibility of observer bias in 
this study.   
  Human subjects considerations.  The project involved human subjects only.  
Nulliparous pregnant women and their infants comprised the population of interest.  The 
study included nulliparous women between the ages of 18 and 40 (childbearing ages) and 
their neonates during the immediate post-birth period of hospitalization.  The study was a 
non-intervention, retrospective, observational design utilizing existing medical 
information in the UCPD database and subjects’ hospital medical records.  Therefore, the 
study had no effect on the standard of care, health, or wellbeing of these women or their 
infants.  
Risk for human subjects from this study was limited to the possible exposure of 
patient’s personal health information through linkage of patient identifiers (medical 
record number) to health information.  Although data retrieved from the UCPD were 
indirectly identified so that personal protected information could not be traced back to the 
subject, medical record matching of UCPD subjects was undertaken to identify certified 
nurse-midwife clients after cross-referencing medical record numbers with the UCH 
CNM database.  Also, the 2nd, 3rd and 4th Aims of this study involved the medical record 
review of subjects’ hospital records. Variables that could be used to identify patients 
were labeled in REDCap as patient identifiers.  Within REDCap, these data were secure, 
with cloud-based back up and automated audit trails for tracking data manipulation 
(Harris et al., 2009).  Following the medical record review of each chart, medical record 
numbers were obliterated from the master list linking subject identification number for 
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this project to their UCH medical record number.  Also, prior to export of data for the 
purposes of analysis in SPSS, REDCap filters for de-identification of the data were used.  
COMIRB approval.  In conjunction with advisor Dr. Nancy Lowe, I applied for 
COMIRB approval for the proposed project in February 2014. An exempt review of the 
Human Subjects regulatory requirements was requested for the study.  Dr. Lowe has 
previously conducted other studies at UCD and other institutions involving 
methodologies similar to this study’s methodologies, and helped guide me in the process 
of COMIRB application.  Prior to COMIRB application, I also arranged for a formal 
review process meeting with a member of COMIRB in February 2013. Both a waiver of 
consent and waiver of HIPAA authorization were requested due to the retrospective 
nature of the study using medical record data.  COMIRB approval and waiver of HIPAA 
Authorization was provided to the project in May 2014 (Protocol # 14-0557).  Following 
these approvals, UCH Research Support Services authorization was sought and granted in 
May 2014.   
Operational Definitions of Variables 
  Exposure variable definitions. 
• Nulliparous:  First full-term pregnancy. 
• Obese:  (BMI ≥ 30 kg/m2) at time of delivery, computed using maternal height 
and weight at time of delivery as listed in the USPD. (Must have maternal height 
[maternheight] and weight fields [maternweight] complete in UCPD to be 
included in study). 
• Total weight gain in pregnancy:  Difference, in kg, between a woman’s pre-
pregnancy weight and her delivery weight, as listed in the UCPD.   
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• Healthy:  Non-diabetic (no gestational diabetes mellitus nor pre-existing diabetes), 
non-hypertensive (no pre-existing hypertension nor pregnancy-induced 
hypertension, no preeclampsia), term (≥ 37 0/7-41 0/7 weeks gestation). 
• Plan for vaginal delivery: Cephalic fetal presentation, singleton pregnancy, no co-
morbidity or complication at start of labor contraindicating trial of labor (i.e. 
complete placenta previa, active herpes, malpresentation, untreated HIV infection, 
major congenital anomaly of fetus). 
• Intrapartum management:  The provider (obstetrician or certified nurse-midwife) 
who admits the woman to the hospital for the visit during which labor and delivery 
occur.   
• Spontaneous labor onset:  No documented use of supervised medical or 
mechanical cervical ripening, AROM, or synthetic oxytocin induction of labor.  
Patients may or may not have used nipple stimulation, castor oil, or other methods 
of labor induction used without medical supervision.   
• Intact bag of waters:  No diagnosis of premature rupture of membranes (PROM) or 
spontaneous rupture of membranes (SROM) for > 24 hours prior to birth, or > 8 
hours prior to hospital admission.  Patients who presented to the hospital with 
SROM for less than 8 hours were included, but analysis for hospital admission and 
synthetic oxytocin use were controlled for SROM prior to hospital admission.   
• Perinatal Background Index:  A revised version of this tool was used to score 
each obese woman meeting inclusion criteria in the UCPD preceding propensity 
score matching of subjects to provider groups.  PBI was taken from the OI-US 
(Cragin & Kennedy, 2006, p. 780).  The PBI for nulliparous women (see Figure 9 
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in previous section) consists of eight socio-demographic and health status items 
(including marital, ethnic minority, smoking/alcohol/drug use, pre-pregnancy BMI, 
pre-existing chronic disease, history of serious antepartum condition, previous poor 
birth outcome) that were extracted in the proposed study from the UCPD.  
Outcome variable definitions. 
Aim 1 variables.   
• Unplanned cesarean delivery:  Outcome of cesarean delivery after a period of labor 
when vaginal birth was the initial plan.  Does not include pre-labor cesarean 
deliveries, or cesarean deliveries taking place within labor urgently and without the 
intention of allowing a trial of labor, after having been planned as pre-labor 
procedures.  
• Labor dystocia:  Diagnosis of the slow, abnormal progression of first stage labor 
(4-10 cm cervical dilation), including diagnoses of failure to progress (FTP), 
cephalopelvic disproportion (CPD), labor protraction or arrest disorder, used as the 
indication for unplanned cesarean delivery.  Includes diagnosis of failure to 
descend if made prior to 10 cm cervical dilation.  Does not include unplanned 
cesareans performed for primary indication of fetal intolerance of labor.  Does 
include unplanned cesareans if secondary indication after labor dystocia was fetal 
intolerance of labor.   
• Arrest of descent:  Diagnosis of failure of fetal head to descend in the maternal 
pelvis as indication for unplanned cesarean delivery.  If this diagnosis is made after 
10 cm cervical dilation as an indication for unplanned cesarean delivery, will be 
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considered a labor obstruction disorder and not counted as a labor dystocia cesarean 
delivery outcome. 
• Fetal intolerance of labor:  Includes diagnoses of non-reassuring fetal heart rate 
tracing and Category 3 fetal heart rate tracing.  When used as the only indication, or 
the primary indication, for unplanned cesarean delivery, this diagnosis will not be 
counted as a labor dystocia cesarean delivery outcome. 
Aim 2 variables. 
• Cervical exam findings:  Includes cm dilation, station, and effacement of cervix, as 
measured by digital exam of nurse, obstetrician, or certified nurse-midwife.  
• Hospital admission:  Time and date of subject’s admission to the hospital for the 
purposes of labor and delivery.   
• Hospital admission at < 4cm cervical dilation:  Occurrence of hospital admission 
on the hospital visit wherein both labor and birth took place in a woman whose 
most recent cervical examination prior to admission decision was recorded as less 
than 4cm dilation.   
• Epidural:  Administration of epidural anesthesia to woman while in labor, utilizing 
any combination of anesthetics and/or opioids.  May include spinal anesthesia or 
combined spinal epidural.   
• Artificial rupture of membranes:  Rupture of membranes done as a procedure by 
the nurse, certified nurse-midwife, or obstetrician after spontaneous onset of labor 
using amni-hook, internal scalp electrode, finger-needle, or other mechanical 
means.  Does not include artificial rupture of forebag after SROM.   
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• Augmentation of labor:  Stimulation of uterine contractions with synthetic oxytocin 
after the onset of spontaneous labor using synthetic oxytocin, misoprostol, cervidil, 
foley bulb, or Cook’s catheter.   
  Aim 3 variables. 
• Synthetic Oxytocin total duration:  Time from onset of synthetic oxytocin drip in 
spontaneously initiated labor until vaginal birth of baby in minutes. This time will 
include periods when pitocin infusion was turned off, if those periods were less 
than 30 min in duration. 
• Synthetic oxytocin total dose:  Total, accumulated dose of synthetic oxytocin 
infused in milliunits, after spontaneous onset of labor, from start of augmentation 
until vaginal birth of baby.   
• First stage of labor duration:  Time in minutes from 4-10 centimeters of cervical 
dilation.  Duration was calculated in reverse, from the first cervical exam revealing 
10cm dilation back in time to lesser dilations.  This methodology was used in labor 
duration studies where repeated measure regression analysis with reverse approach 
was used to model labor progression slopes by BMI (Kominiarek et al., 2011; 
Norman et al., 2012). 
• Second stage labor duration:  Time from 10 centimeters cervical dilation until birth 
of baby.  If no cervical exam was completed to document the time when 10 cm was 
achieved, time when woman began pushing preceding birth would be used. 
  Aim 4 variables. 
• Ambulation in labor:  Walking, while in labor, for ≥ 15 minutes as documented in 
the medical record.  A low-technology intrapartal intervention. 
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• Continuous labor support:  Presence of one-to-one support from a trained labor 
support person (doula or certified nurse-midwife) during labor for more than one 
hour. 
• Intermittent electronic fetal monitoring (iEFM):  Monitoring of fetal heart tones 
with hand held Doppler or bedside machine intermittently for some part of labor. 
With AWHONN or ACOG guidelines for intermittent EFM, woman is allowed at 
least 40 minutes per hour without the fetal heart rate and uterine contraction being 
continuously electronically monitored.  A low-technology intrapartal intervention. 
• Hydrotherapy in labor:  Immersion of woman while in active labor in warm water 
to a level above her abdomen for some period in labor or shower. A low-
technology intrapartal intervention. 
Adverse outcome variables 
• Maternal outcomes: 3rd and 4th degree perineal lacerations, postpartum hemorrhage 
(≥ 500cc estimated blood loss for a vaginal delivery, or ≥ 1000cc following 
cesarean delivery), maternal fever > 100.1° F, transfer to ICU during 
hospitalization, need for D&C in first 24 hours postpartum, unplanned return to 
surgery, need for transfusion of blood or blood products, diagnosis of shoulder 
dystocia, maternal death. 
• Neonatal outcomes: APGAR score < 7 at 5 minutes, NICU admissions, neonatal 
sepsis diagnosis, neonatal death or birth-related injury diagnosis. 
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Potential confounding variables 
• Maternal height:  maternal height, as documented in the UCPD, in meters.  Will be 
analyzed as both a continuous and categorical variable (> or < 1.5m) (Kominiarek 
et al., 2010). 
• Maternal educational attainment:  Years of education, as documented in the 
UCPD. 
• Maternal race:  As documented in UCPD (White, Black, American-Indian, Asian, 
Native Hawaiian, Other) 
• Maternal age:  Age, in years, of mother at date of hospital admission as 
documented in UCPD. 
• Birth weight:  Weight of neonate, in kilograms, as documented on first full 
assessment following birth and recorded in the UCPD.   
Data Analysis Preparation  
 
  With statistical support from Oliwier Dziadkowiec, PhD, director of the University of 
Colorado College of Nursing’s Center for Nursing Research, the following data analysis 
preparation, including a priori power analysis calculations, was conducted for each project aim:   
 Aim 1.  Compare the risk of cesarean delivery for the indication of labor dystocia 
among healthy, nulliparous, overweight or obese women receiving intrapartum care from 
certified nurse-midwives vs. obstetricians. 
 A1H1.  Healthy, nulliparous obese women will be less likely to undergo unplanned 
cesarean delivery for the indication of labor dystocia when managed by certified nurse-
midwives compared to similar women managed by obstetricians.  This hypothesis is based on 
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data from previous studies showing that nurse-midwifery practices tend to have lower rates of 
labor dystocia when compared to obstetrician practices (Leeman & Leeman, 2003). 
  Logistic regression analysis with an alpha level of 0.05 was planned to test for 
differences in the rate of cesarean section between care provider groups. Based on 
expected base rates of 25% in the obstetric care group and 20% in the midwifery care 
group, which is the smallest observed difference that we expected to detect on this 
outcome variable, the projected sample size would provide power = .80 (minimum 
calculated sample size = 601).  
  Aim 2.  Among healthy, nulliparous obese women having cesarean delivery for labor 
dystocia, examine how exposure to labor interventions differs when compared to similar 
women having vaginal delivery. 
  A2H1. Healthy nulliparous obese women who end labor with cesarean delivery for 
labor dystocia will be more likely than similar women ending labor with vaginal delivery to 
receive epidural, AROM, foley bulb, misoprostol, and synthetic oxytocin augmentation. 
  A2H2.  Healthy nulliparous obese women who end labor with cesarean delivery 
for labor dystocia are more likely than similar women ending labor with vaginal delivery 
to receive AROM at < 6cm cervical dilation, synthetic oxytocin augmentation at < 6cm, 
or hospital admission at  < 4 cm cervical dilation. 
  A2H3. Healthy nulliparous obese women who end labor with cesarean delivery 
for the indication of labor dystocia are more likely than similar women ending labor with 
vaginal delivery to experience onset of intrapartum interventions while having normal 
cervical progression. 
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  For these analyses, logistic regression analysis with an alpha level of 0.05 was 
planned to test for differences in delivery outcome based on the use of interventions in 
the ‘red zone’ of the BMI-individualized partograms. Separate logistic regression 
analyses were planned for each intervention: AROM, synthetic oxytocin, and epidural.  
Sample size of 200 subjects per group is based on power analysis for the Aim 2 analysis 
with the lowest expected frequencies (Aim 2, Hypothesis 3).  For Aim 2, H3, beta = .20 
assumed a 30% rate of cesarean among women receiving interventions in the “red zone” 
compared to a 20% cesarean rate among women receiving interventions in the green 
zone, with an anticipated 50% chance that synthetic oxytocin or AROM were performed 
in the red zone and an anticipated 60% chance that epidural occurred in the red zone 
(minimum calculated sample size = 347).  
   Aim 3.  Characterize use of synthetic oxytocin in labor augmentation by maternal 
delivery BMI in nulliparous, obese women who achieve vaginal birth. 
A3H1. Healthy nulliparous obese women with higher delivery BMI will require larger 
total doses of synthetic oxytocin and longer oxytocin infusion duration to achieve vaginal birth 
when compared to women with lower delivery BMI. 
Power analysis for the projected sample size required for this analysis was based 
on alpha = .05, with an effect size of d = 0.15 (conservative estimate, based on published 
findings of BMI-influenced changes in synthetic oxytocin dose and duration (Nuthalapaty 
et al., 2004; Pevzner et al., 2009).  Planned analyses include multiple regression for both 
total time and total dose of synthetic oxytocin against predictor variable of BMI 
(continuous) (minimum sample size = 53 women).  
           127 
A3H2. The hour-to-hour dose of synthetic oxytocin will vary over time from 
hospital admission until birth for each woman, and these hourly dose patterns will tend 
to group depending on the BMI of the women, the woman’s provider, and the size of her 
baby. 
For this final analysis in Aim 3, multi-level modeling was used to test for these 
individual differences in synthetic oxytocin dose, and to test for the influence of several 
grouping variables on the dosing patterns of synthetic oxytocin in obese women.  Power 
analysis for this multi-level analysis was based on the Level 2 units, or the number of 
women required to show a difference in synthetic oxytocin dose during labor.  For this 
continuous outcome (hourly synthetic oxytocin dose), the software “Optimal Design” 
was used to calculate minimum sample size (Spybrook, Bloom, Congdon, Hill, Martinez, 
and Raudenbush, 2011).  It was anticipated that adequate power of 0.80 would be 
obtained from a minimum sample size of 39 women per BMI groupings, assuming alpha 
= 0.05, effect size = 0.15 with number of BMI groupings = 3, average number of hours of 
oxytocin dose per woman = 15, and minimal clinically important variation of hourly 
synthetic oxytocin dose by maternal BMI grouping = 10%.  Thus, 117 women across all 
BMI groups were needed for this analysis.  
  Aim 4.  Among healthy, nulliparous obese women ending labor with cesarean delivery 
for labor dystocia, examine how exposure to low-technology interventions differs from similar 
women ending labor with vaginal delivery. 
  A4H1. Healthy, nulliparous obese women who end labor with vaginal delivery 
are more likely to make use of low-technology interventions in labor compared to similar 
women who end labor with cesarean delivery for the indication of labor dystocia. 
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  A4H2. Healthy nulliparous obese women who end labor with cesarean delivery 
for labor dystocia are less likely than similar women ending labor with vaginal delivery 
to engage in ambulation, hydrotherapy, or intermittent fetal monitoring at > 6 cm 
cervical dilation and to engage in these activities for shorter total periods of time in 
labor. 
  A4H3. Healthy nulliparous obese women who end labor with cesarean delivery 
for the indication of labor dystocia are less likely than similar women ending labor with 
vaginal delivery to experience onset of low-technology intrapartum interventions while 
having abnormal cervical progression. 
  For these analyses, logistic regression analysis with an alpha level of 0.05 was 
planned to test for differences in delivery outcome based on the use of low-technology 
interventions. Separate logistic regression analyses were planned for each low-technology 
intervention: ambulation, hydrotherapy, intermittent electronic fetal monitoring.  Sample 
size of 200 subjects per group is based on power analysis with beta = .20 which assumes 
a 30% rate of cesarean among women receiving low-technology interventions compared 
to a 20% cesarean rate among women receiving no low-technology interventions 
(minimum calculated sample size = 347).  
Analyses described in the above Aims were also planned to include known 
confounders of relationships between maternal delivery BMI and labor processes and 
outcomes.  These variables included: maternal height, maternal race, maternal age, 
maternal educational achievement, gestational age, fetal weight, and components of the 
PBI (including marital, ethnic minority, smoking/alcohol/drug use, pre-existing chronic 
disease, major psychosocial complications, and miscellaneous chronic diseases before or 
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during pregnancy).  Bivariate relationships between these possible confounders and the 
outcomes of each Aim were planned for each analysis, with plans that if any potential 
confounding variable was showed a significant difference by an Aim’s outcome, it would 
be included in multivariate analyses as a covariate.  
In addition to the above analyses, data were also collected for the purpose of 
estimating the rates of maternal and neonatal morbidity outcomes.  Frequency statistics 
on the total incidence of maternal and neonatal adverse events were calculated and 
presented in each Aim.  These outcomes include the following adverse events, suggested 
as national standards by the Institute for Healthcare Improvement to measure perinatal 
harm (2012): 
• Maternal adverse events: 3rd and 4th degree perineal lacerations, postpartum 
hemorrhage (≥ 500cc estimated blood loss for a vaginal delivery, or ≥ 1000cc 
following cesarean delivery), maternal fever > 100.1°F, diagnosis of shoulder dystocia, 
death. 
• Neonatal adverse events: APGAR score < 7 at 5 minutes, NICU admissions, neonatal 
death, neonatal sepsis diagnosis, or birth-related injury diagnosis. 
 





  For each of the four Aims included in this dissertation project, analysis is summarized 
below in text and presented in tables, along with sample selection and key results.  For each of 
the key variables in each Aim, analysis of normality, homogeneity of variance across 
comparison groups, and measurement level (assumptions of parametric tests) were 
calculated using SPSS Version 21, 2012.  All non-normal variables (statistically 
significant p-value < 0.01 on Kolmogorov-Smirnov statistic) are shown with descriptive 
statistics for median and interquartile range, while normal variables (variable of baby’s 
birth weight was the only normally-distributed variable in these analyses) are described 
using mean and standard deviation (Plichta & Kelvin, 2013).  All variables showed 
independence of observations, as the subjects in these analyses were nulliparous women 
with singleton pregnancies (only one birth described for each case).  Any variables with 
heterogeneous distribution of variance across comparison groups (statistically significant 
p-value < 0.01 on Levene’s statistic) are noted in results section for that Aim with 
explanation and further analyses causing this heterogeneity of variance provided.   
  Following the calculation of descriptive statistics, bivariate analyses for each 
variable were conducted comparing groups for that Aim.  For these bivariate analyses, 
non-normally distributed variables with continuous distribution were compared using 
Mann-Whitney U test (Plichta & Kelvin, 2013).  Non-normally distributed categorical 
variables were compared using either chi-square with continuity correction (2 levels) or 
the Kruskal-Wallis H test (> 2 levels).  Normally distributed continuous variables were 
compared using t-tests, while normally distributed categorical variables were compared 
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using ANOVA.  Both p-values and test statistics for each of these bivariate analyses are 
provided in included tables, except for the Kruskal-Wallis H test and the Mann-Whitney 
U test, which are non-parametric analyses reporting only p-values.  Finally, inter-
correlations were calculated using Spearman’s rho (rs) between the primary predictor and 
outcome variables for each Aim.   
  Multivariate analyses for each Aim were calculated using R statistical software (R 
2.14.2) (R Core Development Team, 2013).  Specific R packages used in these 
multivariate analyses are described for each Aim.  If multivariate analyses showed a 
statistically significant relationship between that Aim’s predictor and outcome, 
subsequent multivariate models were built to investigate the influence of covariates 
suggested by the existing literature on the relationship between the predictor and outcome 
variables.  Each model is described in text and tables for the Aims.   
Aim 1 
 Compare the risk of cesarean delivery for the indication of labor dystocia among 
healthy, nulliparous, overweight or obese women receiving intrapartum care from certified 
nurse-midwives or obstetricians. 
Sample 
 After all study exclusions were applied, 1,119 cases of healthy (no diabetes, no 
hypertension), obese or overweight (BMI > 24.99 kg/m2) nulliparous women aged 18-40 
years with spontaneous onset of labor and normal fetus who were managed in labor by 
certified nurse-midwives (CNMs) or obstetricians (OBs) remained from the original 
sample of 22,443 women in the University of Colorado Perinatal Database (UCPD) 
(Figure 15).  It was originally intended that this Aim 1 analysis would focus only on 
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obese women (BMI ≥ 30 kg/m2).  However, there were insufficient numbers of obese 
women in the CNM and OB groups in the UCPD after propensity matching to meet the 
sample size required by a priori by power analysis.  Therefore, the inclusion criteria for 
the Aim 1 sample were revised to include women who were either overweight (BMI 
25.0-29.99 kg/m2) or obese.  Propensity score random matching using Perinatal 
Background Index scores of these 1,119 cases produced a group of 397 women who were 
managed by CNMs and a perinatal risk factor-matched group of 397 women managed by 
OBs in labor.  After propensity score matching, a final exclusion criterion was applied to 
exclude all cases of cesarean delivery for any other indication besides labor dystocia.  
Total remaining sample size after this final exclusion was 718, thus meeting the required 
sample size of 601 cases according to a priori power analysis.  
Key Variables  
  All variables in this analysis had non-normal distributions except baby’s birth 
weight (Tables 7-8).  Only two variables were heterogeneous across groups defined by 
provider type in labor.  Both maternal education attainment and year of delivery were 
heterogeneous on Levene’s test (p < 0.001).  Maternal education attainment was lower in 
the CNM provider group compared to the OB provider group.   This heterogeneity was 
related to the higher numbers of Hispanic women in the CNM group, and is discussed in 
following section presenting bivariate statistical findings.  Year of delivery also showed 
heterogeneity of variance across provider groups; there were more deliveries in the OB 
group from earlier in the UCPD time range than CNM births.  This discrepancy was 
caused by my inability to identify CNM births performed prior to 2008 in the University 
of Colorado Perinatal Database.  Provider type was not included as a variable in this  
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Figure 15. Aim 1 subject selection flow diagram.  Template based on Consolidated 
Standards of Reporting Trails (CONSORT) Flow Diagram, accessed at www.consort-
statement.com.   
 
database, and record of CNM births prior to 2008 were missing from the UNM patient 
logbook.  To control for this discrepancy between OB and CNM groups on year of 
delivery, it was planned that any statistically significant results in multivariate modeling 









OB labor management (n=622)  
Propensity matched using Perinatal 
Background Index score 
Sample created after matching=397 
!
CNM labor management (n=497)  
Propensity matched using Perinatal 
Background Index score 




Analysed (n= 352) OB management after final 
exclusion applied:   
 (Excluded n=45):  Cesarean deliveries for 
indication other than labor dystocia: 
♦!!!Cesarean for fetal intolerance (n=28) 
♦!!!Cesarean for failure to descend (n=17) 
 
!
Analysed (n= 366) CNM management after 
final exclusion applied:   
 (Excluded n=31):  Cesarean deliveries for 
indication other than labor dystocia: 
♦!!!Cesarean for fetal intolerance (n=16) 





Assessed for eligibility in 
University Colorado Perinatal 
Database (n=22,443) 
Excluded  (n= 21,324) 
♦!!!Missing BMI in UCPD (n=1,461) 
♦!!!Missing MRN in UCPD (n=78) 
--- 




♦!!!Fetal anomalies (n=1,180) 
♦!!!Planned cesarean (n=1,508) 
♦!!!Severe maternal co-morbidities (n=212) 
♦!!!Ruptured membranes >24 hour prior to birth (n=1,284) 
♦!!!Low amniotic fluid (n=700) 
♦!!!Contraindicated for vaginal birth (n=57) 
--- 
♦!!!Multiparous (n=6,826) 
♦!!!Maternal age <18 years or >40 years (n=653) 
♦!!!Non-spontaneous labor (n=1,072) 
♦!!!Delivery!BMI < 25.0 kg/m2 (n=573) 
♦!!!Hypertension prior to or during pregnancy (n=182) 
♦!!!Diabetes prior to or during pregnancy (n=72) 
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Table 7:  Aim 1 Demographic Variables for Total Sample and by Provider Group:  
Means or Medians, Standard Deviations or Inter-quartile ranges, Tests of Normality, 
Frequencies and Comparison of Groups by Provider Type 
Variables 
Total Sample 
(N = 794) 
CNM 
(n = 397) 
OB 
(n = 397) 
Group 
Comparisons 
Mother’s age @ delivery in 
yearsr, † 













p < .001* 
Educational attainment of 
mother 
in completed years r, † 






















 p< .001* 
Year of Deliveryr, † 













p < .001* 
Marital statusn 








χ2 = 0.081 










χ2 = 8.250 


















































p = 0.001* 
Note. r = Ratio level variable. n = Nominal level variable. † = Non-Normal distribution of variable 
across total sample. *Kruskal-Wallis H test used for categorical variables (> 2-levels) or Mann-
Whitney U (non-parametric) used for continuous variables.  These non-parametric tests do not 
provide test statistic, but only p-value.  Normality tested using Kolmogorov-Smirnov statistic.  
Homoscedacity tested using Levene’s statistic (L).  Chi-square test with continuity correction 
used for categorical variables (2-levels).  Tests with significant values are shown in bold. 
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Table 8:  Aim 1 Maternal/Infant Variables for Total Sample and by Provider Group: 
Tests of Normality, Means or Medians, Standard Deviations or Inter-quartile ranges, 





(N = 794) 
CNM 
(n = 397) 
OB 
(n = 397) 
Provider Type  
Group 
Comparisons 
Perinatal Background Index 
score i, † 
 


















p = 0.526* 
Pre-Pregnancy BMI (kg/m2) r, † 
 

















p = 0.527* 
Maternal Height (meters) r, † 
 















p = 0.248* 
Maternal Delivery BMI r, † 
 

















p = 0.895* 
Baby’s birthweight (kg) r, †† 
 















t = -2.73 
p = 0.007 
Gestational age (continuous) 
in weeks r, † 
 

















p = 0.003* 
Note. r = Ratio level variable. I = Interval level variable. † = Non-Normal distribution of variable 
across total sample. †† = Normal distribution of variable across total sample. *Kruskal-Wallis H 
test used for categorical variables ( > 2-levels) or Mann-Whitney U (non-parametric) used for 
continuous variables.  These non-parametric tests do not provide test statistic, but only p-value. 
Normality tested using Kolmogorov-Smirnov statistic.  Homoscedacity tested using Levene’s 
statistic (L).  Chi-square test with continuity correction used for categorical variables (2-levels). 
Tests with significant values shown in bold. 
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Bivariate Analysis of Demographic, Maternal/Infant Characteristics, and Labor 
Interventions/Outcomes  
Comparisons were made between the CNM and OB groups on demographic 
variables (Table 7), maternal/infant characteristics (Table 8) and labor 
interventions/outcomes (Table 9). Among the demographic variables, CNM patients were 
significantly younger, had lower educational attainment, and were more likely to be 
Hispanic/Latino and Caucasian than subjects in the OB group (Table 2). The difference in 
maternal age between provider groups reflects the higher percent of Hispanic women in 
the CNM group (52.6% of CNM patients vs. 42.8% of OB patients) who were younger 
than non-Hispanic women in the total sample (median = 23 years vs. median = 24 years, 
p < 0.001). 
 Baby’s birth weight was significantly higher among CNM patients and the only 
maternal/infant characteristic that differed between provider groups (Table 8). Post-hoc 
analysis with ANOVA of the significant difference in baby’s birth weight between OB 
and CNM groups revealed that it was largely explained by the longer gestational ages 
found among CNM patients (14.2% of CNM patients had later term gestational age 
compared to only 10.1% of OB patients).  Baby’s birth weight was significantly 
associated with gestational age (p =0.003) and with provider group (p = 0.007); however, 
there was no significant interaction effect between gestational age and provider type on 
baby’s birth weight (p = 0.809).   
 Among the labor intervention/outcome variables, anesthesia (epidurals/combined 
spinal epidurals) use and operative vaginal delivery were less common among CNM  
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Table 9:  Aim 1 Labor Interventions and Outcomes by Provider Group:  Mean or Median, 





(N = 794) 
OB 
(n = 397) 
CNM 
(n = 397) 










χ2 = 0.408 
p = 0.523 






χ2 = 13.443 
p < 0.001 






χ2 = 5.260  
p = 0.072 








χ2 = 1.319 
p = 0.251 
Cervical dilation @ 
admission (centimeters) 









p = 0.197 
Labor Outcomes 
Cesarean delivery for labor 







χ2 = 0.113 
p = 0.736 
Cesarean delivery for fetal 







χ2 = 2.911 
p = 0.088 
Cesarean delivery for 







χ2 = 0.033 
p = 0.857 






χ2 = 2.641  
p = 0.104 
Operative Vaginal Delivery 








χ2 = 12.348 
p < 0.001 






χ2 = 0.716 
p = 0.397 








χ2 = 0.478 









χ2 = 0.530 
p = 0.467 








χ2 = 3.571 
p = 0.059 






χ2 = 4.349 
p = 0.037 






χ2 = 0.249 
p = 0.618 
Neonatal death 0 0 0  
Neonatal sepsis diagnosis 0 0 0  
Neonatal injury diagnosis 
(Intraventricular 
Hemorrhage/Seizure) 
0 0 0  
Note. *Group comparisons performed using chi-square with continuity correction for categorical variables 
and Mann-Whitney U test for cervical dilation at admission.  Bivariate analyses with statistically significant 
results (p < 0.05) shown in bold. 
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patients, while Apgar scores less than 7 at five minutes were more frequent compared to 
OB patients (Table 9).  Anesthesia use occurred in 70.5% of CNM patients compared to 
81.9% of OB patients (p < 0.001); operative vaginal delivery in 5.0% compared to 12.3% 
(p < 0.001); and Apgar scores less than 7 at 5 minutes in 12 newborns compared to 3 (p = 
0.037).  Among the 12 newborns in the CNM group with 5-minute Apgar scores less than 
7, 11 had 10-minute scores greater than 7 and four were delivered by cesarean.  However, 
there was no difference by provider group in the incidence of neither NICU admission 
(p=0.618) nor APGAR score < 7 at 10 minutes (p = 0.317).  All other variables, including 
the outcome of unplanned cesarean for the indication of labor dystocia, did not show 
statistically significant differences by provider group. 
  Inter-correlations among the primary variables of this analysis were also run 
(Table 10).  Only two variables (maternal delivery BMI and gestational age) were 
correlated with the outcome of cesarean section for labor dystocia at a p < 0.05 level.  
However, there were highly statistically significant (p > 0.01) correlations between 
baby’s birth weight and gestational age, and baby’s birth weight and maternal height.  
These correlation results were used to make decisions about predictors included in the 
multivariate analyses run for this Aim.   
Aim 1, Hypothesis 1 Multivariate Analysis 
  Logistic regression analysis with an alpha level of 0.05 was run to test the Aim 1 
hypothesis that healthy, nulliparous obese women would be less likely to have unplanned 
cesarean delivery for the indication of labor dystocia when managed by certified nurse-
midwives in labor compared to women managed by obstetricians.   Because the outcome of 
cesarean delivery for labor dystocia was rare in the dataset (37 cesareans for labor  
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Table 10: Aim 1 Inter-Correlations of Cesarean Delivery for Labor Dystocia and 
Predictor Variables 
Measure 1 2 3 4 5 6 
1.  Cesarean 
delivery for labor 
dystocia 
--      
2.  Maternal BMI at 
hospital admission 
.105** --     
3.  Gestational age 
at hospital 
admission 
.074* .044 --    
4.  Maternal height -0.50 -0.28 0.080* --   
5.  Maternal age 0.037 -0.133** -0.35 0.123** --  
6.  Baby’s birth 
weight 
0.72 0.127** 0.338** 0.251** 0.041 -- 
Note. Values calculated using Spearmen’s rho (rs).  *p < .05.  **p < 0.01. 
 
 
dystocia/681 vaginal births), rare events logistic regression was used instead of a 
traditional logistic regression based on a generalized linear model.   
  Rare events logistic regression uses the same model as standard logistic 
regression, but corrects for bias in estimates of predictor parameters when the sample is 
small or observed effects are rare (Imai, King, & Lau, 2007; King & Zeng, 2001).  In 
binary variable models with rare outcomes, biases can sometimes be as large as estimated 
effects.  The relogit procedure developed by King and Zeng specifies tau, a vector 
estimating the true population incidence of the event in question (in this analysis, event = 
DV = cesarean delivery for labor dystocia and tau is set at 37 events/681 vaginal births).  
Once tau is defined, the relogit program estimates slope coefficients and constant terms 
with a case control design, then corrects for any bias introduced.  In this way, events are 
balanced with non-events for the purpose of model estimation.   Rare events logistic 
regression was run in R 2.14.2 Statistical Software (R Development Team, 2013) using 
the relogit package for Zelig (Imai et al., 2007).   
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 First, a NULL model (Model 0) was estimated with the DV=cesarean delivery for 
labor dystocia (event) or vaginal birth (non-event) in the propensity score-matched 
dataset and with IV= no predictor variables (Table 11).  Afterwards, predictor groups 
were added to the model based on the Aim 1 hypothesis and the need to evaluate control 
variables.  Each time a new model was fit, it was compared to previous models for fit 
statistics and residual variance.  The sequence of models and findings is summarized 
below.  









M1 -2.73 Provider in 
Labor 
-0.21 0.34 0.539 0.81 [0.41-1.57] 
















0.29 0.19 0.124 1.36 [0.94-1.98] 
Year of 
birth 
0.14 0.09 0.142 1.15 [0.95-1.40] 
Maternal 
height 
-0.14 0.07 0.039 0.87 [0.76-0.99] 
Maternal 
age 




0.87 0.48 0.072 2.38 [0.95-6.27] 
Note. CI = confidence interval for odds ratio (OR) provided for significant predictors. 
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Model 1 (M1)   
  The M1 model was constructed to determine if the odds of cesarean delivery for 
labor dystocia are changed by the provider caring for the woman in labor (Aim 1, H1) 
(Table 11).  Rare events logistic regression was run including DV: cesarean delivery for 
labor dystocia or vaginal birth and IV: provider in labor.  As presented in Table 12, 
higher model fit statistics (Akaike’s Information Criterion “AIC”, residual deviance) 
indicated that the inclusion of the predictor provider in labor did not improve model fit 
for the prediction of cesarean delivery for labor dystocia in this dataset over the null 
model with no predictors.  Therefore, provider in labor does not appear to predict 
cesarean for labor dystocia in this nulliparous, overweight and obese sample of women. 
Model 2 (M2)   
  This model was constructed to determine if the odds of cesarean delivery for labor 
dystocia were changed by the BMI of woman at the time of hospital admission.  Since 
both overweight and obese women were included in this sample, this logistic model 
allowed the influence of BMI on the outcome to be interpreted.  Model 2 (DV: cesarean 
delivery for labor dystocia or vaginal birth and IV: Maternal delivery BMI) was a better 
fit for the data when compared to the Null model (M0), with lower AIC and residual 
deviance (Table 12).  In addition, maternal delivery BMI was significantly associated 
with the outcome of cesarean delivery for labor dystocia (Table 11).  In this model, a one 
point increase in BMI resulted in a 1.07 increased odds that cesarean delivery for labor 
dystocia would occur (OR 1.07 [97.5% CI 1.00-1.13]).  Thus, a morbidly obese woman 
with delivery BMI of 40 kg/m2 would have a 10.7 fold increased risk of cesarean delivery 
for labor dystocia when compared to an obese woman with BMI of 30 kg/m2. 
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Model 3 (M3) 
  This model was constructed to include all variables found to be significantly 
associated on intercorrelation with cesarean delivery for labor dystocia in this sample:  
gestational age and maternal delivery BMI (Table 10).  In addition, M3 was built to 
include other variables shown in the literature to be associated with cesarean delivery for 
labor dystocia:  maternal age, baby’s birthweight, and maternal height (Abenhaim & 
Benjamin, 2011; Kominiarek et al, 2010; Vahratian et al, 2005) to see if the significant 
association shown in M2 between maternal delivery BMI and the outcome of cesarean 
delivery for labor dystocia would remain significant when included in a full logistic 
model alongside other known predictors.  Finally, M3 included the variable of delivery 
year, which was found to be significantly different among CNM or OB groups in this 
sample.  Model 3 (DV:  cesarean delivery for labor dystocia or vaginal delivery, IV: 
maternal delivery BMI + gestational age + year of birth + maternal height + baby’s birth 
weight) showed improved model fit statistics over M2 (Table 12).  The influence of 
maternal BMI remained significant on the outcome of cesarean delivery for labor 
dystocia in this model, and at a similar level of effect (M3 maternal BMI OR = 1.07 
[97.5% CI 1.00-1.14], p = 0.029) (Table 11).  In addition, maternal height was also 
significantly related to cesarean delivery for labor dystocia OR = 0.87 [97.5% CI 0.76-
0.99]).  Thus, for every one-inch increase in maternal height (assuming maternal BMI, 
gestational age, year of birth, baby’s birth weight, and maternal age stayed constant), the 
odds of cesarean delivery for labor dystocia decreased by 13%. Gestational age was no 
longer significantly associated with the outcome in this final model. 
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In conclusion, this analysis is consistent with retention of the null hypothesis for 
Aim 1:  provider caring for obese and overweight women in labor did not influence the 
outcome of cesarean delivery for labor dystocia in this sample of nulliparous women 
giving birth at the University of Colorado Hospital.  However, maternal BMI at the time 
of hospital admission (maternal delivery BMI) was significantly associated with the 
outcome of cesarean delivery for labor dystocia.  Even when evaluated in a logistic 
regression model including known predictors of cesarean delivery for labor dystocia 
(M3), maternal BMI at the time of hospital admission, along with maternal height, was 
significant and not diminished in its association with the outcome.  Thus, maternal BMI 
at the time of hospital admission is an independent risk factor for the outcome of cesarean 
delivery for labor dystocia.     
 
Table 12:  Aim 1 Residual Variance and Model Fit Statistics for Models 0 (Null model) 
and Model 1 
 

























293.51 295.12 291.2 284.65 
Note. *Model 3 includes predictors of: maternal delivery BMI, gestational age, year of 
birth, maternal age, maternal height, baby’s birth weight. 
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Aim 2 
 
  Among healthy, nulliparous obese women having cesarean delivery for labor dystocia, 
examine how their exposure to labor interventions differs when compared to similar women 
having vaginal delivery. 
  In A2H1, healthy nulliparous obese women who end labor with cesarean delivery for 
labor dystocia will be more likely than similar women ending labor with vaginal delivery to 
receive epidural, AROM, foley bulb, misoprostol, and synthetic oxytocin augmentation. 
  In A2H2, healthy nulliparous obese women who end labor with cesarean delivery 
for labor dystocia are more likely than similar women ending labor with vaginal delivery 
to receive AROM or synthetic oxytocin at <6 cm cervical dilation, or hospital admission 
at <4 cm cervical dilation.    
  In A2H3, healthy nulliparous obese women who end labor with cesarean delivery 
for the indication of labor dystocia are more likely than similar women ending labor with 
vaginal delivery to experience onset of intrapartum interventions including synthetic 
oxytocin, AROM, and epidural while having normal cervical progression.   
Sample   
  The sample for Aims 2 and 4 was created from the same database, the UCPD, as 
was used to create Aim 1.  However, Aim 2/4 did not include cases with overweight 
delivery BMIs (BMI 24.99-29.99 kg/m2), which were included in the Aim 1 sample.  
After all Aim 2/4 study exclusions were applied, 542 cases of healthy (no diabetes, no 
hypertension), obese (BMI > 30.00 kg/m2) nulliparous women aged 18-40 years with 
spontaneous onset of labor and normal fetus who were managed in labor by certified 
nurse-midwives (CNMs) or obstetricians (OBs) remained from the original sample of 
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22,443 women in the UCPD (Figure 16).  Propensity score random matching using 
Perinatal Background Index scores of these 542 cases produced a group of 200 women 
who were managed by CNMs and a perinatal risk factor-matched group of 200 women 
managed by OBs in labor.  After propensity score matching, medical record reviews were 
performed for each case, and a final exclusion criterion was applied to exclude all cases 
of cesarean delivery for any other indication besides labor dystocia.  When choosing 
cases from the UCPD for this Aim, cesarean deliveries coded as “fetal intolerance of 
labor” and “failure to descend” were included if they were also coded as ‘failure to 
progress’.  After medical record review of the provider’s progress notes for cesarean 
indication details, 52 cases were excluded where the primary indication for cesarean 
delivery was either fetal intolerance of labor or failure to descend.  Thus, the final sample 
for Aim 2 included only women who had either vaginal delivery (operative or 
spontaneous) or cesarean delivery for labor dystocia.  In addition, several cases were also 
excluded because their medical record could not be located, or was missing essential 
information.  Total remaining sample size after these final exclusions was 348, thus 
meeting the required sample size of 347 cases according to a priori power analysis.  
Key Variables   
 Although subjects in this sample were selected after the application of inclusion 
criteria to the UCPD, data presented for all Aim 2 analyses were obtained from medical 
record review only.  This is different from Aim 1, where all inclusion criteria and all 
analyses were based on data contained in the UCPD, and no medical record review was 
performed.  All variables in this analysis had non-normal distributions except baby’s 
birth weight (Tables 13 & 14).  
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Figure 16:  Subject Selection Flow Diagram for Aims 2-4. Template based on 











OB labor management (n=287)  
Propensity matched using Perinatal 
Background Index score 
!
CNM labor management (n=255) 
Propensity matched using Perinatal 




Reviewed charts (n= 200) OB management 
♦!Excluded from analysis (n= 27):  
Cesarean for fetal intolerance (18), Cesarean 
for failure to descend (7), missing chart (2) 
!
Reviewed charts (n= 200) CNM management 
♦!Excluded from analysis (n= 25):   
Cesarean for fetal intolerance (15), Cesarean 
for failure to descend (6), missing chart (4) 
!
Assessed for eligibility in 
University Colorado Perinatal 
Database (n=22,443) 
Excluded  (n= 21,901) 
♦!!!Missing BMI in UCPD (n=1,461) 
♦!!!Missing MRN in UCPD (n=78) 
--- 




♦!!!Fetal anomalies (n=1,180) 
♦!!!Planned cesarean (n=1,508) 
♦!!!Severe maternal co-morbidities (n=212) 
♦!!!Ruptured membranes >24 hour prior to birth (n=1,284) 
♦!!!Low amniotic fluid (n=700) 
♦!!!Contraindicated for vaginal birth (n=57) 
--- 
♦!!!Multiparous (n=6,826) 
♦!!!Maternal age <18 years or >40 years (n=653) 
♦!!!Non-spontaneous labor (n=1,072) 
♦!!!Delivery!BMI < 30.0 kg/m2 (n=1,150) 
♦!!!Hypertension prior to or during pregnancy (n=182) 
♦!!!Diabetes prior to or during pregnancy (n=72) 










Excluded from analysis (n=212): 
♦!!!No vaginal birth (n=24) 
♦!!!Did not receive synthetic oxytocin 
(n=188) 
 
Analysed  (n= 136) OB & CNM 
management 
 
Analysed  (n= 348) OB & CNM 
Aim 4 
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  To create some of the variables for this Aim, BMI-individualized partograms including 
dilations of 4-10 centimeters were constructed using the centimeter-to-centimeter median 
cervical change times calculated in the Consortium of Safe Labor (CSL) study focusing on the 
labors of obese women (Kominiarek et al., 2011) (Figures 17-19).  Then, chart reviews were 
conducted on the subjects of this study, and cervical examination results were retrieved from 
labor and delivery nurse’s notes.  For each subject, cervical progression was compared to 
national cervical progression norms by plotting her labor progress on the CSL partogram 
matching her delivery BMI.  Also collected during chart review was the precise time and last 
known cervical dilation at the onset of AROM or synthetic oxytocin initiation.  AROM and 
synthetic oxytocin for each woman were plotted atop her cervical changes on the same BMI-
individualized partogram.  Each intervention was then classified as 1) “preactive,” meaning that 
the intervention was initiated prior to 4cm cervical dilation, 2) “green zone,” meaning that the 
intervention occurred while the woman was progressing through labor normally according to 
her BMI-individualized partogram 3) “red zone,” meaning that the intervention occurred while 
the woman was progressing abnormally slowly according to her BMI-individualized 
partogram, or 4) “second stage,” if the intervention occurred after the woman attained 10 cm 
cervical dilation.  Interventions initiated during either pre-active labor or the “green zone” were 
tested as predictors in multivariate analyses for the outcome of cesarean delivery for labor 
dystocia and described descriptively below. 
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Table 13:  Aim 2 & 4 Demographic Variables for Total Sample and by Delivery 
Outcome:  Means or Medians, Standard Deviations or Inter-quartile Ranges, Tests of 










(n = 24) 
Vaginal 
Delivery 






Mother’s age @ delivery 
in yearsr, † 

















p = 0.071 
Year of Deliveryr, † 














p = 0.900 
Marital statusn 


















p = 0.622 
Maternal Racen  
Caucasian 106 
(30.4%) 










Note. r = Ratio level variable. n = Nominal level variable †=Non-Normal distribution of variable 
across total sample. Normality tested using Kolmogorov-Smirnov statistic. *Chi-square test with 
continuity correction used for categorical variables (2-levels); Kruskal-Wallis H test used for 
categorical variables (> 2-levels).  Mann-Whitney U (non-parametric) used for continuous 
variables.  These non-parametric tests do not provide test statistics, only p-values.  Tests with 
significant values shown in bold. 
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Table 14:  Aim 2 & 4 Maternal/Infant Variables for Total Sample and by Delivery 
Outcome: Tests of Normality, Means or Medians, Standard Deviations or Inter-quartile 


















Perinatal Background Index score 
i, † 

















p = 0.778 
Maternal Height (meters) r, † 
 


















p = 0.498 
Maternal Delivery BMI r, † 
 


















Provider Type in Labor 







p = 0.694 
Baby’s birthweight (kg) r, †† 
 














p = 0.007 
Estimated fetal weight (kg) r, † 
 














p = 0.094 
Gestational age (continuous) in 
weeks r, † 
 
Median & Interquartile range 
Minimum/Maximum values 

















p = 0.018 
Note. r = Ratio level variable.i = Interval level variable. n = Nominal level variable. † = Non-Normal 
distribution of variable across total sample. †† = Normal distribution of variable across total sample. 
Normality tested using Kolmogorov-Smirnov statistic.  *Chi-square test with continuity correction 
used for categorical variables (2-levels); Kruskal-Wallis H test used for categorical variables (> 2-
levels).  Mann-Whitney U (non-parametric) used for continuous variables. These non-parametric tests 
do not provide test statistic, only p-values.  Tests with significant values shown in bold. 
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Figure 17: BMI-individualized Partograph for Maternal Delivery BMI Ranges 30-35 
kg/m2.  Design based on “Physiologic partograph to improve birth safety and outcomes 
among low-risk, nulliparous women with spontaneous labor onset,” by J. L. Neal and N. 
K. Lowe, 2012, Medical Hypotheses, 78, p. 319-326.  Labor progression data adapted 
from “Contemporary labor patterns:  The impact of maternal body mass index,” by M. 
Kominiareket al., 2011, American Journal of Obstetrics & Gynecology, 205, 244.e.1-8. 
 
Figure 18:  BMI-individualized Partograph for Maternal Delivery BMI Ranges 35-40 
kg/m2.  Design based on “Physiologic partograph to improve birth safety and outcomes 
among low-risk, nulliparous women with spontaneous labor onset,” by J. L. Neal and N. 
K. Lowe, 2012, Medical Hypotheses, 78, p. 319-326.  Labor progression data adapted 
from “Contemporary labor patterns:  The impact of maternal body mass index,” by M. 
Kominiareket al., 2011, American Journal of Obstetrics & Gynecology, 205, 244.e.1-8. 
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Figure 19: BMI-individualized Partograph for Maternal Delivery BMI Ranges > 40 
kg/m2.  Design adapated from “Physiologic partograph to improve birth safety and 
outcomes among low-risk, nulliparous women with spontaneous labor onset,” by J. L. 
Neal and N. K. Lowe, 2012, Medical Hypotheses, 78, p. 319-326.  Labor progression data 
adapted from “Contemporary labor patterns:  The impact of maternal body mass index,” 
by M. Kominiareket al., 2011, American Journal of Obstetrics & Gynecology, 205, 
244.e.1-8. 
 
Bivariate Analysis of Demographic, Maternal/Infant Characteristics, and Labor 
Interventions/Outcomes   
  Comparisons were made between the delivery outcome groups on demographic 
variables (Table 13), maternal/infant characteristics (Table 14) and labor 
interventions/outcomes (Table 15). Among the demographic variables, there were no 
significant differences by delivery outcome group (Table 13). Maternal racial background 
was under-reported in the charts reviewed for this analysis.  Therefore, breakdowns of maternal 
racial background are not presented in Table 13 by delivery outcome groupings. 
 Among labor intervention and outcome variables, use of epidural, use of synthetic 
oxytocin, initiation of synthetic oxytocin or AROM at less than six centimeters cervical 
dilation, and initiation of synthetic oxytocin during periods of normal labor progression were 
more common among obese women with the outcome of cesarean delivery for labor dystocia 
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when compared to obese women with vaginal deliveries (Table 15).  Epidural anesthesia use 
was significantly more likely among obese women ending labor with cesarean delivery for 
labor dystocia (χ2 = 6.60, p = 0.005).  Although an effort was made during medical chart 
abstraction to only count epidural anesthesia uses that were initiated in labor and not in 
immediate preparation for cesarean delivery, all of the women in this sample had epidural 
anesthesia before the time that a cesarean was decided by their providers.   
  Use of synthetic oxytocin (pitocin) augmentation in the spontaneous labors of 
subjects included in this analysis was analyzed by delivery outcome groupings in the 
entire sample, and again on only those subjects who had intact membranes at the time of 
hospital admission.  This second analysis was necessary because ruptured membranes on 
hospital admission is an indication for synthetic oxytocin augmentation at small cervical 
dilations, even in the absence of slow labor progress (Dare, Middleton, Crowther, 
Flenady, & Varatharaju, 2006).  Obese women who ended labor with cesarean delivery 
for labor dystocia were more statistically significantly more likely than similar obese 
women ending labor with vaginal delivery to receive synthetic oxytocin regardless of 
their membrane status at the time of hospital admission (χ2v= 16.14, p < 0.001, 87.5% in 
subjects with cesarean vs. 42.9% among subjects with vaginal delivery, (χ2 = 8.11, p = 
0.004 for synthetic oxytocin use in subjects with intact membranes on admission, 81.3% 
among subjects with cesarean vs. 41.5% among subjects with vaginal delivery).  
  Initiation of synthetic oxytocin at less than six centimeters cervical dilation was 
also statistically significantly more likely among women with cesarean delivery for labor 
dystocia (58.3% among women with cesarean vs. 20.7% among women with vaginal 
delivery, (χ2=15.70 p < 0.001), even when only women with intact amniotic membranes 
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at the time of hospital admission were considered (50% among women with cesarean vs. 
19.4% among subjects with vaginal delivery, (χ2=6.72, p = 0.010).  Although cervical 
exam is not required for initiation of synthetic oxytocin, in this setting cervical 
examinations were typically performed within minutes prior to the decision to start 
oxytocin infusions.  Even if the last cervical exam prior to synthetic oxytocin initiation 
was more than a few minutes prior, this variable reflects the knowledge of the provider at 
the time they decided to initiate the intervention. Similarly, initiation of synthetic 
oxytocin during times of normal labor progression was also statistically significantly 
more likely among women ending labor with cesarean delivery for labor dystocia (70.8% 
among women with cesarean vs. 30.2% among subjects with vaginal delivery, χ2 = 14.85, 
p < 0.001), even when only women with intact amniotic membranes at hospital admission 
were considered (70.8% among women with cesarean vs. 30.2% among subjects with 
vaginal delivery, χ2 = 6.07, p = 0.014).  All other variables, including all labor outcomes, 
were not statistically significantly different among women depending on their delivery 
outcome or occurred too infrequently for group difference statistics to be meaningful.    
 Inter-correlations among the primary variables of this analysis were also run 
(Table 16).  Gestational age (rs = 0.127, p < 0.05) and baby’s birth weight (rs = 0.145, p < 
0.01) were correlated with the outcome of cesarean delivery for labor dystocia.  Maternal 
delivery BMI was not statistically significantly related to the outcome of cesarean for 
labor dystocia, or with use of artificial rupture of membranes (AROM).  However, 
maternal BMI was statistically significantly correlated with the use of synthetic oxytocin 
(rs = 0.130, p < 0.01), the use of synthetic oxytocin at < 6cm (rs = 0.181, p < 0.01), and 
the use of synthetic oxytocin during times of normal labor progression (rs = 0.159, p < 
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0.01).  There was a correlation between baby’s birth weight and gestational age  (rs = 
0.377, p < 0.01).  This finding is logical, as babies having a longer gestation would 
usually weigh more at birth.  Because these two variables were statistically-significantly 
correlated, interaction terms containing these predictors were run in the multivariate 
analyses for Aim 2.  
Aim 2, Hypothesis 1 Multivariate Analysis.    
 Logistic regression analysis with an alpha level of 0.05 was run to test the Aim 2, 
H1 hypothesis that healthy, nulliparous obese women ending labor with cesarean for labor 
dystocia would be more likely than similar women ending labor with vaginal delivery to 
receive epidural, AROM, or labor augmentation.  Although evidence of all forms of labor 
augmentation (foley bulb, misoprostol, synthetic oxytocin) was sought during chart review, 
only one subject had documented use of misoprostol for labor augmentation and no subjects 
had documented use of foley bulb for labor augmentation. Therefore, Aim2, H1 was analyzed 
on only the use of synthetic oxytocin in addition to the use of AROM and epidural.  
In this analysis, event = DV = cesarean delivery for labor dystocia.  Binary 
logistic regression was run in R 2.14.2 Statistical Software (R Development Team, 2013) 
using the glm package.  Unlike Aim 1, these analyses in Aim 2 did not require rare events 
logistic regression because the event ratio in this dataset was higher (24 cesarean 
deliveries for labor dystocia /324 vaginal births = 7.4% event rate), thus meeting the 5% 
event ratio requirements for binary logistic regression using a generalized linear model  
(Plichta & Kelvin, 2013, p. 327).  To start each of the following regression analyses for 
Aim 2, a NULL model (Model 0) was estimated with the DV = cesarean delivery for 
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Table 15: Aim 2 & 4 Labor Interventions and Outcomes by Delivery Group:  Means or 
Medians, Standard Deviations or Inter-Quartile ranges, Frequencies and Comparison of 
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following birth 
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Maternal death 0  
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Cell counts too 
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Cell counts too 
small 
     
Note. *Chi-square test with continuity correction used for categorical variables, Fisher’s exact test 
with 2-tailed significance testing if expected cell count < 5.  Mann-Whitney U Test for 
continuous variables.  Tests with statistically significant values shown in bold.  
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labor dystocia (event) vs. vaginal birth (non-event) with IV = no predictor variables.  
Afterwards, predictor groups were added to the model based on each Aim 2 hypothesis.  
Each time a new model was fit, it was compared to previous models for fit statistics and 
residual variance.  The sequence of models and findings is summarized below.   
 A2H1: Epidural.  The first intervention to be tested in A2H1 was use of epidural 
analgesia/anesthesia (not including anesthesia given immediately prior to cesarean).     
Thus, for this analysis DV: cesarean delivery for labor dystocia vs. vaginal birth and IV: 
epidural in labor.  Multivariate analysis for this DV and IV was not performed because 
there was no variance in the use of epidural in the group of women having cesarean 
delivery for labor dystocia.  Epidural was used in 24/24 (100%) women who ended labor 
with cesarean delivery for labor dystocia, and in only 242/324 (74.6%) of women who 
ended labor with vaginal births, thus creating quasi-complete separation of this IV against 
the DV of cesarean delivery for labor dystocia (Allison, 2008).  
 In conclusion, A2H1’s hypothesis that obese women in this dataset having 
cesarean for labor dystocia would be more likely to have epidural is accepted.  Use of 
epidural was statistically significantly correlated to the outcome of cesarean delivery for 
labor dystocia; 100% of women having cesarean delivery for labor dystocia had epidural 
in labor.  
A2H1: Artificial rupture of membranes (AROM).  The second intervention 
tested was AROM.  A first logistic regression model (M1) for AROM was constructed 
using R procedure of glm (binary logistic regression) with DV: cesarean delivery for 
labor dystocia vs. vaginal birth and IV: epidural in labor (Table 17).  Compared to the 
NULL model (M0), M1 showed increased fit statistics, reflecting a poorer fit to the data.   
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            In addition, AROM’s ß coefficient showed a non-statistically significant 
association with the outcome of cesarean for labor dystocia (p = 0.531).  Therefore, the 
null hypothesis is retained for A2H1 (AROM); obese women in this dataset having 
cesarean delivery for labor dystocia were not more likely to have AROM than obese 
women having vaginal delivery.  
A2H1: Synthetic oxytocin augmentation.  The third intervention tested for this 
part of Aim 2, H1 was synthetic oxytocin augmentation.  A first logistic regression model 
(M1) for synthetic oxytocin was constructed with DV: cesarean delivery for labor 
dystocia vs. vaginal birth and IV: use of synthetic oxytocin in labor (Table 18).  
Compared to the NULL model (M0), M1 showed decreased fit statistics, reflecting a 
better fit to the data.  In addition, synthetic oxytocin’s ß coefficient showed a statistically 
 
Table 17: Aim 2, H1 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Artificial Rupture of Membranes (AROM) in Labor 
 
Statistic Model 0 
(Null Model) 
Model 1 
(Predictor: AROM in 
labor) 
Residual deviance 174.66 174.27 





-2.61 (0.21) -2.74 (0.31) 
  Coefficient: 
AROM in Labor 
B  0.26 
SE  0.43 
p  0.531 
OR  1.30 
97.5% CI  [0.57-3.05] 
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Table 18: Aim 2, H1 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Synthetic Oxytocin Augmentation in Labor 
 












































-4.12 (0.59) -3.96 (1.94) -26.03 -8.68 
  Coefficient:  Oxytocin in Labor 
B  2.23 2.24 2.26 2.21 
SE  0.63 0.63 0.63 0.63 
p  <0.001 <0.001 <0.001 <0.001 
OR  9.32 9.36 9.63 9.13 














B   -0.004 0.438 -0.49 
SE   0.05 0.29 0.47 
p   0.931 0.122 0.309 
OR   0.99 1.55 0.61 
97.5% CI   [0.88-1.10] [0.91-2.79] [0.25-1.64] 
    Coefficient: Baby’s birth 
weight 
B    1.29 1.59 
SE    0.59 0.56 
p    0.028 0.005 
OR    3.64 4.90 
97.5% CI    [1.18-12.03] [1.67-15.42] 
Note. *SROM=Spontaneous Rupture of Membranes  
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significant association with the outcome of cesarean for labor dystocia, although with a 
wide confidence interval (OR 9.32, 97.5% CI [3.13-40.00], p < 0.001). 
  Model 2 (M2).  A second model (M2) was constructed to determine if the odds of 
cesarean delivery for labor dystocia were changed by both exposure to synthetic oxytocin 
and the BMI of woman at the time of hospital admission (Table 18).  Model 2 was run to 
understand if the statistically significant association between the DV of cesarean delivery 
for labor dystocia and the IV of synthetic oxytocin use would be changed by inclusion in 
a new model with the covariate of maternal delivery BMI.  Model 2 (DV: cesarean 
delivery for labor dystocia vs. vaginal birth and IV: Exposure to synthetic oxytocin in 
labor + Maternal delivery BMI) was a poorer fit for the data when compared to Model 1, 
with increased residual and nearly equal AIC.  In addition, maternal delivery BMI was 
not statistically significantly associated with the outcome of cesarean delivery for labor 
dystocia (ß = -0.004, Odds Ratio (OR) = 0.99, 97.5% Confidence Interval (CI) [0.88, -
1.10]. p = 0.931).  Maternal delivery BMI was therefore discarded in further modeling of 
the relationship between cesarean for labor dystocia and the use of synthetic oxytocin 
augmentation.   
  Model 3 (M3).  A third model (M3) was constructed to further evaluate the 
statistically significant association between the DV of cesarean delivery for labor 
dystocia and the IV of synthetic oxytocin use by including other predictor variables 
having statistically significant inter-correlations with the outcome of cesarean delivery 
for labor dystocia (Table 16).  Therefore, Model 3 included three predictors (DV: 
cesarean delivery for labor dystocia vs. vaginal birth, IV: exposure to synthetic oxytocin 
+ baby’s birth weight + gestational age) (Table 18).  M3 improved upon M1 in fit 
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statistics (Table 18).  M3 also showed a statistically significant association between both 
synthetic oxytocin augmentation in labor (undiminished significance from M1, p < 0.001, 
and similar OR as M1 OR: 9.63, 97.5% CI [3.19-41.76]) and baby’s birth weight (p = 
0.028) with the outcome of cesarean delivery for labor dystocia. Gestational age was not 
associated with the outcome in this model, and was therefore dropped from further 
analysis.  In conclusion, M3 showed that the effect of synthetic oxytocin augmentation 
exposure on the outcome of cesarean delivery for labor dystocia remained statistically 
significant even when included in a model which controlled for gestational age and 
baby’s birth weight.  Further, this model demonstrates that there was a 3.64 fold increase 
(97.5% CI [1.18-12.03]) in cesarean delivery for labor dystocia among women receiving 
synthetic oxytocin in labor for every kilogram their baby weighed at delivery.  
  Because gestational age and baby’s birth weight were highly correlated (rs = 
0.377, p < 0.01) (Table 16), Model 3 was also run with an interaction term (DV: cesarean 
delivery for labor dystocia vs. vaginal birth, IV: exposure to synthetic oxytocin + baby’s 
birth weight + gestational age + baby’s birth weight X gestational age).  This version of 
Model 3 (not included in Table 18) was not an improvement in the fit of the data 
(residual deviance = 143.96, AIC = 153.96), and had only one statistically significant 
predictor (exposure to synthetic oxytocin, significance and OR unchanged from M3).  
Because the interaction term was non-statistically significant in this analysis, it was 
dropped from further analyses.   
  Model 4 (M4).  Finally, a fourth logistic regression model was constructed to 
determine how presence of spontaneously ruptured membranes at the time of hospital 
admission (variable: SROM prior admit) affected the relationship shown in M3 between 
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synthetic oxytocin augmentation, baby’s birth weight, and the outcome of cesarean 
delivery for labor dystocia.  M4 was built because SROM on hospital admission is an 
indication for synthetic oxytocin augmentation, even in the absence of slow labor 
progress (Dare et al., 2006).  Also, on bivariate analysis (Table 15) comparing the use of 
synthetic oxytocin by maternal delivery BMI grouping, synthetic oxytocin use in women 
with intact membranes on hospital admit was non-statistically significantly different (p = 
0.150) while its use was statistically significant (p < 0.001) in the entire sample 
(including women who entered the hospital with ruptured membranes).  A2H1 is focused 
on the use of synthetic oxytocin augmentation for the indication of slow labor progress, 
not ruptured membranes.  Model 4 was thus constructed to test if the statistically 
significant association between synthetic oxytocin augmentation shown in M1 and M3 
would be diminished when included in a model with a variable for SROM on hospital 
admit.  Model 4 (DV: cesarean delivery for labor dystocia vs. vaginal delivery, IV: 
synthetic oxytocin augmentation exposure + baby’s birth weight + SROM on admit) 
showed slightly poorer model fit statistics over M3.  The influence of synthetic oxytocin 
augmentation exposure remained statistically significant on the outcome of cesarean 
delivery for labor dystocia in this model, and at a similar level of effect (M4 synthetic 
oxytocin OR = 9.13 [97.5% CI 3.03-39.49], p < 0.001) (Table 18).  In addition, baby’s 
birth weight was also statistically significantly related to cesarean delivery for labor 
dystocia OR = 4.90 [97.5% CI 1.67-15.42], p = 0.005).  However, SROM on admit was 
not statistically significantly associated with the outcome in this final model (p = 0.309).  
Thus, the association between synthetic oxytocin exposure and the outcome of cesarean 
for labor dystocia was not changed by the membrane status of subjects at the time of 
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hospital admission.  However, baby’s birth weight remained a statistically significant 
predictor of cesarean delivery for labor dystocia among women receiving synthetic 
oxytocin in labor. 
  Further models were built to model the statistically significant relationship 
between use of synthetic oxytocin and outcome of cesarean delivery for dystocia (not 
included in Table 18) including M5 (DV: cesarean delivery for labor dystocia, IV: use of 
synthetic oxytocin + provider type + baby’s birth weight) and M6 (DV: cesarean delivery 
for labor dystocia, IV: use of synthetic oxytocin + provider type + baby’s birth weight + 
interaction term of provider type X use of synthetic oxytocin). M5 and M6 were built to 
include provider type with the rationale that since provider type was statistically 
significantly related to synthetic oxytocin use (rs = .131, p < 0.05, Table 16), perhaps 
some part of the association between the IV of synthetic oxytocin use to the DV of 
cesarean for labor dystocia was explained by provider type.  In both M5 and M6, use of 
synthetic oxytocin and baby’s birth weight were statistically significantly associated (p < 
0.001) with the outcome of cesarean for labor dystocia, and provider type was not 
statistically significant.  
  In conclusion, Model 3 was the best fit for the data overall, with the lowest model 
fit statistics.  Based on the M3 analysis, A2H1’s hypothesis that obese women in this 
dataset having cesarean for labor dystocia would be more likely to have synthetic 
oxytocin augmentation is accepted; obese women in this analysis who ended their labors 
with cesarean delivery for labor dystocia were 9.13 times more likely [97.5% CI 3.19-
41.76] to have synthetic oxytocin exposure than obese women ending labor with vaginal 
delivery, even when weight of their baby at birth and gestational age were held constant. 
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Although provider type and maternal delivery BMI were statistically significantly 
correlated with synthetic oxytocin use in this sample, neither the type of provider nor the 
degree of obesity were statistically important in the relationship between the use of 
synthetic oxytocin and the outcome of cesarean delivery for labor dystocia.   
  Residuals were run for the A1H1 synthetic oxytocin use Model 3 to describe how 
well the data fit this model’s predictions.  Standardized residuals showed a good fit for 
the model, as there were only 8 cases (2.3% of sample) where the standard residual value 
was > 2.0 standard deviations above the mean.  Logistic models are classified as having a 
good fit if no more than 5% of their standardized residuals lie outside 2 standard 
deviations (Field, 2009).  A binned residual plot was created (Figure 20) plotting raw 
residual values against the fitted values for the logistic model.  Ideally, 95% of the dots 
on this graph should be inside the two gray lines representing 2 standard deviation error 
bounds (Gelman & Hill, 2007, p. 97).   In the binned residual plot of M3, 50% (10/20) of 
the dots fall outside the 2 standard deviation lines, reflecting that M3 was not an ideal fit 
for the data. It is possible that the small number of cesarean deliveries for labor dystocia 
in this logistic regression limited the ability of any model to fit the data well.   
Aim 2, Hypothesis 2 Multivariate Analysis    
Logistic regression analysis with an alpha level of 0.05 was run to test the Aim 2, 
H2 hypothesis that healthy, nulliparous obese women ending labor with cesarean for labor 
dystocia would be more likely than similar women ending labor with vaginal delivery to 
receive AROM or synthetic oxytocin augmentation at less than 6cm cervical dilation, or 
hospital admission at less than 4cm cervical dilation.  
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Figure 20:  Aim 2, H1 Logistic Regression Analysis Predicting Cesarean Delivery for 
Labor Dystocia on Use of Synthetic Oxytocin Augmentation in Labor (Model 3) Binned 
Residual Plot constructed using r command: binnedplot(x,y, nclass=20). 
 
  In this analysis, event = DV = cesarean delivery for labor dystocia.  Binary 
logistic regression was run in R 2.14.2 Statistical Software (R Development Team, 
2013)using the glm package.  Similar to the methodology outlined for A2H1, null (M0) 
and predictor models for each analysis (M1--) are presented in both tables and text below.   
  A2H2:  Artificial rupture of membranes prior to 6cm cervical dilation.  The 
first intervention to be tested in A2H2 was use of AROM prior to 6cm cervical dilation 
(Table 19).  Model 1 for AROM < 6cm was constructed to determine if the odds of 





















           167 
cesarean delivery for labor dystocia were changed by use of AROM prior to 6cm.  A first 
logistic regression model (M1) included the DV: cesarean delivery for labor dystocia vs. 
vaginal birth and IV: AROM prior to 6cm.  Compared to the NULL model (M0), M1 
showed decreased fit statistics, reflecting a better fit to the data.  In addition, AROM < 
6cm’s ß coefficient showed a statistically significant association with the outcome of 
cesarean for labor dystocia, although with a wide confidence interval (OR 3.82, 97.5% CI 
[1.52-9.13], p = 0.003).   
  Model 2 (M2).  A second model (M2) was constructed to determine if the 
statistically significant relationship between the DV of cesarean delivery for labor 
dystocia and the IV of AROM < 6cm would be changed by inclusion in a model with the 
BMI of the woman at the time of hospital admission.  Model 2 (DV: cesarean delivery for 
labor dystocia vs. vaginal birth and IV: AROM at < 6cm + Maternal delivery BMI) was a 
poorer fit for the data when compared to the Model 1, with decreased residual and 
slightly increased AIC (Table 19).  In addition, maternal delivery BMI was not 
statistically significantly associated with the outcome of cesarean delivery for labor 
dystocia (p = 0.837).  Maternal delivery BMI therefore was discarded in further modeling 
of the relationship between cesarean for labor dystocia and the use of AROM at less than 
6cm cervical dilation.   
 Model 3 (M3).  A third model (M3) was constructed to include all variables found 
to have statistically significantly inter-correlations with the outcome of cesarean delivery 
for labor dystocia (Table 16). Therefore, Model 3 included three predictors (DV: cesarean 
delivery for labor dystocia vs. vaginal birth, IV: AROM at < 6cm + baby’s birth weight +  
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Table 19: Aim 2, H2 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Artificial Rupture of Membranes (AROM) prior to 6  
Centimeters Cervical Dilation in Labor 
 











































-2.93 (0.27) -3.23 (1.81) -20.36 
(10.98) 
-8.49 
  Coefficient:  AROM prior to 6cm cervical dilation 
B  1.34 1.33 1.32 1.33 
SE  0.45 0.45 0.46 0.48 
p  =0.003 =0.003 =0.003 =0.005 
OR  3.82 3.79 3.83 3.77 
97.5% CI  [1.52-9.13] [1.51-9.09] [1.49-9.41] [1.43-9.54] 









B   0.01 0.40 -0.01 
SE   0.05 0.28 0.22 
p   0.837 0.156 0.957 
OR   1.01 1.49 0.99 
97.5% CI   [0.91-1.11] [0.87-2.69] [0.63-1.55] 
    Coefficient: Baby’s birth 
weight 
B    1.35 1.64 
SE    0.60 0.57 
p    0.025 0.004 
OR    3.86 5.16 
97.5% CI    [1.20-12.92] [1.72-16.35] 
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gestational age).  M3 improved upon M1 in fit statistics (Table 19).  M3 also showed a 
statistically significant association between both AROM at < 6cm cervical dilation 
(undiminished significance from M1, p = 0.003, and similar OR as M1: 3.83, 97.5% CI 
[1.49-9.41]) and baby’s birth weight (p = 0.025) with the outcome of cesarean delivery 
for labor dystocia.  Gestational age was non-statistically significantly associated with the 
outcome in this model, and was therefore dropped from further analysis.  In conclusion, 
M3 showed that the effect of AROM exposure at less than 6cm cervical dilation on the 
outcome of cesarean delivery for labor dystocia remained statistically significant even 
when included in a model that controlled for gestational age and baby’s birth weight.  
  Because gestational age and baby’s birth weight were highly correlated (Table 16, 
rs = 0.377, p < 0.01), Model 3 also was run with an interaction term (DV: cesarean 
delivery for labor dystocia vs. vaginal birth, IV: AROM at < 6cm + baby’s birth weight + 
gestational age + baby’s birth weight X gestational age).  This version of Model 3 (not 
included in Table 19) was not an improvement in the fit of the data (residual deviance = 
155.93, AIC = 165.93), and had only one statistically significant predictor (AROM < 
6cm, significance and OR unchanged from M3).  Because the interaction term was non-
statistically significant in this analysis, it was dropped from further analyses.   
  Model 4 (M4).  Finally, a fourth logistic regression model was constructed to 
determine how provider caring for the subject during labor affected the relationship 
shown in M3 between AROM at less than 6cm, baby’s birth weight, and the outcome of 
cesarean delivery for labor dystocia (Table 19).  Provider type was shown to statistically 
significantly correlate with the use of AROM at less than 6cm (Table 16, rs = 0.186, p < 
0.01).  Model 4 thus was constructed to test if the statistically significant association 
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between AROM at < 6cm and the outcome of cesarean for labor dystocia shown in M1 
and M3 was changed when included in a model with a variable for provider type.   
Model 4 (DV: cesarean delivery for labor dystocia vs. vaginal delivery, IV: AROM < 
6cm + baby’s birth weight + provider type) showed slightly poorer model fit statistics 
over M3.  The influence of AROM at < 6cm exposure remained statistically significant 
on the outcome of cesarean delivery for labor dystocia in this model, and at a similar 
level of effect (M4 AROM < 6cm OR = 3.77, 97.5% CI [1.43-9.54], p = 0.005).  In 
addition, baby’s birth weight was also statistically significantly related to cesarean 
delivery for labor dystocia OR = 5.16, 97.5% CI [1.72-16.35], p = 0.004).   
  In conclusion, Model 3 was the best fit for the data overall, with the lowest model 
fit statistics.  Based on the M3 analysis, A2H2’s hypothesis that obese women having 
cesarean for labor dystocia would be more likely to have AROM at less than 6cm 
cervical dilation is accepted; obese women who ended their labors with cesarean delivery 
for labor dystocia were 3.83 times more likely (97.5% CI [1.49-9.41]) to have exposure 
to AROM at less than 6cm compared to obese women ending labor with vaginal delivery, 
even when weight of their babies at birth and gestational age were held constant.  In 
addition, obese women of the same gestational ages who received AROM at less than 
6cm were 3.86 fold more likely (97.5% CI [1.20-12.92] to end labor with cesarean 
delivery for labor dystocia for every kilogram of baby weight.  
  Residuals were run for A2H2’s AROM < 6cm Model 3 to describe how well the 
data fit this model’s predictions.  Standardized residuals showed a good fit for the model, 
as there were only 11 cases (3.2% of sample) where the standard residual value was > 2.0 
standard deviations above the mean, reflecting a good fit for the data overall.  A binned 
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residual plot was created (Figure 21) plotting raw residual values against the fitted values 
for the logistic model, where 50% (10/20) of the dots fell outside the 2 standard deviation 
lines, reflecting that M3 was not an ideal fit for the data. It is possible that the small 
number of cesarean deliveries for labor dystocia in this logistic regression limited the 
ability of any model to fit the data well.   
 
Figure 21:  Aim 2, H2 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Artificial Rupture of Membranes (AROM) prior to 6 Centimeters 
Cervical Dilation in Labor (Model 3). Binned Residual Plot constructed using r 
command: binnedplot(x,y, nclass=20).  
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  A2H2:  Hospital admission at less than 4cm cervical dilation.  The second 
intervention to be tested in A2H2 was admission to the hospital at less than 4cm cervical 
dilation (Table 20).  Model 1 for admit < 4cm was constructed to determine if the odds of 
cesarean delivery for labor dystocia were changed by use of hospital admission prior to 
4cm.  A first logistic regression model (M1) included DV: cesarean delivery for labor 
dystocia vs. vaginal birth and IV: admit prior to 4cm.  Compared to the NULL model 
(M0), M1 showed only slightly decreased fit statistics, reflecting non-statistically 
significant improvement in fit to the data.  In addition, admit < 4cm’s coefficient showed 
a non-statistically significant association with the outcome of cesarean for labor dystocia 
with confidence intervals that crossed 1, (OR 1.92, 97.5% CI [0.80-4.44], p = 0.133).   
Thus, there was a non-statistically significant association between hospital admission 
prior to 4cm and the outcome of cesarean for labor dystocia.  Further modeling of this 
predictor was not conducted, based on the fact that model fit statistics in even this M1 
model did not statistically significantly improve upon M0, the null model. Therefore, the 
null hypothesis is retained for A2H2 (hospital admission prior to 4cm); obese women in 
this dataset having cesarean delivery for labor dystocia were not more likely to have 
hospital admission at less than four centimeters cervical dilation than obese women 
having vaginal delivery. 
  A2H2:  Synthetic oxytocin augmentation prior to 6cm cervical dilation.  The 
last intervention to be tested in A2H2 was use of synthetic oxytocin prior to 6cm cervical 
dilation (Table 21).  Model 1 for synthetic oxytocin < 6cm was constructed to determine 
if the odds of cesarean delivery for labor dystocia were changed by initiation of this 
intervention prior to 6cm.  A first logistic regression model (M1) was run including DV:  
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Table 20: Aim 2, H2 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Hospital Admission Prior to 4 Centimeters Cervical Dilation 
 
Statistic Model 0 
(Null Model) 
Model 1 
(Admit < 4cm) 
Residual deviance 174.66 172.50 
AIC (Akaike’s Information Criterion) 176.66 176.5 
Intercept  
(standard error) 
-2.61 (0.21) -2.82 (0.28) 
  Coefficient: Admit 
<4cm 
B  0.65 
SE  0.43 
p  0.133 
OR  1.92 
97.5% CI  [0.80-4.44] 
 
cesarean delivery for labor dystocia vs. vaginal birth and IV: synthetic oxytocin prior to 
6cm.  Compared to the NULL model (M0), M1 showed decreased fit statistics, reflecting 
a better fit to the data.  In addition, synthetic oxytocin < 6cm’s coefficient showed a 
statistically significant association with the outcome of cesarean for labor dystocia, 
although with a wide confidence interval (OR 5.37, 97.5% CI [2.30-12.97], p < 0.001).   
 Model 2 (M2).  A second model (M2) was constructed to determine if the odds of 
cesarean delivery for labor dystocia were changed by both exposure to synthetic oxytocin 
< 6cm and the BMI of woman at the time of hospital admission (Table 21).  Maternal 
BMI was included as a predictor for Model 2 because it was significantly correlated with 
the use of synthetic oxytocin at < 6cm in this sample (Table 16, rs = 0.181, p < 0.01), and 
could thus theoretically explain part of the variance in the outcome of cesarean delivery 
for labor dystocia which was statistically significantly associated with the predictor of 
synthetic oxytocin initiation at < 6cm.  M2 (DV: cesarean delivery for labor dystocia vs.  
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Table 21: Aim 2, H2 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Synthetic Oxytocin Augmentation prior to 6 Centimeters 
Cervical Dilation in Labor 
 










































-2.64 (1.92) -20.04 
(10.61) 
-2.32 
  Coefficient:  Synthetic oxytocin prior to 6cm  
B  1.68 1.71 1.54 1.68 
SE  0.44 0.44 0.45 0.45 
p  <0.001 <0.001 <0.001 <0.001 
OR  5.37 5.51 4.67 5.38 
97.5% CI  [2.30-
12.97] 
[2.32-13.53] [1.96-11.48] [2.25-13.34] 









B   -0.02 0.32 -0.42 
SE   0.06 0.28 0.46 
p   0.766 0.228 0.366 
OR   0.98 1.39 0.65 
97.5% CI   [0.88-1.09] [0.83-2.46] [0.27-1.72] 





B    1.16 -0.09 
SE    0.59 0.22 
p    0.050 0.679 
OR    3.18 0.91 
97.5% CI    [1.02-10.48] [0.58-1.42] 
Note. SROM = Spontaneous Rupture of Membranes  
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vaginal birth and IV: synthetic oxytocin at < 6cm + Maternal delivery BMI) was a poorer 
fit for the data when compared to the Model 1, with nearly equal residual deviance and 
slightly increased AIC (Table 21).  In addition, maternal delivery BMI was not 
statistically significantly associated with the outcome of cesarean delivery for labor 
dystocia (p = 0.766).  Maternal delivery BMI was therefore discarded in further modeling 
of the relationship between cesarean for labor dystocia and the use of synthetic oxytocin 
at less than 6cm cervical dilation.   
  Model 3 (M3).  A third model (M3) was constructed to include other predictor 
variables that were statistically significantly correlated (Inter-correlations in Table 16) 
with cesarean delivery for labor dystocia (Table 21).  Model 3 thus included three 
predictors (DV: cesarean delivery for labor dystocia vs. vaginal birth, IV: synthetic 
oxytocin at < 6cm + baby’s birth weight + gestational age).  M3 improved upon M1 in fit 
statistics (Table 21).  M3 also showed a statistically significant association between both 
synthetic oxytocin at < 6cm cervical dilation (undiminished significance from M1, p < 
0.001, and similar OR as M1: 4.67, 97.5% CI [1.96-11.48]).  Both baby’s birth weight (p 
= 0.50) and gestational age (p = 0.228) were not statistically significantly associated with 
the outcome in this model, and were therefore dropped from further analysis.  In 
conclusion, M3 showed that the effect of synthetic oxytocin initiation at less than 6cm 
cervical dilation on the outcome of cesarean delivery for labor dystocia remained 
statistically significant even when gestational age and baby’s birth weight were 
controlled.  
  Because gestational age and baby’s birth weight were highly correlated (Table 16, 
rs = 0.377, p < 0.01), Model 3 was also run with an interaction term (DV: cesarean 
           176 
delivery for labor dystocia vs. vaginal birth, IV: synthetic oxytocin < 6cm + baby’s birth 
weight + gestational age + baby’s birth weight X gestational age).  This version of Model 
3 (not included in Table 21) was not an improvement in the fit of the data (residual 
deviance = 151.31, AIC = 161.31), and had only one statistically significant predictor 
(synthetic oxytocin < 6cm, significance and OR unchanged from M3).  Because the 
interaction term was non-statistically significant in this analysis (p = 0.554), it was 
dropped from further analyses.   
  Model 4 (M4).  Finally, a fourth logistic regression model was constructed to 
determine how provider type (CNM or OB) and SROM prior to admission affected the 
relationship shown in M3 between synthetic oxytocin initiation at less than 6cm, baby’s 
birth weight, and the outcome of cesarean delivery for labor dystocia (Table 21).  Model 
4 thus was constructed to test if the statistically significant association between synthetic 
oxytocin at < 6cm shown in M1 and M3 would be changed when included in a model 
with a variable for provider type and SROM prior to hospital admission.  Rationale for 
M4 was that initiation of synthetic oxytocin at < 6cm was statistically significantly 
correlated with provider type (Table 16, rs = 0.176, p < 0.01), and provider type could 
thus explain part of the variance in the outcome of cesarean for labor dystocia that was 
explained by the use of synthetic oxytocin at less than 6cm in M3. A further rationale for 
M4 was to test if the statistically significantly association between cesarean delivery for 
labor dystocia and the initiation of synthetic oxytocin at < 6cm was partially explained by 
the presence of ruptured membranes on hospital admission.  Model 4 (DV: cesarean 
delivery for labor dystocia vs. vaginal delivery, IV: synthetic oxytocin initiation < 6cm + 
provider type + SROM prior to admit) showed slightly poorer model fit statistics over 
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M3.  The influence of synthetic oxytocin initiation at < 6cm exposure remained 
statistically significant on the outcome of cesarean delivery for labor dystocia in this 
model, and at a similar level of effect (M4 synthetic oxytocin < 6cm OR = 5.38, 97.5% 
CI [2.25-13.34], p < 0.001).  Neither SROM prior to admission (p=0.366) nor provider 
type (p = 0.679) were statistically significantly associated with the outcome of cesarean 
delivery for labor dystocia in this final model.   
  In conclusion, Model 3 was the best fit for the data overall, with the lowest model 
fit statistics (Table 21).  Based on the M3 analysis, A2H2’s hypothesis that obese women 
in this dataset having cesarean for labor dystocia would be more likely to have synthetic 
oxytocin augmentation initiated at less than 6cm cervical dilation is accepted; obese 
women in this analysis who ended their labors with cesarean delivery for labor dystocia 
were 4.67 times more likely 97.5% CI [1.96-11.48] to have synthetic oxytocin 
augmentation initiated at less than 6 centimeters cervical dilation than obese women 
ending labor with vaginal delivery, even when infant birthweight and gestational age 
were held constant.  Presence of ruptured membranes at the time of hospital admission 
and provider type did not change this association between cesarean section for dystocia 
and synthetic oxytocin initiation prior to 6cm.  
  Residuals were run for A2H2 synthetic oxytocin < 6cm Model 3 to describe how 
well the data fit this model’s predictions.  Standardized residuals showed a good fit for 
the model, as there were only 12 cases (3.4% of sample) where the standard residual 
value was >2.0 standard deviations above the mean, reflecting a good fit for the data 
overall.  A binned residual plot was created (Figure 22) plotting raw residual values 
against the fitted values for the logistic model.  In the binned residual plot of M3, 39% 
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(7/18) of the dots fall outside the 2 standard deviation lines, reflecting that M3 is not an 
ideal fit for the data. It is possible that the small number of cesareans for labor dystocia in 
this logistic regression limited the ability of any model to fit the data well.  
 
Figure 22: Aim 2, H2 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Synthetic Oxytocin Augmentation prior to 6 Centimeters 
Cervical Dilation in Labor (Model 3) Binned Residual Plot constructed using r 
command: binnedplot(x,y, nclass=18).  
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Aim 2, Hypothesis 3 Multivariate Analysis    
Logistic regression analysis with an alpha level of 0.05 was run to test the Aim 2, 
H3 hypothesis that healthy, nulliparous obese women ending labor with cesarean for labor 
dystocia would be more likely than similar women ending labor with vaginal delivery to 
experience onset of intrapartum interventions designed to speed labor, including AROM and 
synthetic oxytocin, while having normal cervical progression in active phase labor or during 
pre-active labor.  For this final Aim 2 analysis, binary logistic regression was run for these 
analyses in R 2.14.2 Statistical Software (R Development Team, 2013) using the glm 
package.  Similar to the methodology outlined for A2H1, null (M0) and predictor models 
for each analysis (M1--) are presented in tables and summarized in text below.   
  A2H3:  Artificial rupture of membranes during normal labor progression or 
in pre-active labor.  The first intervention to be tested in A2H3 was use of AROM in 
times of normal cervical dilation or pre-active labor (Table 22).  Model 1 for AROM 
during normal labor progression was constructed to determine if the odds of cesarean 
delivery for labor dystocia are changed by use of AROM during normal labor 
progression.  A first logistic regression model (M1) was run including DV: cesarean 
delivery for labor dystocia vs. vaginal birth and IV: AROM in normal progress.  
Compared to the NULL model (M0), M1 showed slightly larger fit statistics, reflecting a 
poorer fit for the data.  In addition, AROM during normal labor’s ß coefficient showed a 
non-statistically significant association with the outcome of cesarean for labor dystocia (p 
= 0.696).  No further models were tested for this variable, as the M1 model did not show 
improved fit to the data over the null model (M0).     
           180 
  Based on this analysis, the null hypothesis is retained for A2H3 (AROM during 
normal labor progression); obese women in this dataset having cesarean delivery for 
labor dystocia were not more likely to have artificial rupture of membranes during times 
of normal labor progression or pre-active labor than obese women having vaginal 
delivery. 
Table 22: Aim 2, H3 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Artificial Rupture of Membranes (AROM) During Normal Labor 
Progression or in Pre-Active Labor 
Statistic Model 0 
(Null Model) 
Model 1 
(AROM in normal progress) 






-2.61 (0.21) -2.66  
(0.27) 
  Coefficient:  AROM during normal 
progression 
B  0.17 
SE  0.43 
p  = 0.696 
OR  1.18 
97.5% CI  [0.50-2.73] 
 
  A2H3:  Synthetic oxytocin augmentation during normal cervical progression 
or in pre-active labor.  The last intervention to be tested in A2H3 was use of synthetic 
oxytocin during times of normal labor progression or pre-active labor (Table 23).  Model 
1 was constructed to determine if the odds of cesarean delivery for labor dystocia were 
changed by initiation of synthetic oxytocin during normal labor progression.  A first 
logistic regression model (M1) was run including DV: cesarean delivery for labor 
dystocia vs. vaginal birth and IV: initiation of synthetic oxytocin during normal labor 
progression.  Compared to the NULL model (M0), M1 showed decreased fit statistics, 
reflecting a better fit to the data.  In addition, synthetic oxytocin in normal labor’s ß 
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coefficient showed a statistically significant association with the outcome of cesarean for 
labor dystocia, although with a wide confidence interval (OR 5.60, 97.5% CI [2.34-
14.88], p < 0.001).   
  Model 2 (M2).  A second model (M2) was constructed to determine if the 
statistically significant association between the initiation of synthetic oxytocin during 
normal labor progression and the outcome of cesarean delivery for labor dystocia would 
be changed when included in a model with the covariate of maternal delivery BMI (Table 
23).  Maternal delivery BMI was included as a predictor for Model 2 it was statistically 
significantly correlated with the initiation of synthetic oxytocin during times of normal 
labor progression in this sample (Table 16, rs = 0.159, p < 0.01).  M2 (DV: cesarean 
delivery for labor dystocia vs. vaginal birth and IV: synthetic oxytocin in normal labor + 
Maternal delivery BMI) was a poorer fit for the data when compared to the Model 1, with 
nearly equal residual deviance and slightly increased AIC (Table 23).  In addition, 
maternal delivery BMI was not statistically significantly associated with the outcome of 
cesarean delivery for labor dystocia.  Maternal delivery BMI was therefore discarded in 
further modeling of the relationship between cesarean for labor dystocia and the use of 
synthetic oxytocin during times of normal labor progression.   
  Model 3 (M3).  A third model (M3) was constructed to include other predictor 
variables that were statistically significantly correlated (Inter-correlations in Table 16) 
with cesarean delivery for labor dystocia (Table 23).   
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Table 23: Aim 2, H3 Logistic Regression Predicting Cesarean Delivery for Labor 
































SROM prior to 






















  Coefficient:  Synthetic Oxytocin in normal progress  
B  1.73 1.74 1.70 1.69 
SE  0.47 0.47 0.47 0.47 
p  <0.001 <0.001 <0.001 <0.001 
OR  5.60 5.70 5.47 5.42 
97.5% CI  [2.34-
14.88] 
[2.35-15.30] [2.25-14.75] [2.23-14.60] 








B   -0.01 0.39 -0.53 
SE   0.05 0.29 0.48 
p   0.799 0.175 0.270 
OR   0.99 1.47 0.59 
97.5% CI   [0.88-1.09] [0.86-2.66] [0.24-1.57] 
    Coefficient: Baby birth weight 
B    1.25 1.56 
SE    0.60 0.60 
p    0.036 0.005 
OR    3.49 4.74 
97.5% CI    [1.11-11.70] [1.63-14.72] 
*SROM=Spontaneous Rupture of Membranes  
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Model 3 thus included three predictors (DV: cesarean delivery for labor dystocia vs. 
vaginal birth, IV: synthetic oxytocin initiation during normal labor progression + baby’s 
birth weight + gestational age).  M3 improved upon M1 in fit statistics (Table 23).  M3 
also showed a statistically significant association between synthetic oxytocin in normal 
labor and the outcome of cesarean for labor dystocia (undiminished significance from 
M1, p < 0.001, and similar OR as M1: 4.67, 97.5% CI [2.25-14.75]).  Gestational age was 
not statistically significantly associated with the outcome in this model (p = 0.175), and 
was therefore dropped from further analysis.  Baby’s birth weight was statistically 
significantly associated with the outcome in M3 (p = 0.036), however.  In conclusion, M3 
showed that synthetic oxytocin initiation in normal labor was statistically significantly 
associated with the outcome of cesarean delivery for labor dystocia in this sample of 
obese women, even when included in a model which controlled for gestational age and 
baby’s birth weight, and that baby’s birth weight was also statistically significantly 
associated with this outcome.  
  Because gestational age and baby’s birth weight were highly correlated (Table 16, 
rs = 0.377, p < 0.01), Model 3 was also run with an interaction term (DV: cesarean 
delivery for labor dystocia vs. vaginal birth, IV: initiation of synthetic oxytocin in normal 
labor progress + baby’s birth weight + gestational age + baby’s birth weight X gestational 
age).  This version of Model 3 (not included in Table 23) was not an improvement in the 
fit of the data (residual deviance = 148.52, AIC = 158.52), and had only one statistically 
significant predictor (synthetic oxytocin in normal labor progression, significance and 
OR unchanged from M3).  Because the interaction term was non-statistically significant 
in this analysis, it was dropped from further analyses.   
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  Model 4 (M4).  A fourth logistic regression model was constructed to determine if 
SROM prior to admission affected the relationship found in M3 between synthetic 
oxytocin initiation in normal labor progression, baby’s birth weight, and the outcome of 
cesarean delivery for labor dystocia.  Model 4 was constructed to test if the statistically 
significant association between synthetic oxytocin in normal labor shown in M1 and M3 
would be changed when included in a model with a variable for baby’s birth weight and 
SROM prior to hospital admission.  Model 4 (DV: cesarean delivery for labor dystocia 
vs. vaginal delivery, IV: synthetic oxytocin initiation in normal labor + baby’s birth 
weight + SROM prior to admit) showed almost equivalent fit statistics when compared to 
M3 (Table 23).  The influence of synthetic oxytocin initiation in normal labor exposure 
remained statistically significant on the outcome of cesarean delivery for labor dystocia 
in this model, and at a similar level of effect (M4 synthetic oxytocin in normal labor OR 
= 5.42, 97.5% CI [2.23-14.60], p < 0.001).  Baby’s birth weight (p = 0.005) remained 
statistically significant in this model, while SROM prior to admission was not statistically 
significantly associated with the outcome.  Thus, the association between synthetic 
oxytocin exposure and the outcome of cesarean for labor dystocia is not changed by 
baby’s birth weight or the presence of ruptured membranes prior to hospital admission.   
  In conclusion, Model 3 was the best fit for the data overall, with the lowest model 
fit statistics.  Based on the M3 analysis, A2H3’s hypothesis that obese women in this 
dataset having cesarean for labor dystocia would be more likely to have synthetic 
oxytocin augmentation initiated during normal labor progression or in pre-active labor is 
accepted; obese women in this analysis who ended their labors with cesarean delivery for 
labor dystocia were 4.67 times more likely 97.5% CI [2.25-14.75] to have synthetic 
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oxytocin initiated during normal labor progression/pre-active labor than obese women 
ending labor with vaginal delivery, even when weight of their baby at birth and 
gestational age were held constant.  Presence of ruptured membranes at the time of 
hospital admission did not change this association between cesarean section for dystocia 
and synthetic oxytocin initiation during times of normal labor progression.  Baby’s birth 
weight was also statistically significantly associated with the outcome of cesarean for 
labor dystocia in this analysis; for every additional kilogram of baby weight, obese 
women of the same gestational age exposed to synthetic oxytocin augmentation during 
times of normal labor progression or pre-active labor were 3.49 times more likely (97.5% 
CI [1.11-11.70]) to have cesarean delivery for labor dystocia.   
  Residuals were run for A2H3’s synthetic oxytocin use during normal labor 
progression Model 3 to describe how well the data fit this model’s predictions.  
Standardized residuals showed a good fit for the model, as there were only 12 cases 
(3.1% of sample) where the standard residual value was > 2.0 standard deviations above 
the mean, reflecting a good overall fit for the data.  A binned residual plot was created 
(Figure 23) plotting raw residual values against the fitted values for the logistic model, 
where 56% (10/18) of the dots fell outside the 2 standard deviation lines, reflecting that 
M3 was not an ideal fit for the data.  It is possible that the small number of cesarean 
deliveries for labor dystocia in this logistic regression limited the ability of any model to 
fit the data well.   
  In conclusion, this analysis is consistent with rejection of the null hypothesis for 
Aim 2:  use of some interventions in the labors of obese women was associated with the 
outcome of cesarean delivery for labor dystocia in this sample.  Specifically, use of 
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synthetic oxytocin, AROM at less than 6cm cervical dilation, synthetic oxytocin at less 
than 6cm cervical dilation, and synthetic oxytocin initiation during times of normal labor 
progression/pre-active labor were all statistically significantly associated with the 
outcome of cesarean delivery for labor dystocia.  However, maternal BMI at the time of 
hospital admission (maternal delivery BMI) was not statistically significantly associated  
 
Figure 23: Aim 2, H3 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Synthetic Oxytocin During Normal Labor Progression or in Pre-
Active Labor (Model 3) Binned Residual Plot constructed using r command: 
binnedplot(x,y, nclass=18).   
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with the outcome of cesarean delivery for labor dystocia in these multivariate analyses or 
on inter-correlation, despite the fact that subjects with higher BMI groupings had 
statistically significantly increased exposure to synthetic oxytocin initiation during labor 
(overall, at < 6cm cervical dilation, and at times of normal labor progression, results not 
shown).  Thus, increasing BMI among the obese subjects of this sample was associated 
with increased use of synthetic oxytocin, yet was not associated with the outcome of 
labor dystocia for cesarean delivery.   
Aim 3 
Characterize use of synthetic oxytocin in labor augmentation by maternal delivery BMI 
in nulliparous, obese women who achieve vaginal birth. 
A3H1 
Healthy, nulliparous obese women of higher BMI will require larger total dosages 
of synthetic oxytocin and longer times of administration in order to achieve vaginal birth 
when compared to similar women of lower BMI.   
A3H2 
The hour-to-hour dose of synthetic oxytocin will vary over time from hospital 
admission until birth for each woman, and these hourly dose patterns will tend to group 
depending on the BMI of the women, the woman’s provider, and the size of her baby.   
Sample 
Starting with the sample described for Aim 2, all subjects were excluded who had a 
cesarean delivery (n = 24) or who did not receive synthetic oxytocin augmentation in labor (n = 
212), resulting in a new sample for Aim 3 analyses of n = 136 nulliparous, obese women who 
received synthetic oxytocin augmentation in their spontaneous labors and achieved vaginal 
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delivery (either spontaneous or operative) (Figure 17).   Subjects with cesarean delivery were 
excluded from this analysis so that all included cases would have a similar end point (vaginal 
delivery) for this analysis of synthetic oxytocin augmentation dosing characteristics. This 
sample of 136 subjects met size requirements for both multivariate Aim 3 analyses according to 
a priori power analysis (required sample size for A3H1 multivariate analysis: 53; required 
sample size for A3H2 analysis: 117).   
Key Variables 
 All variables in this analysis had non-normal distributions except baby’s birth 
weight.  Only one variable was heterogeneous across groups defined by maternal delivery 
BMI.  Perinatal Background Index (PBI) score was heterogeneous on Levene’s test (p < 
0.001), an expected finding, as higher levels of obesity are known to be associated with 
higher perinatal risk.   
Bivariate Analysis of Demographic, Maternal/Infant Characteristics, and Labor 
Interventions/Outcomes   
 Demographic variables (Table 24) are presented for this sample overall and broken 
down by obesity groupings.  Maternal racial background was under-reported in the charts 
reviewed for this analysis.  Therefore, breakdowns of maternal racial background are not 
presented in Table 24 by BMI groupings.  Maternal/infant characteristics (Table 25) and labor 
interventions/outcomes (Table 26) are also presented for this sample overall and broken down 
by obesity groupings.   No variables were found to be statistically significantly different 
between maternal delivery BMI-defined groups, reflecting a relatively homogenous group of 
subjects by obesity grouping in this sample on demographic and maternal/infant variables.  
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  Bivariate correlations were run for the primary outcome variables (total dose of 
synthetic oxytocin in labor and total duration of synthetic oxytocin augmentation) and 
possible predictor variables (maternal delivery BMI, gestational age, time interval 
between admission and synthetic oxytocin infusion start, cervical dilation at synthetic 
oxytocin start, baby’s birth weight, maternal height, year of delivery, provider in labor, 
and maternal age) (Table 27). Four predictor variables were statistically significantly 
correlated to the total oxytocin dose: time interval from admit to synthetic oxytocin start 
(p < 0.01), cervical dilation at synthetic oxytocin start (p < 0.01), baby’s birth weight (p < 
0.01), and provider type in labor (p < 0.05).  In this sample of only obese women, 
maternal delivery BMI was not statistically significantly correlated with total synthetic 
oxytocin dose.  Two variables were statistically significantly (p < 0.01) correlated with 
the total duration of oxytocin infusion: time interval from admit to synthetic oxytocin 
start (p < 0.01) and cervical dilation at synthetic oxytocin start (p < 0.01).  These 
statistically significant correlations were used to inform the choice of predictors for the 
multivariate analyses described next. 
Aim 3, Hypothesis 1 Multivariate Analysis 
Linear regression analysis was run to test the hypothesis that healthy, nulliparous 
obese women of higher BMI would require larger total dosages and longer times of 
administration of synthetic oxytocin in order to achieve vaginal birth when compared to 
similar women of lower BMI.  
 For both multivariate analyses in A3H1, multiple linear regressions were run in R 
2.14.2 Statistical Software (R Development Team, 2013) using the lm package.  To start 
each of the regression analyses for Aim 3, a NULL model (Model 0) was estimated with  
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Table 27: Aim 3 Inter-Correlations of Total Synthetic Oxytocin Dose, Synthetic Oxytocin 
Duration in Labor and Predictor Variables* 
Measure 1 2 3 4 5 6 7 8 9 
1.  Total 
Synthetic 
Oxytocin Dose 
--         







--        
3.  Gestational 
age at hospital 
admission 
.06 .04 --       











-.05 --      













--     






.07 -.07 --    
7.  Maternal 
Height 
-.77 -.48 .21* .02 -.06 .41** --   
8.  Year of 
Delivery 
-.66 -.58 -.02 .32*
* 
.21* -.12* -.15 --  
9.  Provider 
type in labor 






.06 .06 -.39**  
10. Maternal 
delivery BMI 






Note. Values calculated using Spearmen’s rho (rs).  *p < .05.  **p < 0.001 *Also tested maternal 
age against above variables; all correlations were non-statistically significant at p < 0.05 level.  
Maternal delivery BMI tested against all variables; only correlated (p = .01) with maternal height. 
 
no predictor variables.  Afterwards, predictor groups were added to the model in a step-
wise manner, starting with the predictor of maternal delivery BMI, which was the 
hypothesized predictor of the A3H1 outcomes.  Each time a new model was fit, it was 
compared to previous models for fit statistics and residual variance.  The sequence of 
models and findings is summarized below.   
           194 
  A3H1: Total synthetic oxytocin dose in labor.  The first outcome to be tested in 
A3H1 was the total dose of synthetic oxytocin received by subjects during labor.  The 
first model run for this outcome was Model 1 (M1), a linear regression analysis including 
DV: Total dose of synthetic oxytocin in labor and IV: maternal delivery BMI (Table 28).  
In M1, maternal delivery BMI only explained 0.08% of the variance in total synthetic 
oxytocin dose, and maternal delivery BMI was non-statistically significantly associated 
with the outcome (p = 0.348).  Thus, the inclusion of maternal delivery BMI as a 
predictor in this model resulted not only in poor model fit for the data when compared to 
M0, but also in a non-statistically significant coefficient.  On the basis of M1, the 
hypothesis of A3H1 that the total dose of synthetic oxytocin in labor would be larger 
among subjects with higher maternal delivery BMI is rejected in favor of the null 
hypothesis that the variance in total synthetic oxytocin dose during subject’s labors was 
not associated with maternal BMI.   
 In conclusion, maternal delivery BMI was not statistically significantly associated 
with total synthetic oxytocin dose received in labor by subjects with spontaneous onset of 
labor, synthetic oxytocin augmentation, and vaginal delivery.  The total dose of synthetic 
oxytocin received in labor by obese women achieving vaginal delivery was statistically 
significantly correlated to baby’s birth weight (higher total dose with higher infant 
birthweights), the time interval between hospital admission and the initiation of synthetic 
oxytocin infusion (lower total dose with later initiation), the cervical dilation at the onset  
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of synthetic oxytocin (lower total dose with more advanced cervical dilations at onset), 
and provider type (lower total dose with CNM providers) (Table 27).  Differences by 
provider type on the total dose of synthetic oxytocin received in labor by obese women 
achieving vaginal delivery were explained by provider differences in both the time 
interval between hospital admission and synthetic oxytocin initiation and the cervical 
dilation when synthetic oxytocin infusions were initiated (CNMs were statistically 
significantly more likely to start synthetic oxytocin later after hospital admission and at 
more advanced cervical dilations when compared to OBs).    
  A3H1: Total synthetic oxytocin duration in labor.  The second outcome to be 
tested in A3H1 was the total duration of synthetic oxytocin received during labor.  The 
first model for this outcome was Model 1 (M1), a linear regression analysis including 
DV: Total duration of synthetic oxytocin in labor and IV: maternal delivery BMI (Table 
30).  In M1, maternal delivery BMI only explained 0.04% of the variance in total 
synthetic oxytocin dose, and the coefficient of maternal delivery BMI was non-
statistically significantly associated with the outcome (p = 0.496).  Thus, inclusion of 
maternal delivery BMI as a predictor in this model resulted not only in poor model fit for 
the data, but also in a non-statistically significant coefficient.  On the basis of M1, the 
null hypothesis of A3H1 (total duration of synthetic oxytocin in labor) is retained; the 
total duration of synthetic oxytocin in labor in this sample of obese women with vaginal 
delivery was not longer with higher maternal delivery BMIs.   
  In conclusion, maternal delivery BMI was not statistically significantly associated 
with total synthetic oxytocin duration in labor.  In this sample of obese subjects with 
spontaneous onset of labor and vaginal delivery, total synthetic oxytocin duration was 
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significantly correlated to the time interval between hospital admission and the start of 
synthetic oxytocin infusion (later initiation of synthetic oxytocin after hospital admission 
correlated to smaller durations of infusion) and by the cervical dilation at the time of 
synthetic oxytocin initiation (more advanced dilations resulted in lower duration of 
oxytocin infusion).  
Aim 3, Hypothesis 2 Multivariate Analysis 
Multi-level (hierarchical) linear modeling was run to test the A3H2 hypothesis 
that the hour-to-hour dose of synthetic oxytocin would vary over time from hospital 
admission until birth for each subject, and these hourly dose patterns would be grouped 
depending on the BMI of the women, the woman’s provider, and the size of her baby. 
 This analysis was performed to better understand if women of the same BMI cohorts 
received hourly doses of synthetic oxytocin which were different than women from other 
BMI cohorts.  Multi-level modeling provides the ability to test the effects of BMI 
grouping while also including the effects of other variables which are theorized to predict 
the hourly dose of pitocin.   
Two levels were described for this multi-level model: Level 1 was the hourly dose 
of synthetic oxytocin received by each subject throughout her augmentation.  According 
to the A3H2 hypothesis, additional Level 1 predictors were: cervical dilation at time of 
synthetic oxytocin initiation, hour of oxytocin infusion, baby’s birth weight and provider 
type.  Type of provider caring for woman in labor was included as a predictor in this 
hypothesis because it has been shown to be associated with both the cervical dilation on 
admission (Jackson, 2003) and the interval between admission and start of synthetic 
oxytocin infusion (Hodnett, Gates, Hofmeyr, & Sakala, 2013). Statistically significant 
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correlation between provider type and time interval between hospital admission and 
synthetic oxytocin initiation was also demonstrated in this dataset (Table 27). The Level 
2 predictors in this analysis were maternal delivery BMI group of the woman (maternal 
delivery BMI split into 18 groups, with each group including subjects with maternal 
delivery BMI within one integer BMI point, e.g. Group 1 = BMI 30.00-30.99, Group 2 = 
BMI 31.00-31.99…) and the hour of synthetic oxytocin infusion.  This analysis was 
originally designed to include only three BMI groupings, according to Institute of 
Medicine groups (Group 1 = BMI 30.00-34.99, Group 2 = BMI 35.00-39.99, Group 3 = 
BMI ≥ 40).  However, 18 BMI groupings were instead used in this analysis to better 
capture the effect of small differences in obesity on hourly synthetic oxytocin dose.   
All multi-level models for this analysis were estimated in R 2.14.2 Statistical 
Software (R Development Team, 2013) using the lme4 package (Bates, Maechler, 
Bolker, & Walker, 2014).  To fit the multi-level model, a basic model was first run 
without any predictors (Model 0).  Then, additional models were built (M1-M4) with new 
predictors added on each model.   
Table 30 provides a comparison of the Level 2 predictor’s intercept and residual 
across each model.  Model fit statistics are provided in Table 31.  As in the linear models 
run for Aim3H1, model fit statistics showing a decrease between models reflects that the 
second model is a better fit for the data.  Finally, Table 32 provides the coefficients and 
standard errors for each model’s fixed (Level 1) predictors.  Instead of providing 
significance values for each individual Level 1 predictor, a comparison of each model is 
in Table 32 with chi-square comparison of models and p-values for the comparisons.  
Significance values for individual predictors are not calculated in the lmer package   
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Table 30:  Aim 3H2 Group-level Error Variance Models 0 (Null model) and Models 1-4 
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Note. Model syntax: M0: pitHOURLYdose ~ 1 + (1 | BMIcat1). M1: pitHOURLYdose ~ hour + 
(hour | BMIcat1). M2: pitHOURLYdose ~ hour + pitaugcvxdil1 + (hour | BMIcat1). M3: 
pitHOURLYdose ~ hour + pitaugcvxdil1 + bbirthweight + (hour| BMIcat1).  M4: 
pitHOURLYdose ~ hour + pitaugcvxdil1 + bbirthweight + providertype + (hour| BMIcat1). 
 
Table 31:  Aim 3H2 Model Fit Statistics for Models 0 (Null model) and Models 1-4 












































37441 37027 35991 35971 35971 
Deviance 37424 36988 35946 35910 35907 
Note. Model syntax: M0: pitHOURLYdose ~ 1 + (1 | BMIcat1). M1: pitHOURLYdose ~ hour + 
(hour | BMIcat1). M2: pitHOURLYdose ~ hour + pitaugcvxdil1 + (hour | BMIcat1). M3: 
pitHOURLYdose ~ hour + pitaugcvxdil1 + bbirthweight + (hour| BMIcat1). M4: 
pitHOURLYdose ~ hour + pitaugcvxdil1 + bbirthweight + providertype + (hour| BMIcat1).
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because there are concerns with the accuracy of p-values on individual predictors 
resulting from these calculations (Bates, 2009).  However, the multi-level models for 
this analysis were fit with one predictor added at a time, thereby allowing for easy 
comparison of model fit (and model significance) with new predictors.  
Sample size.  Sample size requirements for the multi-level model according to a 
priori power analysis calculations were n = 117 subjects, which was met for this 
analysis (Aim 3H2 sample: n = 136).   
Null model (M0).  First, a null model was estimated with no predictors to 
explain the hourly dose of synthetic oxytocin variance among 18 maternal delivery 
BMI groupings.  Using this null model, two analyses were run to determine the 
usefulness of multi-level modeling for this outcome in this dataset.  First, an interclass 
correlation (ICC) was calculated to estimate the proportion of variance in the dependent 
variable (hourly synthetic oxytocin dose) explained by differences in the grouping 
variable (maternal BMI group).  The ICC (Null model group variable intercept/ group 
variable intercept + group variable residual) is an important statistic when planning a 
multi-level modeling, because it reports on the percentage of variability in the outcome 
variable that can be attributed to the differences in the grouping variable (Level 2 
variable, or maternal BMI group) (Grace-Martin, 2013).  If the ICC is close to 0, it is 
recommended that multi-level analysis is not necessary because the data would be 
better fit using a flat (one level) model.  For this dataset, the ICC = (2897.9/2897.9 + 
40558.4 = 0.067).  Thus, 6.7% of the variance in the hourly synthetic oxytocin doses 
was related to BMI grouping and multi-level modeling was therefore a good choice for 
these data.   
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Another analysis to ascertain if a multi-level model was necessary over a simple 
linear regression model involved the construction of a caterpillar plot with the 95th 
percentile intervals of hourly synthetic oxytocin dose for each BMI group (Bates, 2011; 
Hox, 2010).  In a caterpillar plot of a multi-level dataset, the range of the outcome 
variable (hourly synthetic oxytocin dose) should not cross 0 (median hourly synthetic 
oxytocin dose across all BMI groups) for most of the groups.  If the outcome variable 
range does cross zero for most of the groups, that dataset would be better modeled 
using a flat, linear regression because the grouping variable is not changing the 
variance in the outcome variable. The finished plot (Figure 24) shows that over half 
(10/19) of the BMI groups had hourly synthetic oxytocin dose intervals which did not 
cross zero.   Thus, both the ICC and the caterpillar plot run for this Null model suggest 
that a multi-level model using BMI groupings was a good fit for the hourly synthetic 
oxytocin data. 
Model 1 (M1).  Model 1 built off of the Null model by adding one individual 
and a grouping predictor for hour of synthetic oxytocin dosing (DV: Hourly synthetic 
oxytocin dose, IV: Level 2- maternal BMI group + Hour of dosing, Level 1: Hour of 
dosing).  This model was created to understand how the hourly synthetic oxytocin 
doses (DV) varied based on the number of hours that the infusion was running (Level 
1) and the impact of maternal BMI group on the hourly dose (Level 2).  M1 included 
both a random intercept and random slope.  Lower model fit statistics (Table 31) 
indicated that M1 improved the model fit over the Null model (M0).  Including the hour   
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Figure 24: Aim 3, H2 caterpillar plot of 95%ile intervals for hourly synthetic oxytocin 
dose in each BMI group. 
 
 
that the synthetic oxytocin dose was infusing in M1 increased the ICC over M0 (BMI’s 
ICC = 6.7%) to an ICC for M1 of 0.213, meaning that 21.3% of the variance in the 
hourly synthetic oxytocin dose was explained by the maternal BMI grouping.  Given 
the random slope and intercept of this model, this result can be interpreted that the 
hourly synthetic oxytocin doses varied not only with the hour of infusion, but also that 
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Model 2 (M2).  Model 2 was built on M1 to test the effect of adding the 
predictor of the last known cervical dilation at the time of synthetic oxytocin initiation.  
Thus, M2 included (DV: Hourly synthetic oxytocin dose, IV: Level 2- maternal BMI 
group + Hour of dosing, Level 1: Hour of dosing + Cervical dilation at time of 
synthetic oxytocin initiation).  M2 showed lower model fit statistics (Table 31) 
compared to M1, reflecting a better fit for the data.  In addition, M2 was statistically 
significantly better than M1 (p<0.001) in explaining the variance in hourly synthetic 
oxytocin dose (Table 32).  According to M2, in each successive hour of synthetic 
oxytocin infusion, the hourly synthetic oxytocin dose decreased by 12.6 mU among 
women with the same starting cervical dilations.  Also from M2, during the same hour 
of infusion, a one centimeter increase in the cervical dilation prior to synthetic oxytocin 
initiation was associated with a 21.03 mU decrease in the average hourly synthetic 
oxytocin dose.  Thus, hourly synthetic oxytocin doses tended to decrease over time and 
with greater starting cervical dilations.  Also in M2, the Level 2 variable of BMI 
grouping predicted 17.6% of the variance in the hourly synthetic oxytocin doses, and 
the Hour of infusion predicted 0.034% of the variance in the hourly doses.   
Model 3 (M3).  Model 3 added an additional Level 1 predictor of baby’s birth 
weight to M2 (DV: Hourly synthetic oxytocin dose, IV: Level 2- maternal BMI group + 
Hour of dosing, Level 1: Hour of dosing + Cervical dilation at time of synthetic 
oxytocin initiation + baby’s birth weight).  This model was built because baby’s birth 
weight showed a statistically significant correlation to total synthetic dose in labor 
(Table 27, rs = 0.18, p < 0.01), and was thus theorized to have an influence on hourly 
synthetic oxytocin doses.  This model had better fit statistics (Table 31) and was 
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statistically significantly better modeling of variance in synthetic oxytocin dose (Table 
32, p < 0.001) when compared to previous models.  In Model 3, the coefficients for the 
predictors: hour of synthetic oxytocin infusion and cervical dilation at time of oxytocin 
start remained about the same when the additional predictor of baby’s birth weight was 
added to the new model.  According to M3, a one gram increase in baby’s birth weight 
resulted in a 0.05 mU increase in the average hourly synthetic oxytocin dose when both 
the cervical dilation at oxytocin infusion onset and the hour of infusion were held 
constant.  Also in M3, the group predictor of maternal BMI explained 16.56% of the 
variance in hourly synthetic oxytocin dose.   
Model 4 (M4).  A final model was fit to test the effect of adding the Level 1 
predictor of provider type to M3 (M4 DV: Hourly synthetic oxytocin dose, IV: Level 2- 
maternal BMI group + Hour of dosing, Level 1: Hour of dosing + Cervical dilation at 
time of synthetic oxytocin initiation + baby’s birth weight + provider type).  M4 had 
roughly equal fit statistics compared to M3 (Table 31), and was not a statistically 
significantly better explanation of the variance in hourly synthetic oxytocin dose (Table 
32, p = 0.088).  Therefore, provider type did not statistically significantly improve this 
model’s ability to explain variance in the hourly synthetic oxytocin dose over Model 3 
(Rafferty, 1995).  Although there was a statistically significant correlation between 
provider type and the total dose of synthetic oxytocin infused in labor on bivariate 
analysis (Table 27, rs = 0.19, p < 0.05), provider type did not statistically significantly 
improve the explanation of the hour-to-hour synthetic oxytocin doses in a multi-level 
model including both baby’s birth weight and onset cervical dilation.  Possibly, 
differences by provider type in the hour-to-hour synthetic oxytocin dose are explained 
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in this multi-level model by the predictor of synthetic oxytocin onset cervical dilation 
(provider type was also statistically significantly correlated with onset cervical dilation, 
Table 27, rs = -0.32, p < 0.01).  Other models were tested (results not shown) where 
alternative predictors were added to M3 individually to evaluate model fit.   Gestational 
age, presence of spontaneously ruptured membranes at hospital admission, and hospital 
admission cervical exams were all tested in alternate M4s, and none of these predictors 
resulted in a new model with better fit statistics or explanation of variance in hourly 
synthetic oxytocin dose when compared to M3.   
In conclusion, M3 (DV:  Hourly synthetic oxytocin dose, IV: Level 2—BMI 
group, Hour of infusion, Level 1—Cervical dilation at last check prior to synthetic 
oxytocin initiation, baby’s birth weight) was the best fit for the data.  In this model, 
the mean synthetic oxytocin dose in one hour across all measurements in this dataset 
was 182.66 mU (the intercept).  That means that at an average level of all the other 
fixed effects, the average pit dose in an hour was 182.66 mU.  The coefficient for 
“hour” was -12.79.  This means that the hourly synthetic oxytocin dose decreased by 
12.79 mU when the accumulated infusion time increased by an hour when baby’s birth 
weight was held constant.  The coefficient for cervical dilation at the time of synthetic 
oxytocin initiation for M3 was -20.17.  This means that the hourly synthetic oxytocin 
dose went down by 20.17 mU each time a woman moved up by one centimeter in her 
cervical dilation at the time of pitocin initiation (baby’s birth weight held constant).   
The beta coefficient for baby’s birth weight was 0.053.  This means that hourly pit dose 
increased by 0.053 mU each time a woman's baby had a one gram increase in birth 
weight.  Thus, if two women of equivalent BMIs had the same starting cervical 
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dilations and were in the same hour of oxytocin infusion, the woman with a 3kg baby 
would receive an average of 53 less units of oxytocin per hour than the matched woman 
with a 4kg baby.   
To estimate group effects in M3, the ICC was calculated and compared to other 
models.  The ICC of BMI in M3 was 0.1656, meaning that 16.56% of the variability in 
hourly synthetic oxytocin dose was explained by BMI grouping in this model (Table 
30). The ICC for Hour of oxytocin dose as a Level 2 predictor for M3 was 0.000044, 
meaning that only 0.0044% of the variance in hourly synthetic oxytocin doses in this 
sample were predicted by the hour of dosing.  Thus, the maternal BMI group had a 
larger Level 2 effect than the Hour of dosing.  This ICC for BMI in M3 was lower than 
that calculated for M1 (M1 BMI ICC = 0.213, or 21.3% of variance in hourly synthetic 
oxytocin dose predicted by BMI group).  Thus, M3’s Level 1 predictors (hour + 
cervical dilation at synthetic oxytocin onset + baby’s birthweight) were better able to 
explain hourly synthetic oxytocin dose than the Level 1 predictors included in M1 
(hour).   
The group effect of BMI in M3 had a variance of 6216.099 and a standard 
deviation of 78.84 (Table 30).  The standard deviation of this group effect is 
comparable to the coefficient values of the fixed effects.  Therefore, the variability in 
hourly synthetic oxytocin dose between BMI groups was larger than any of the fixed 
effect variables (baby's birth weight, cervix at synthetic oxytocin initiation, or hour 
variables).   This means that even when the hour, cervical exam at synthetic oxytocin 
initiation, and baby's birth weight are all held constant, there was still a large influence 
of maternal BMI on synthetic oxytocin hourly doses.  By contrast, the standard 
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deviation of the Level 2 predictor of Hour in M3 was 3.27 (Table 30).  When compared 
to the coefficients of the individual predictors in M3, the group effect of Hour was not 
as powerful.  In M3, average hourly oxytocin doses were different between BMI 
groups, but within these BMI groups, the effect on the hourly oxytocin dose of 
increasing the duration of infusion (the random slope in M3 of Hour) was only slightly 
different from other BMI groups.   
To more clearly demonstrate this complex relationship, a plot of hourly 
synthetic oxytocin dose across time for each BMI group was created (Figure 25).  Each 
blue line in Figure 25 traces the hourly synthetic oxytocin doses for a single subject 
from the time of synthetic oxytocin initiation until end.  Subjects are grouped in boxes 
by their delivery BMI.  It is clear that the hourly synthetic oxytocin dose slopes are 
different across BMI groupings, and across time within each grouping.  In general, 
hourly synthetic oxytocin dose moves upward in a sharp slope upon initiation of 
infusion to a high point, followed by maintenance at a high level for a period of time 
(creating a plateau in the slope), or by a rapid decrease in dose when oxytocin infusion 
is ceased for that subject.  With increasing BMI, more subjects reach higher hourly 
synthetic oxytocin doses (higher peaks in the blue lines) compared to subjects in the 
lower BMI groups.  Groups for BMI 41-47 kg/m2 each had only a few subjects, 
resulting in graphs that have too little information to identify clear patterns.   
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Figure 25: Aim 3, H2 Plot of Hourly Synthetic Oxytocin Dose Slopes by Hour of 
Infusion for Groups Defined by Maternal Delivery BMI (kg/m2). 
 
To summarize Aim 3 analyses, in this dataset composed of obese, nulliparous 
subjects who achieved vaginal birth after synthetic oxytocin augmentation, both total 
synthetic oxytocin dose and synthetic oxytocin duration were not statistically 
significantly related to maternal delivery BMI in neither bivariate correlation analysis 
nor  in multivariate linear regression.  There was a trend toward higher total dose of 
synthetic oxytocin and longer total duration of synthetic oxytocin infusion with 
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morbidly obese group (n = 15) led to decreased variance of both dose and duration 
across BMI, thus limiting comparisons.  
Timing of synthetic oxytocin initiation after hospital admission was statistically 
significantly correlated with both total dose and total duration of oxytocin infusion, as 
predicted in A3H1 hypothesis (Table 27); when obese women started synthetic 
oxytocin infusions later in labor, they received smaller doses for shorter durations.  In 
addition, baby’s birth weight was positively and statistically significantly correlated 
with total dose, but not with total duration of synthetic oxytocin.  Provider type was 
also statistically significantly correlated with total dose of synthetic oxytocin; CNM 
providers tended to infuse lower doses of synthetic oxytocin to the obese women 
achieving vaginal delivery in their care when compared to OBs (Table 27).  
Although the total dose of synthetic oxytocin was not statistically significantly 
associated with maternal BMI in this sample, 16.56% of the variance in the hourly dose 
of synthetic oxytocin received by the obese women in this sample was explained by 
delivery BMI group on multilevel analysis when controlling for both the hour of 
infusion and infant birthweight (Table 30-32).  Women with higher BMIs tended to 
have higher hourly oxytocin doses when compared to women with lower BMIs (Figure 
27).  Subjects also tended to have higher hourly doses of synthetic oxytocin when their 
babies were heavier and when their cervix was less dilated at the time of oxytocin onset 
(Table 31).    
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Aim 4 
 Among healthy, nulliparous obese women ending labor with cesarean delivery for 
labor dystocia, examine how exposure to low-technology interventions differs from similar 
women ending labor with vaginal delivery 
A4H1 
 Healthy, nulliparous obese women who end labor with vaginal delivery are 
more likely to make use of low-technology interventions in labor compared to similar 
women who end labor with cesarean delivery for the indication of labor dystocia. 
A4H2 
  Healthy nulliparous obese women who end labor with cesarean delivery for 
labor dystocia are less likely than similar women ending labor with vaginal delivery to 
engage in ambulation, hydrotherapy, or intermittent fetal monitoring at > 6 cm cervical 
dilation and to engage in these activities for shorter total periods of time in labor.  
A4H3 
  Healthy nulliparous obese women who end labor with cesarean delivery for the 
indication of labor dystocia are less likely than similar women ending labor with 
vaginal delivery to experience onset of low-technology intrapartum interventions while 
having abnormal cervical progression.   
Sample 
  The sample for this analysis is the same as the sample for the Aim 2 analyses:  a 
combined group of both OB and CNM patients meeting all inclusion criteria (healthy, 
obese, nulliparous, age 18-40 years, spontaneous labor onset, normal fetus in vertex 
position) having either vaginal delivery (spontaneous or operative) or cesarean for labor 
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dystocia (n = 348) (Figure 17).  Medical record reviews were performed on all of these 
subjects, and information on the use of low-technology interventions was collected 
from the nurse’s notes and provider’s progress notes about the timing in labor of 
intervention use, the total duration of intervention use, and the choice of interventions.  
Key Variables 
  See tables on key variables considered in Aim 4 in Tables 13-15. The same 
findings on normality and group variance were true for Aim 4 as were found for Aim 2, 
since these Aims shared the same sample.   
Bivariate Analysis of Demographic, Maternal/Infant Characteristics, and Labor 
Interventions/Outcomes 
  Comparisons were made between BMI groups on demographic variables (Table 
13), maternal/infant characteristics (Table 14), Maternal/Infant outcomes (Table 15) 
and low-technology interventions (Table 33).  Results for Tables 13-15 are discussed in 
Aim 2.  Bivariate analysis of low-technology intervention use by delivery outcome 
groupings did not show statistically significant differences in the overall use, timing of 
low-technology intervention initiation, or duration of low-intervention use in the labors 
of the obese women in this sample.   
Bivariate correlations were run between key Aim 4 variables (Table 34).  The 
use of none of the low-technology labor interventions was significantly correlated with 
the outcome of cesarean delivery for labor dystocia.  Use of ambulation, hydrotherapy, 
and intermittent fetal monitoring were all positively and statistically significantly 
correlated with baby’s birth weight (p < 0.05), possibly because these women had 
longer labors with more time for various interventions.  Use of low-technology  
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Table 33: Aim 4 Labor Interventions by Delivery Outcome Group:  Means or Medians, 
Standard Deviations or Inter-quartile ranges, Frequencies and Comparison of Groups 
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Note. * Chi-square test with continuity correction used for group comparison on 
categorical variables. Mann-Whitney U Test used for group comparison of continuous 
variables.  Tests with statistically significant values shown in bold. 
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interventions was also statistically significantly correlated to provider type (p < 0.01), 
with CNMs being morelikely to use each of these low-technology interventions than 
OBs in this sample of obese women.  Finally, statistically significant correlations (p < 
0.01) were found between the use of each low-technology intervention; therefore, 
subjects having one low-technology intervention tended to have several low-tech 
interventions.   
Table 34: Aim 4 Inter-Correlations of Cesarean Delivery for Labor Dystocia and 
Predictor Variables 
Measure 1 2 3 4 5 6 7 
1.  Cesarean 
delivery for 
labor dystocia 
--       










.13* -.45 --     
4.  Baby’s 
birth weight 
.15** -.27 .38** --    
5.  Provider 
type in labor 
.02 .09 -
.14** 
-0.89 --   
6. Use of 
ambulation 
.01 -.25 .026 .12* -
.25** 
--  
















Note. Values calculated using Spearmen’s rho (rs).  *p < .05.  **p < 0.01. 
  
Aim 4, Hypothesis 1 Analysis 
Logistic regression analysis with an alpha level of 0.05 was run to test the Aim 
4, H1 hypothesis that healthy, nulliparous obese women who ended labor with vaginal 
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delivery were more likely to make use of low-technology interventions in labor after 
hospital admission.  Women with different delivery outcomes (cesarean for indication 
of labor dystocia vs. vaginal birth) were compared by logistic regression on their 
exposure to 1) ambulation, 2) hydrotherapy, and 3) intermittent external fetal 
monitoring.  If a difference between the two groups of women was found on their 
exposure to these interventions, sub-analysis was conducted to understand how much of 
this difference was explained by CNM or OB provider affiliation. Although evidence of 
continuous labor support (doula) was also sought during chart review, only two subjects had 
documented use of this support.  Many other subjects had the support of their family 
members or nurses during labor, yet only rarely was this support documented in nurse’s notes 
consistently.  Therefore, Aim4, H1 was analyzed on only the use of ambulation, 
hydrotherapy, and intermittent fetal monitoring.  
  In this analysis, event = DV = cesarean delivery for labor dystocia.  Binary 
logistic regression was run in R 2.14.2 Statistical Software (R Development Team, 
2013) using the glm package.  Unlike Aim 1, these analyses in Aim 4 did not require 
rare events logistic regression because the event ratio in this dataset was higher (24 
cesarean for labor dystocia /324 vaginal births = 7.4% event rate), thus meeting the 5% 
event ratio requirements for binary logistic regression using a generalized linear model 
(Plichta & Kelvin, 2013, p. 327).  To start each of the following regression analyses for 
Aim 4, a NULL model (Model 0) was estimated with the DV=cesarean delivery for 
labor dystocia (event) vs. vaginal birth (non-event) with IV = no predictor variables.  
Afterwards, predictor groups were added to the model based on each Aim 4 hypothesis.  
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Each time a new model was fit, it was compared to previous models for fit statistics and 
residual variance.  The sequence of models and findings is summarized below.   
  A4H1: Ambulation.  The first low-technology intervention to be tested in 
A4H1 was ambulation (Table 35).  Model 1 for ambulation was constructed to 
determine if the odds of cesarean delivery for labor dystocia were changed by use of 
ambulation during labor.  Logistic regression was run including DV: cesarean delivery 
for labor dystocia vs. vaginal birth and IV: ambulation in labor.  Compared to the 
NULL model (M0), M1 showed increased fit statistics, reflecting a poorer fit to the 
data.  In addition, the coefficient for hydrotherapy showed a non-statistically significant 
association with the outcome of cesarean for labor dystocia (p = 0.933).  This non-
statistically significant association between cesarean for dystocia was logical, given the 
nearly equivalent frequencies of ambulation among women with cesarean for labor 
dystocia (33.13% ambulated) vs. vaginal delivery (32.1% ambulated).  Therefore, the 
null hypothesis is retained for the A4H1’s hypothesis that obese women in this sample 
having cesarean for labor dystocia would be less likely to have ambulation in labor; 
obese women were just as likely to have ambulation in labor, regardless of their 
delivery outcome. 
 A4H1: Hydrotherapy.  The second intervention tested was hydrotherapy.  At 
the University of Colorado Hospital, hydrotherapy could take the form of either shower 
or tub.  All types of hydrotherapy are included in this analysis; however, the large 
majority of these hydrotherapy episodes involved tub immersion (89/100, 89.0%).  A 
first logistic regression model (M1) for hydrotherapy was constructed with DV:  
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Table 35: Aim 4, H1 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Ambulation in Labor 
Statistic Model 0 
(Null Model) 
Model 1 
(Predictor: Ambulation in 
labor) 
Residual deviance 174.66 174.09 





-2.61 (0.21) -2.60 (0.26) 
  Coefficient: 
Ambulation in Labor 
B  0.04 
SE  0.45 
p  0.933 
OR  1.04 
97.5% CI  [0.41-2.44] 
 
cesarean delivery for labor dystocia vs. vaginal birth and IV: hydrotherapy in labor 
(Table 36).  Compared to the NULL model (M0), M1 showed increased fit statistics, 
reflecting a poorer fit to the data.  In addition, the coefficient for hydrotherapy use 
showed a non-statistically significant association with the outcome of cesarean for labor 
dystocia (p=0.60).  This non-statistically significant result makes sense, given the 
nearly equivalent use of hydrotherapy among women having vaginal delivery (27.8% 
had hydrotherapy) compared to women having cesarean for labor dystocia (33.3% had 
hydrotherapy).  Therefore, the null hypothesis is retained for A4H1’s (hydrotherapy); 
obese women in this sample having cesarean for labor dystocia were just as likely to 
have hydrotherapy as women having vaginal delivery.   
 A4H1: Intermittent Fetal Monitoring.  The third low-technology intervention 
tested in A4H1 was intermittent fetal monitoring in labor.  A first logistic regression 
model (M1) for intermittent fetal monitoring (iEFM) was constructed with DV: 
cesarean delivery for labor dystocia vs. vaginal birth and IV: iEFM exposure (Table 
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37).  Compared to the NULL model (M0), M1 showed nearly equivalent fit statistics, 
reflecting a non-statistically significant improvement in the fit of M1 to the data.  In 
addition, the coefficient for iEFM use showed a non-statistically significant association 
with the outcome of cesarean for labor dystocia (p=0.544).  This non-statistically 
significant result was logical, given the nearly equivalent use of iEFM among women 
having vaginal delivery (43.2% had intermittent monitoring) compared to women 
having cesarean for labor dystocia (50.0% had intermittent monitoring).  Therefore, 
A4H1’s hypothesis that obese women in this sample having cesarean for labor dystocia 
would be less likely to have intermittent fetal monitoring is rejected in favor of the null. 
 
Table 36: Aim 4, H1 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Hydrotherapy in Labor 
Statistic Model 0 
(Null Model) 
Model 1 
(Predictor: Hydrotherapy in 
labor) 
Residual deviance 174.66 173.53 





-2.61 (0.21) -2.66 (0.26) 
  Coefficient: 
Hydrotherapy in Labor 
B  0.24 
SE  0.45 
p  0.6 
OR  1.27 
97.5% CI  [0.50-2.99] 
 
Aim 4, Hypothesis 2 Analysis 
Logistic regression analysis with an alpha level of 0.05 was run to test the Aim 
4, H2 hypothesis that healthy nulliparous obese women who end labor with cesarean 
delivery for labor dystocia are less likely than similar women ending labor with vaginal 
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delivery to initiate ambulation, hydrotherapy, or intermittent fetal monitoring at >6cm 
cervical dilation and that subjects with cesarean for labor dystocia would engage in 
these activities for shorter total periods of time compared to subjects with vaginal 
delivery. 
 
 Table 37: Aim 4, H1 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Intermittent Fetal Monitoring in Labor 




Fetal Monitoring in labor) 
Residual deviance 174.66 173.87 





-2.61 (0.21) -2.71 (0.30) 
  Coefficient: 
Intermittent Fetal 
Monitoring in Labor 
B  0.26 
SE  0.42 
p  0.544 
OR  1.29 
97.5% CI  [0.56-3.00] 
 
  A4H2:  Ambulation after 6cm cervical dilation.  The first intervention to be 
tested in A4H2 was use of ambulation after 6cm cervical dilation (Table 38).  Model 1 
for ambulation > 6cm was constructed to determine if the odds of cesarean delivery for 
labor dystocia were changed by initiation of ambulation after 6cm.  A first logistic 
regression model (M1) was run including DV: cesarean delivery for labor dystocia vs. 
vaginal birth and IV: ambulation after 6cm.  Compared to the NULL model (M0), M1 
showed increased fit statistics, reflecting a poorer fit to the data.  In addition, the 
coefficient for ambulation after 6cm showed a non-statistically significant association 
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with the outcome of cesarean for labor dystocia (p = 0.589).   This non-statistically 
significant result was logical, given the nearly equivalent use of ambulation at > 6cm in 
subjects having vaginal delivery (7.1% had ambulation > 6cm) compared to women 
having cesarean for labor dystocia (4.2% had ambulation > 6cm).  Therefore, the null 
hypothesis is accepted for A4H1 (ambulation > 6cm); obese women in this sample 
having cesarean for labor dystocia were just as likely to have ambulation initiated later 
in labor compared to women having vaginal delivery. 
 
Table 38: Aim 4, H2 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Ambulation after to 6 Centimeters Cervical Dilation in Labor 
Statistic Model 0 
(Null Model) 
Model 1 
(Predictor: Ambulation > 
6cm in labor) 
Residual deviance 174.66 174.32 





-2.61 (0.21) -2.57 (0.22) 
  Coefficient: 
Ambulation > 6cm in Labor 
B  -0.56 
SE  1.04 
p  0.589 
OR  0.57 
97.5% CI  [0.03-2.90] 
 
  A4H2:  Hydrotherapy after 6cm cervical dilation.  The second intervention 
to be tested in A4H2 was initiation of hydrotherapy after 6cm cervical dilation (Table 
39).  Model 1 for hydrotherapy > 6cm was constructed to determine if the odds of 
cesarean delivery for labor dystocia are changed by use of hydrotherapy after 6cm.  A 
first logistic regression model (M1) was run including DV: cesarean delivery for labor 
dystocia vs. vaginal birth and IV: hydrotherapy after 6cm.  Compared to the NULL 
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model (M0), M1 showed increased fit statistics, reflecting a poorer fit to the data.  In 
addition, the coefficient for hydrotherapy after 6cm showed a non-statistically 
significant association with the outcome of cesarean for labor dystocia (p = 0.866).   
This non-statistically significant result was logical, given the nearly equivalent use of 
hydrotherapy at > 6cm in subjects having vaginal delivery (4.9% had hydrotherapy > 
6cm) compared to women having cesarean for labor dystocia (4.2% had hydrotherapy > 
6cm).  Therefore, the null hypotheis was retained for A4H1 (hydrotherapy > 6cm); 
obese women in this sample having cesarean for labor dystocia were just as likely to 
have hydrotherapy initiated later in labor as women having vaginal delivery. 
 
Table 39: Aim 4, H2 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Use of Hydrotherapy after 6 Centimeters Cervical Dilation 
 
Statistic Model 0 
(Null Model) 
Model 1 
(Predictor: Hydrotherapy > 
6cm in labor) 
Residual deviance 174.66 174.63 





-2.61 (0.21) -2.59 (0.22) 
  Coefficient: 
Hydrotherapy > 6cm in 
Labor 
B  -0.18 
SE  1.05 
p  0.866 
OR  0.84 
97.5% CI  [0.05-4.39] 
 
  A4H2:  Intermittent fetal monitoring after 6cm cervical dilation.  The third 
intervention to be tested in A4H2 was use of intermittent fetal monitoring (iEFM) after 
6cm cervical dilation (Table 40).  Model 1 for iEFM > 6cm was attempted to determine 
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if the odds of cesarean delivery for labor dystocia were changed by initiation of iEFM 
after 6cm.  M1 included DV: cesarean delivery for labor dystocia vs. vaginal birth and 
IV: iEFM after 6cm. However, this multivariate model was not able to be fit because 
the variable of iEFM > 6cm in labor showed quasi-complete separation when evaluated 
against the outcome of cesarean birth for labor dystocia. This is likely because iEFM > 
6cm was found in 0/24 of cases with cesarean for labor dystocia, and in 29/324 (9.0%) 
of vaginal births, thus creating a situation in this generalized linear model of 
convergence failure (Allison, 2008).  
  Therefore, no multivariate model was fit for the relationship between iEFM use 
at > 6cm in labor and the outcome of cesarean for labor dystocia.  This fit difficulty was 
caused by the quasi-complete separation occurring on the use of iEFM > 6cm among 
subjects having vaginal birth and those having cesarean for labor dystocia, with 0% of 
women having cesarean delivery for labor dystocia experiencing iEFM initiation after 
6cm compared to 9.0% of women having vaginal delivery. However, bivariate statistics 
showed a non-significant relationship between the use of iEFM > 6cm and the outcome 
of cesarean delivery for labor dystocia (χ2 = 1.32, p = 0.251). Therefore, the null 
hypothesis is retained for A4H2 (iEFM > 6cm); obese women in this sample having 
cesarean for labor dystocia were as likely to have iEFM initiated at > 6cm cervical 
dilation as women having vaginal delivery. 
  A4H2:  Total duration of ambulation in labor.  The first intervention to be 
tested in A4H2’s total duration question concerned ambulation (Table 40).  Model 1 for 
total duration of ambulation was constructed to determine if the length of ambulation 
use in labor changed the odds of cesarean delivery for labor dystocia. A first logistic 
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regression model (M1) was run including DV: cesarean delivery for labor dystocia vs. 
vaginal birth and IV: duration of ambulation after hospital admission.  Compared to the 
NULL model (M0), M1 showed much decreased fit statistics, reflecting an improved fit 
to the data.  However, the coefficient for ambulation duration showed a non-statistically 
significant association with the outcome of cesarean for labor dystocia (p = 0.362).   
This non-statistically significant result was logical, given the non-statistically 
significant difference in the total duration of ambulation (U test p=0.421) between 
subjects having vaginal birth (median duration ambulation = 78 minutes) and those 
having cesarean for labor dystocia (median duration ambulation = 75.5 minutes).  
Improvements in M1 fit for the data likely reflect the fact that total duration of 
ambulation is correlated with length of first stage labor (rs = 0.236, p < 0.05).  
Therefore, the null hypothesis is retained for A4H2 (total duration of ambulation); 
obese women in this sample having cesarean for labor dystocia had relatively similar 
durations of ambulation after hospital admission as women having vaginal delivery. 
Table 40: Aim 4, H2 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Total Duration of Ambulation in Labor 
Statistic Model 0 
(Null Model) 
Model 1 
(Predictor: Duration of 
Ambulation) 
Residual deviance 174.66 56.484 





-2.61 (0.21) -2.05 (0.61) 
  Coefficient: 
Duration of Ambulation 
B  -0.007 
SE  0.007 
p  0.362 
OR  0.99 
97.5% CI  [0.98-1.01] 
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  A4H2:  Total duration of hydrotherapy in labor. The second intervention to be 
tested in A4H2’s total duration question was hydrotherapy (Table 41).  Model 1 for 
total duration of hydrotherapy was constructed to determine if the length of 
hydrotherapy use in labor changes the odds of cesarean delivery for labor dystocia. A 
first logistic regression model (M1) was run including DV: cesarean delivery for labor 
dystocia vs. vaginal birth and IV: duration of hydrotherapy after hospital admission.  
Compared to the NULL model (M0), M1 showed much decreased fit statistics, 
reflecting an improved fit to the data.  However, the coefficient for hydrotherapy 
duration showed a non-statistically significant association with the outcome of cesarean 
for labor dystocia (p=0.179).  Thus, there was a non-statistically significant association 
between duration of hydrotherapy and the outcome of cesarean for labor dystocia. This 
non-statistically significant result makes sense, given the non-statistically significant 
difference (U-test p = 0.694) in the total duration of hydrotherapy between subjects 
having vaginal birth (median duration hydrotherapy = 58 minutes) and those having 
cesarean for labor dystocia (median duration hydrotherapy = 78 minutes). Therefore, 
the null hypothesis is retained for A4H2 (total duration hydrotherapy);  obese women in 
this sample having cesarean for labor dystocia had similar durations of hydrotherapy as 
women having vaginal delivery. 
 A4H2:  Total duration intermittent fetal monitoring in labor.  The final 
intervention to be tested in A4H2’s total duration question was iEFM (Table 42).  
Model 1 for total duration of iEFM was constructed to determine if the length of iEFM 
use in labor changed the odds of cesarean delivery for labor dystocia. A first logistic 
regression model (M1) was run including DV: cesarean delivery for labor dystocia vs. 
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Table 41: Aim 4, H2 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Total Duration of Hydrotherapy in Labor 





Residual deviance 174.66 53.62 





-2.61 (0.21) -3.14 (0.71) 
  Coefficient: 
Duration Hydrotherapy 
B  0.01 
SE  0.008 
p  0.179 
OR  1.01 
97.5% CI  [0.99-1.03] 
 
vaginal birth and IV: duration of iEFM after hospital admission.  Compared to the 
NULL model (M0), M1 showed much decreased fit statistics, reflecting an improved fit 
to the data.  However, the coefficient for iEFM duration showed a non-statistically 
significant association with the outcome of cesarean for labor dystocia (p = 0.998).  
Thus, there was a non-statistically significant association between total duration of 
iEFM and the outcome of cesarean for labor dystocia.  This non-statistically significant 
result was logical, given the non-statistically significant difference (U-test p = 0.454) in 
the total duration of iEFM between subjects having vaginal birth (median duration 
iEFM = 191 minutes) and those having cesarean for labor dystocia (median duration 
iEFM = 148.5 minutes). Improvements in M1 fit for the data likely reflect the fact that 
total duration of iEFM was correlated with length of first stage labor (rs = 0.295, p < 
0.01).  Therefore, the null hypothesis is retained for A4H2 (total duration of iEFM); 
obese women in this sample having cesarean for labor dystocia had similar durations of 
iEFM as those going on to have vaginal delivery. 
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Aim 4, Hypothesis 3 Analysis 
A final series of logistic regressions were planned to evaluate the hypothesis 
that healthy nulliparous obese women who ended labor with cesarean delivery for the 
indication of labor dystocia were less likely than similar women ending labor with 
vaginal delivery to experience onset of low-technology intrapartum interventions while 
having abnormal cervical progression.  For this final Aim 4 analysis, the same BMI-
individualized partograms created for Aim 2 (Figures 17-19) were used to map low-
technology interventions in each woman’s labor.  Low-technology interventions initiated 
during the ‘red zone’ were tested as predictors in the A4H3 analyses for the outcome of 
cesarean delivery for labor dystocia. 
Table 42: Aim 4, H2 Logistic Regression Predicting Cesarean Delivery for Labor 
Dystocia on Total Duration of Intermittent Fetal Monitoring (iEFM) in Labor 
Statistic Model 0 
(Null Model) 
Model 1 
(Predictor: Duration iEFM) 
Residual deviance 174.66 83.04 





-2.61 (0.21) -2.15 (0.47) 
  Coefficient: 
Duration iEFM 
B  -0.002 
SE  0.003 
p  0.467 
OR  0.998 
97.5% CI  [0.99-1.00] 
 
  Multivariate analyses for A4H3 were not run because the frequencies for use of all 
low-technology intervention in the ‘red zone’, or during abnormally progressing labor, were 
very low (number of subjects having intervention in red zone: ambulation (n = 4), 
hydrotherapy (n = 2), iEFM (n = 4)).  These frequencies were too small to use with 
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multivariate analyses.  To conclude, the A4H3 hypothesis that women ending labor with 
cesarean for labor dystocia would be less likely to have use of low-technology interventions 
during times of abnormal labor progression is unable to be tested due to the infrequent 
occurrences of these predictors.  It appears that among these nulliparous, obese women, use 
of low-technology interventions was very rare when labor was progressing abnormally 
slowly.   
  Residual binned plots were not produced for Aim 4 analyses because the models for 
low-technology interventions were known to be poor fits for the data.  Also, none of the 
models created in Aim 4 included any statistically significant predictors.  Residual deviance 
and AIC statistics were provided for each model in Tables 8-16, however.   
  In conclusion, this analysis is consistent with retention of the null hypothesis for 
Aim 4: use of low-technology interventions in labor was not statistically significantly 
associated with the outcome of cesarean delivery for labor dystocia in this sample of 
obese nulliparous women giving birth at the University of Colorado Hospital.  Low-
technology interventions were used roughly equivalently in terms of timing in labor and 
duration with subjects having cesarean for labor dystocia or vaginal delivery.  
However, there were statistically significant differences in the way low-technology 
labor interventions were used by CNMs or OBs with women in this randomly-chosen, 
perinatal risk score-matched dataset (Table 34).  Subjects receiving their labor care 
from CNMs were statistically significantly more likely to use ambulation, hydrotherapy 
and intermittent fetal monitoring while laboring after hospital admission.  Although the 
use of low-technology interventions were not associated with a change in these obese, 
nulliparous women’s risk for cesarean delivery for labor dystocia, differences in their 
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use illustrate that the model of care provided by CNMs is different than that provided 
by OBs in the same institution, between matched groups of nulliparous obese women.   
  Overall, these analyses demonstrate that in this sample of healthy, nulliparous 
obese women with spontaneous labor onset who delivered at the University of 
Colorado Hospital, provider type was not significantly related to their odds of ending 
labor with a cesarean delivery for labor dystocia.  However, maternal delivery BMI was 
significantly associated with this outcome, and the uses of several interventions were 
more often seen in the labors of obese women whe ended labor with cesarean because 
of their slow labor progress (Figure 26).   
 
Figure 26.  Unadjusted odds ratios:  Risk of Cesarean delivery for labor dystocia in 
women exposed to various intrapartum interventions.  Green dotted line denotes odds 
ratio = 1.   
Unadjusted Odds Ratios:  Risk of Cesarean Delivery for 
Labor Dystocia 
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  The key connection seen in this study between maternal BMI and the increased 
use of labor interventions among women ending labor with cesarean delivery for labor 
dystocia is the delay of active labor seen with increased maternal obesity.  As 
demonstrated in Figures 27-29, when subjects were split into groups by their maternal 
delivery BMI and plotted on partograms individualized for their level of obesity, 
increasing proportions of women were exposed to an intervention designed to speed 
labor progress before they reached active phase labor or when they were demonstrating 
normal labor progress (28.1% of women in Obese I group, 42.4% of women in Obese II 
group, and 44.7% of women in the Morbid Obese group received synthetic oxytocin 
initiation during pre-active phase labor or during normal labor progress).  
  
Figure 27.  Plot of synthetic oxytocin augmentation initiation among subjects with 
maternal delivery BMI between 30.00-34.99 kg/m2 atop BMI-individualized 
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Figure 28.  Plot of synthetic oxytocin augmentation initiation among subjects with 
maternal delivery BMI between 35.00-39.99 kg/m2 atop BMI-Individualized 
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Figure 29.  Plot of synthetic oxytocin augmentation initiation among subjects with 
maternal delivery BMI ≥ 40 kg/m2 atop BMI-individualized partogram.  Partogram is 





































  This study was designed to examine labor outcomes and labor intervention use 
among nulliparous women with high maternal delivery BMIs.  Using the unique 
approach of comparing two different models of intrapartum care (CNM or OB), this 
study allowed for the comparison of matched groups of subjects on their risk of ending 
labor with cesarean delivery for the indication of labor dystocia when exposed to 
different models of care and specific labor interventions. As the obesity epidemic in the 
United States continues, it is vitally important that the most effective labor management of 
obese women is understood and used to prevent complications associated with unnecessary 
cesarean delivery.    
  Gaps exist in our knowledge of the use of different labor management packages and 
the correct use (timing and dosing) of synthetic oxytocin in healthy obese women.  Prior to 
this study, it was known that obese women were more likely than normal-weight women to 
receive early hospital admission, synthetic oxytocin augmentation, artificial rupture of 
membranes (AROM), and epidural, and unplanned cesarean delivery (Abenhaim & 
Benjamin, 2011; Carlson & Lowe, 2013; Fyfe et al., 2011; Green & Shaker, 2011; 
Vahratian et al., 2005).  However, it was unknown until this study how the use of 
interventions like early hospital admission, synthetic oxytocin augmentation, and 
AROM might change an obese woman’s risk for unplanned cesarean delivery 
secondary to labor dystocia, or slow labor progress.  Prior to this study, it was known 
that synthetic oxytocin augmentation is often employed in obese women’s labors and is more 
likely to fail to bring obese women to full cervical dilation compared to normal-weight 
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women (Usha-Kiran et al., 2005).  It was also known from several studies of induction 
protocols that obese women required longer administration times and larger dosages to 
achieve vaginal delivery when compared to normal-weight women (Pevzner et al., 2009; J. 
Walsh et al., 2011).  However, until this study it had not been quantified how much maternal 
BMI explains the variance in synthetic oxytocin doses when infant’s birthweight, provider 
type, and timing of synthetic oxytocin use in labor were also considered.   Until this study, it 
was unknown how low-technology interventions like intermittent external fetal monitoring, 
ambulation in labor, and hydrotherapy might be used in the labors of obese women, and how 
these interventions might change obese women’s chances to achieve vaginal delivery.  It was 
also unknown how different types of intrapartum providers (CNMs or OBs) might compare 
in their use of labor interventions with obese clients, and in the labor outcomes resulting from 
this management.   Thus, outcomes from this study address many existing gaps in the 
understanding of labor management in obese women.  
Study Aims and Methodology Review 
 Aims and methodology in this study were based on a biobehavioral model.  This 
model clarifies how the phenomenon of unplanned cesarean delivery secondary to labor 
dystocia in healthy obese nulliparous women is theorized to be a result of the interplay 
between biological (obese women’s myometrial dysfunction in labor) and behavioral 
determinants (tendency of providers to apply labor interventions and timelines that are 
unrealistic for obese women).  The overall hypothesis of this study was that the diagnosis of 
labor dystocia in healthy, nulliparous obese women is partially attributable to the strict 
timelines and early use of labor interventions including hospital admission, epidural, 
synthetic oxytocin augmentation, AROM, and unplanned cesarean delivery. The study 
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setting was at The University of Colorado Hospital, where certified nurse-midwives attend 
nearly half of the births, thus offering two models of intrapartum care side-by-side.  Specific 
Aims for this study were to:   
Aim 1   
 Compare the risk of cesarean delivery for the indication of labor dystocia among 
healthy, nulliparous, overweight or obese women receiving intrapartum care from certified 
nurse-midwives or obstetricians. 
Hypothesis of Aim 1 
 Healthy, nulliparous obese women will be less likely to undergo unplanned cesarean 
delivery for the indication of labor dystocia when managed by certified nurse-midwives 
compared to similar women managed by obstetricians.   
Aim 2   
 Among healthy, nulliparous obese women having cesarean delivery for labor 
dystocia, examine how exposure to labor interventions differs when compared to similar 
women having vaginal delivery. 
 Hypothesis 1 of Aim 2. Healthy nulliparous obese women who end labor with 
cesarean delivery for labor dystocia will be more likely than similar women ending labor 
with vaginal delivery to receive epidural, AROM, foley bulb, misoprostol, and synthetic 
oxytocin augmentation. 
 Hypothesis 2 of Aim 2.  Healthy nulliparous obese women who end labor with 
cesarean delivery for labor dystocia are more likely than similar women ending labor 
with vaginal delivery to receive AROM at < 6cm cervical dilation, synthetic oxytocin 
augmentation at < 6cm, or hospital admission at  < 4 cm cervical dilation.    
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 Hypothesis 3 of Aim 2.  Healthy nulliparous obese women who end labor with 
cesarean delivery for the indication of labor dystocia are more likely than similar 
women ending labor with vaginal delivery to experience onset of intrapartum 
interventions while having normal cervical progression.   
Aim 3   
 Characterize use of synthetic oxytocin in labor augmentation by maternal delivery 
BMI in nulliparous, obese women who achieve vaginal birth. 
 Hypothesis 1 of Aim 3.  Healthy nulliparous obese women with higher delivery 
BMI will require larger total doses of synthetic oxytocin and longer oxytocin infusion 
duration to achieve vaginal birth when compared to women with lower delivery BMI.    
Hypothesis 2 of Aim 3.  The hour-to-hour dose of synthetic oxytocin will vary 
over time from hospital admission until birth for each woman, and these hourly dose 
patterns will tend to group depending on the BMI of the women, the woman’s provider, 
and the size of her baby.   
Aim 4 
 Among healthy, nulliparous obese women ending labor with cesarean delivery for 
labor dystocia, examine how exposure to low-technology interventions differs from similar 
women ending labor with vaginal delivery. 
 Hypothesis 1 of Aim 4.  Healthy, nulliparous obese women who end labor with 
vaginal delivery are more likely to make use of low-technology interventions in labor 
compared to similar women who end labor with cesarean delivery for the indication of 
labor dystocia.   
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 Hypothesis 2 of Aim 4.  Healthy nulliparous obese women who end labor with 
cesarean delivery for labor dystocia are less likely than similar women ending labor 
with vaginal delivery to engage in ambulation, hydrotherapy, or intermittent fetal 
monitoring at > 6 cm cervical dilation and to engage in these activities for shorter total 
periods of time in labor.  
 Hypothesis 3 of Aim 4.  Healthy nulliparous obese women who end labor with 
cesarean delivery for the indication of labor dystocia are less likely than similar women 
ending labor with vaginal delivery to experience onset of low-technology intrapartum 
interventions while having abnormal cervical progression. 
Methodology Review 
 This retrospective cohort and case-control study compared the labor outcomes 
and interventions of healthy, term, nulliparous women pregnant with healthy, singleton 
fetuses who entered spontaneous labor with a plan for vaginal delivery and received 
labor care from either certified nurse-midwives (CNMs) or obstetricians (OBs) at UCH 
between October 2005-December 2012.  I used these strict inclusion criteria in order to 
isolate the effect of maternal obesity without the confounding influence of various 
medical co-morbidities on both labor processes and outcomes.  Women meeting 
inclusion criteria were identified by reviewing the University of Colorado Perinatal 
Database (UCPD), resulting in three samples:  Aim 1 sample included 718 overweight 
and obese women (BMI ≥ 25.00 kg/m2) who ended labor with either vaginal delivery 
(spontaneous or operative) or cesarean delivery for labor dystocia, Aim 2 and 4 samples 
included 348 obese women (BMI ≥ 30.00 kg/m2) who ended labor with either vaginal 
delivery (spontaneous or operative) or cesarean delivery for labor dystocia, and the Aim 
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3 sample included 136 obese women (BMI ≥ 30.00 kg/m2) who ended labor with 
vaginal delivery (spontaneous or operative) and received synthetic oxytocin 
augmentation in labor.  Each of these samples met the required sample size for that 
Aim’s analyses according to a priori power analysis. 
 Each subject for this study received a perinatal risk score based on the Perinatal 
Background Index (PBI).  Nearest neighbor random matching using propensity scores 
based on the PBI was performed to select subjects from both CNM and OB groups to 
form final samples.  Thus, propensity score matching reduced confounding in this 
study’s analyses between group allocation and the outcomes of each Aim.  In the past, 
studies comparing the care processes and outcomes of different intrapartum providers 
were criticized on the basis that group allocation by provider type introduced numerous 
known and unknown confounding factors into analyses (Hatem, Sandall, Devane, 
Soltani, & Gates, 2008).  Randomized-controlled studies, where group allocation is 
randomized and confounding factors are theoretically distributed equally across 
samples, are valued in clinical research for this reason.  Propensity score matching, 
such as used in this study, allows for a similar balancing of perinatal risk factors across 
groups while being cost-effective and feasible with retrospective study design.   
 Once inclusion criteria were applied and propensity score matched samples 
were created, detailed review of subjects’ medical records was performed to collect 
information on labor progress, interventions, and outcomes for Aims 2-4 of this study.  
Aim 1 used medical information contained in the UCPD that was collected by trained 
research nurses.  Over the inclusion years of this study, UCH used electronic labor and 
delivery nurse’s notes with precise data (times, synthetic oxytocin dosages, etc) for all 
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labor processes including cervical examinations, labor interventions, and both maternal 
and fetal outcomes.  In addition, providers’ notes were also available in the medical 
records, providing critical information on providers’ rationale for labor management 
decisions and allowing for accurate classification of labor outcomes.  For example, 
provider’s notes were used to differentiate cesarean deliveries performed for the 
primary indication of fetal intolerance of labor from those performed for the primary 
indication of labor dystocia.  Standardized forms were used to collect data from each 
medical record while protecting personal protected health information (REDcap), in 
compliance with the institutional review board authorizations granted for this study 
(COMIRB protocol #14-0557).  Accuracy of chart abstraction processes was formally 
evaluated by intra-rater chart abstraction reliability testing in a random selection 
representing 5.7% of this study’s subjects, resulting in a satisfactory 95.14% accuracy 
measurement (Mi et al., 2013).  
Discussion of Results 
Aim 1 
 Using Aim 1’s sample of both overweight and obese women with data extracted 
from the UCPD, both bivariate and multivariate analyses were performed to address the 
Aim 1 hypothesis that subjects receiving management by CNMs in labor would be less 
likely to have an unplanned cesarean delivery for labor dystocia when compared to 
perinatal risk score-matched women managed by obstetricians.  Although women 
managed by CNMs in Aim 1 were statistically significantly younger, less educated, 
more Hispanic, and had heavier babies and longer gestational ages than matched groups 
of women managed by OBs, there was no statistically significant difference in the 
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delivery BMI or perinatal background index (PBI) score across provider groups.  Thus, 
propensity matching for this sample achieved the goal of creating groups with subjects 
matched on perinatal risk factors.   
 On bivariate Aim 1 analyses, cesarean delivery for labor dystocia was 
statistically significantly associated with maternal delivery BMI (p = 0.005) and 
gestational age (p = 0.047).  In none of the Aim 1 bivariate or multivariate analyses was 
cesarean delivery for labor dystocia associated with provider type; therefore, Aim 1’s 
hypothesis that cesarean delivery for labor dystocia would be predicted by provider 
type was not accepted in favor of the null.  Post-op power analysis of the Aim1H1 
logistic regression revealed that in order for the effect size seen in this analysis of 
provider type on the outcome of cesarean delivery for labor dystocia to be detected 
(80% chance) as significant at the 5% level, a sample of 3,673 subjects would be 
required.  It therefore appears that the lack of statistical significance seen in this Aim 1 
multivariate analysis is likely not caused by a limited sample size.   
 CNM care of overweight and obese women in Aim1 was associated with a 
statistically significantly decreased risk for both epidural and operative vaginal delivery 
(p < 0.001) compared to OB care, despite the fact that CNM patients had statistically 
significantly heavier babies.  CNM care was also associated with a statistically 
significant increase in the incidence of five-minute Apgar scores < 7 (p < 0.001) when 
compared to OB care of obese and overweight women in this sample.  However, there 
was no significant association between CNM care and lower 10-minute Apgar scores (p 
= 0.317) or with CNM care and NICU admission in this sample (p=0.618).  Other 
           240 
maternal and neonatal outcomes for Aim 1 subjects were equivalent between provider 
groups.   
  To conclude, these Aim 1 analyses reveal that although the model of care 
provided by CNMs or OBs were different at the UCH, these differences were not 
statistically significantly associated with the outcome of cesarean delivery for labor 
dystocia.  However, maternal BMI at the time of hospital admission (maternal delivery 
BMI) was significantly associated with the outcome of cesarean delivery for labor 
dystocia.  Even when evaluated in a logistic regression model including known 
predictors of cesarean delivery for labor dystocia (gestational age, infant birthweight, 
maternal age, maternal height), maternal BMI at the time of hospital admission, along 
with maternal height, was significant and not diminished in its association with the 
outcome of cesarean delivery for labor dystocia over an unadjusted model (OR 1.07, 
95% CI [1.00-1.14], p = 0.024).  Thus, maternal BMI at the time of hospital admission 
was an independent risk factor for the outcome of cesarean delivery for labor dystocia 
in this sample of overweight and obese women.  
  Additional questions stemming from this Aim 1 analysis are whether these 
findings of a statistically significant relationship between the outcome of cesarean 
delivery for labor dystocia and maternal delivery BMI would also be found in an 
expanded sample of women with normal, overweight, and obese BMIs.  Furthermore, 
would a repeat analysis including samples with all maternal BMI scores show that 
covariates included in this Aim 1 analysis (gestational age, infant birthweight, maternal 
age, maternal height) were statistically significantly associated with cesarean delivery 
for labor dystocia? On meta-analysis, maternal BMI was statistically significantly 
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associated with the outcome of cesarean delivery performed for multiple indications in 
mixed samples of nulliparous and obese women (Chu, Kim, Schmid et al, 2007) and in 
nulliparous women specifically (Poobalan et al, 2009).  However, neither of these 
analyses focused on the risks of cesarean delivery for labor dystocia, and neither 
focused on women in spontaneous labor.     
Aim 2 
 Aim 2’s sample included only obese women whose perinatal data were 
extracted using detailed medical record reviews.  Both bivariate and multivariate 
analyses were run to address the Aim 2 hypotheses that subjects ending their labors 
with cesarean delivery for labor dystocia would be more likely than matched subjects 
ending their labor with vaginal delivery to receive the following labor interventions: 
A2H1) epidural, AROM and synthetic oxytocin augmentation, A2H2) AROM or 
synthetic oxytocin at less than 6cm cervical dilation or hospital admission at less than 
4cm cervical dilation, and A2H3) AROM or synthetic oxytocin during times of normal 
labor progression.   
 Maternal BMI was not a statistically significant predictor in any Aim 2 
multivariate analysis for the outcome of cesarean delivery for labor dystocia.  Thus, 
within Aim 2’s sample of only obese women (with a low median BMI for the entire 
sample of only 33.85 kg/m2 (interquartile range = 5.41), maternal BMI did not change 
the relationship between the use of various intrapartum interventions and the outcome 
of cesarean delivery for labor dystocia.  It is possible that, unlike the sample from Aim 
1, the sample used in Aim 2 was too homogeneous on maternal BMI to detect any 
associations between BMI and the association of labor interventions with cesarean 
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delivery for labor dystocia.  It is also possible that differences in the risk of cesarean 
delivery for labor dystocia among Aim 2 subjects, which might be predicted by 
maternal delivery BMI, were explained in multivariate models by specific interventions 
that were statistically significantly associated on bivariate analyses with maternal BMI 
(use of synthetic oxytocin, initiation of synthetic oxytocin before 6cm, and initiation of 
synthetic oxytocin during normal labor progression).   
 Subjects in Aim 2 who ended their labors with cesarean for labor dystocia were 
statistically significantly more likely than subjects having vaginal delivery on bivariate 
and multivariate analyses to receive synthetic oxytocin (p < 0.001), AROM at less than 
6cm cervical dilation (p = 0.003), initiation of synthetic oxytocin at < 6cm (p < 0.001), 
and initiation of synthetic oxytocin during times of normal labor progression based on 
Consortium of Safe Labor-based partograms specific for obese women (p < 0.001).  
Despite findings in other studies that early hospital admission (< 4cm cervical dilation) 
was associated with increased risk for cesarean delivery (Jackson, 2003), there was no 
statistically significant association in this sample between early hospital admission and 
cesarean delivery for labor dystocia. Baby’s birth weight was also significantly 
associated with cesarean for labor dystocia on bivariate correlation. 
 To conclude, obese women ending labor with cesarean for labor dystocia 
received more interventions designed to speed up their labors (synthetic oxytocin 
augmentation, AROM) than obese women ending labor with vaginal delivery, often 
while their cervix was still less than 6cm.  Recommendations based on modern analyses 
of labor progress in mixed weight groups of women (Zhang et al., 2010) and in obese 
women (Kominiarek et al., 2011) stipulate that active phase labor does not begin until 
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6cm, and the use of interventions designed to speed labor progress should await onset 
of active phase labor (Spong, Berghella, Wenstrom, Mercer, & Saade, 2012).  
However, obese women in my analyses received multiple interventions to speed 
progress, likely while still in latent phase or pre-active labor.    
 Additional questions to be answered from this Aim 2 sample include comparing 
the management of CNMs or OBs in the choice of and timing of intrapartum 
interventions during the spontaneous labors of obese, nulliparous women.  In the Aim 1 
analysis, there was no statistically significant association between provider type and the 
outcome of cesarean delivery for labor dystocia.  However, it is unknown how provider 
type may have changed the choice and timing of intrapartum interventions in this 
sample, nor how the use of different intervention choices and timing might change the 
risk for other perinatal outcomes in a sample of obese women, including postpartum 
hemorrhage, maternal fever, or outcomes reflecting neonatal morbidity.      
Aim 3 
 Aim 3’s sample was a sub-set of subjects from Aim 2 who achieved vaginal 
delivery and received synthetic oxytocin augmentation.  Both bivariate and multivariate 
analyses were run to address the Aim 3 hypotheses that the total dose, the total duration 
(A3H1), and the hourly doses of synthetic oxytocin (A3H2) would be statistically 
significantly higher among women with higher BMIs.   
 Bivariate analyses comparing Aim 3 groups defined by maternal BMI were 
conducted, revealing that subjects in this sample were homogenous on demographic 
variables, including baby’s birth weight and PBI score.  Thus, this sub-set of the Aim 2 
sample including only women with vaginal delivery did not have a statistically 
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significant difference by BMI on perinatal risk, as was seen among the mixed group of 
women in Aim 2 who ended labor with both vaginal or cesarean delivery.  This 
difference was seen despite the fact that the median BMI among Aim 3 subjects (34.19, 
interquartile range = 6.00) was higher than the median BMI among Aim 2 subjects 
(33.85, interquartile range = 5.41).  There was also no statistically significant difference 
by BMI groups on the time of synthetic oxytocin initiation or the total dose or duration 
of synthetic oxytocin infusion.  
 To conclude, neither the total dose of synthetic oxytocin nor the total duration 
of synthetic oxytocin was predicted by maternal delivery BMI; therefore, the null 
hypothesis was retained for Aim 3, H1.  Post-hoc power analysis showed that sample 
sizes for these Aim 3, H1 analyses would have to increase to10,000 subjects (total dose 
of synthetic oxytocin) and 200 subjects (total duration of oxytocin) in order for an 
effect of the size seen in these analyses to be detected (80% chance) as significant at the 
5% level.   It is possible, therefore, that a modest increase in sample size may have 
yielded a significant result in the analysis of synthetic oxytocin duration by maternal 
BMI.  However, it is likely that the lack of statistical significance seen in the 
association between maternal BMI and the total dose of synthetic oxytocin was not due 
to inadequate sample size.  Statistically significant correlates with total dose of 
synthetic oxytocin included the time interval between hospital admission and oxytocin 
infusion initiation (lower dose with later initiation, rs = -0.24, p < 0.01), cervical 
dilation at the time of oxytocin infusion initiation (greater cervical dilations correlated 
with lower total dose, rs = -0.65, p < 0.01), baby’s birth weight (heavier birthweight 
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correlated with larger total dose, rs = 0.18, p < 0.01), and provider type in labor (CNM 
patients received lower total dose, rs = 0.19, p < 0.05).  
 Following up from the Aim 3H1 finding that total dose of synthetic oxytocin in 
women having vaginal delivery was not explained by maternal delivery BMI but 
instead by baby’s birth weight and labor timing for oxytocin initiation, a multi-level 
analysis was conducted to address the second Aim 3 hypothesis that hourly synthetic 
oxytocin doses might be predicted by maternal delivery BMI.  Prior to my study, 
differences by maternal BMI in synthetic oxytocin doses had only been shown in total 
dose (Pevzner et al., 2009; Walsh et al., 2011).  Synthetic oxytocin infusions in labor 
are carefully titrated to the milli-unit, with infusion rates often being increased every 
15-30 minutes until women’s contraction patterns become stronger and more regular, 
and cervical changes occur. During times in labor like late active phase, when a 
woman’s myometrial cells may be more responsive to synthetic oxytocin and she 
produces increased amounts of her own oxytocin, lower (or steady) hourly doses of 
synthetic oxytocin are often sufficient to effect continued cervical progression.  Thus, 
each woman’s hourly synthetic oxytocin dose is a result of her unique infusion pattern 
during that time, which in is turn influenced by a mix of factors ranging from her labor 
phase to her baby’s birth weight and myometrial responsiveness.   
 Higher maternal BMI has been linked to decreased myometrial efficiency 
(Moynihan et al., 2006; Smith et al., 2005; Zhang, Kendrick, et al., 2007) and slower 
labor progress, especially during early active phase labor (Kominiarek et al., 2011).  
However, two women of different BMIs and with theoretically different myometrial 
efficiencies might still have the same total synthetic oxytocin dose if, for example, the 
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woman with a higher BMI had a shorter pushing phase of labor (as has been shown 
with morbidly obese women compared to obese I women in Kominiarek et al, 2011) or 
if the women with the lower BMI also had a heavier baby.   Thus, Aim 3 H2’s analysis 
was conducted to determine if obese women’s hourly doses of synthetic oxytocin 
followed different patterns across labor as a result of maternal BMI, even when 
evaluated in a model that accounted for baby’s birth weight and the stage of labor when 
the augmentation was initiated.   
 Unlike the total doses of synthetic oxytocin in labor, which were shown in Aim 
3H1 analyses to be unrelated to maternal delivery BMI in this sample of obese women 
achieving vaginal delivery, hourly doses of synthetic oxytocin varied by maternal BMI 
with 6.7% of the variance in hourly doses attributable solely to maternal BMI.   When 
included in a multi-level model with cervical dilation at the time of synthetic oxytocin, 
baby’s birth weight, and the accumulated infusion time (Level 1 predictors) and 
allowing for different slopes of hourly infusion doses within BMI groups (Level 2 
predictor of Hour and maternal BMI), maternal delivery BMI grouping explained 
16.56% of the variability in hourly synthetic oxytocin doses.  Thus, even when included 
in a model that controlled for baby’s birth weight, the accumulated time of infusion, 
and cervical progression when oxytocin was initiated, maternal delivery BMI still 
explained nearly a fifth of the variance in hourly synthetic oxytocin doses.  Graphical 
representation (Figure 27) of hourly synthetic oxytocin doses over time and by maternal 
delivery BMI groupings demonstrated that women with BMIs 35-40 kg/m2 tended to 
have oxytocin infusions which reached higher hourly doses and continued over more 
hours than women with BMIs 30-34 kg/m2.  Perhaps myometrial inefficiency in these 
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women contributed to this tendency for them to receive higher hourly doses and longer 
infusion durations during labor augmentation.   
 Additional questions to be asked about the use of synthetic oxytocin among 
obese women include an exploration of total dose and total duration of synthetic 
oxytocin among obese women with labor augmentation who ended labor with either 
cesarean delivery for labor dystocia or with vaginal delivery.  These Aim 3 analyses 
excluded women with cesarean delivery.  Perhaps the non-significant association 
between maternal delivery BMI and either the total dose or total duration of synthetic 
oxytocin augmentation found in Aim 3, H1 would be significant if those women 
showing the slowest labor progress, and theoretically the most blunted response to 
synthetic oxytocin augmentation, were included.   
 Post-hoc power analysis for this continuous outcome (hourly synthetic oxytocin 
dose) was performed.  When using the actual number of BMI groups for this analysis 
(18) rather than the anticipated number of groups (3), a minimum sample size of 12 
women were needed to achieve adequate power of 0.80, assuming alpha = 0.05, effect 
size = 0.15 with number of BMI groupings = 18, average number of hours of oxytocin 
dose per woman = 7, and minimal clinically important variation of hourly synthetic 
oxytocin dose by maternal BMI grouping = 10%.  Thus, 216 women across all BMI 
groups were needed for this analysis. Since the Aim 3, H2 multi-level model was 
underpowered by 70 women to have a 80% chance of detecting a significant result in 
the influence of maternal BMI on the hourly synthetic oxytocin doses, future analyses 
including greater sample sizes of women (with both vaginal and cesarean outcomes) 
could establish more definitively the influence of maternal delivery BMI on hourly 
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synthetic oxytocin dose.  It would also be interesting to analyze the dose of synthetic 
oxytocin used to augment these obese women’s labors by provider type.  This study is 
unique in the inclusion of perinatal-risk score matching to create groups of obese 
women managed by different intrapartum provider types.  It is possible that differences 
in the use of synthetic oxytocin augmentation by provider type could reveal the relative 
importance of the behavioral mechanism of labor interventions or the biological 
mechanism of obese women’s myometrial unresponsiveness to synthetic oxytocin on 
the primary phenomenon of this study: cesarean delivery for the indication of labor 
dystocia.  
Aim 4 
 Aim 4’s sample was the same used for Aim 2, including obese women who 
ended labor with either vaginal delivery or cesarean delivery for labor dystocia.  Both 
bivariate and multivariate analyses were run to address the Aim 4 hypotheses that use 
of low-technology labor interventions after hospital admission including ambulation, 
hydrotherapy, and intermittent fetal monitoring would be:  used more frequently 
(A4H1), initiated more frequently after 6cm cervical dilation, used for longer durations 
(A4H2), and initiated more frequently during times of abnormally slow labor 
progression (A4H3) among obese women having vaginal delivery than those ending 
labor with cesarean delivery for labor dystocia.   
 Bivariate analyses of the Aim 4 sample showed non-statistically significant 
correlations between the outcome of cesarean for labor dystocia and the use of 
ambulation, hydrotherapy, or intermittent fetal monitoring.  Multivariate analyses with 
each of these interventions modeled against the outcome of cesarean for labor dystocia 
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confirmed this bivariate finding; use of low-technology interventions with the women 
in this sample was not statistically significantly related to cesarean for labor dystocia.  
Initiation of low-technology interventions later in labor (> 6cm cervical dilation) was 
also not predictive of cesarean delivery for labor dystocia, nor was the total duration of 
low-technology intervention use.  Initiation of low-technology interventions during 
times of abnormally slow labor progression happened very infrequently (0.6%-1.1% of 
the sample), and was therefore not analyzed against delivery outcome.   
 Prior to this study, no published work described use of low-technology 
interventions among obese women.  In this sample, the most frequent low-technology 
intervention employed during obese women’s labor was intermittent external fetal 
monitoring (used with 42.9% of the sample), followed by ambulation (31.6%), and 
hydrotherapy (28.0%).  Thus, some kind of low-technology intervention was used with 
nearly half of the sample.  However, roughly 75% of the time these types of 
interventions were initiated prior to 6cm cervical dilation and only continued for 1-3 
hours among women in this sample.  Given that most obese women do not start active 
phase labor until after 6cm and can take up to 9 hours to move from 6-7 cm 
(Kominiarek et al., 2011), this finding implies that low-technology interventions were 
initiated infrequently during active labor with the obese women in this sample.  
Moreover, low-technology interventions were not often initiated during times of 
abnormally slow labor progression.  Thus, low-technology interventions in this sample 
were primarily initiated in early labor and were then discontinued for most obese 
women when labor became active or when labor progress was judged to be slow 
enough to require interventions like synthetic oxytocin or epidural (both typically 
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require continuous fetal monitoring and limited maternal movement).  Interestingly, 
women’s BMI was not statistically significantly related to her chances of having low-
technology labor interventions in this sample or to the total duration of her use.  
However, although subjects in both Obese I and Obese II groups had intermittent fetal 
monitoring initiated at cervical dilations greater than 6cm around 10% of the time, no 
subjects with BMI ≥ 40 kg/m2 had this intervention initiated after 6cm.  Similarly, 
hydrotherapy and ambulation were not initiated beyond 6cm with morbidly obese 
women.  When analyzed by provider type, multiple statistically significant differences 
emerge in the use of low-technology interventions among these obese women.  CNM 
care was statistically significantly associated (p<0.001) with use of ambulation, 
hydrotherapy, and intermittent fetal monitoring and with the initiation of these 
interventions at cervical dilations greater than 6cm.  
 Upright positioning during first stage labor was found to decrease mixed-weight 
women’s risk for cesarean delivery and decreased their duration of labor (Lawrence, 
Lewis, Hofmeyr, & Styles, 2013).  Given these findings, why were more obese women 
in this sample not using these low-technology interventions to promote out-of-bed 
positioning?  It is possible that providers offered low-technology interventions later in 
labor with subjects, but were declined.  It is also possible that these providers, 
managing labors between 2005-2012 when these births occurred, were practicing under 
older definitions of active phase labor onset (3-4cm) and expected active phase 
progress (1 cm/hr) at those cervical dilations.  New evidence was introduced in 2010 
that contemporary populations of women start active phase labor at 6cm, and tend to 
progress during active phase labor at a minimal rate of 0.5 cm/hr (Zhang et al, 2010; 
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Neal et al, 2010).  Therefore, when obese women in this sample were admitted to the 
hospital at a median cervical dilation of 4cm, most were assumed to be in active phase 
labor, and lack of hourly cervical progress over the first few hours of their hospital 
admission was taken as a sign of abnormal labor progress by their providers.  Although 
low-technology interventions might be used with women progressing normally through 
labor, they were not considered appropriate for women showing slow labor progress.   
 Additional questions that could be asked about this Aim 4 sample include:  what 
differences exist in the length of time and choice of low-technology interventions 
among obese women who had different types of intrapartum providers?  Were there 
differences in the risk for the outcome of cesarean delivery for labor dystocia among 
these obese women when low technology interventions were not discontinued until 
later in labor?  The current study only included analysis of cervical dilation when these 
low-technology interventions were initiated, but not when they were discontinued.  No 
existing published literature describes the use of any low-technology intervention in the 
labors of obese women; therefore, these additional questions would be important 
contributions.   
 To conclude, these analyses reveal that the outcome of cesarean delivery for the 
indication of labor dystocia among healthy, nulliparous obese women appears to 
involve an interaction between the biological determinant of obese women’s increased 
risk for labor dystocia and the behavioral determinant of a technology-driven package 
of labor management for obese women, as suggested by the biobehavioral model 
guiding the design and research questions of this project (Figure 1).  However, new 
information produced in this study suggests several important revisions of this model.   
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 Among behavioral mechanisms contributing to an increased risk for labor 
dystocia ending with unplanned cesarean delivery among obese, nulliparous women, 
this study supports the contributions of early use of synthetic oxytocin and early 
amniotomy.  However, early uses of epidural or hospital admission were not 
statistically significant predictors of cesarean delivery for labor dystocia in these 
analyses.  In a revised biobehavioral model of cesarean delivery for labor dystocia 
among obese, nulliparous women (Figure 30), early hospital admission and early 
epidural are dropped, leaving the labor management practices of early amniotomy and 
early use of synthetic oxytocin.  Linking these two practices is an unrealistic timeline 
for labor progress in early labor that is applied by providers while managing obese 
women.  Most obese women in this sample were admitted to the hospital at 4 cm 
cervical dilation, and then received interventions as if they were in active phase labor.  
Although studies were released in 2010 prompting the change in obstetric providers’ 
understanding of active phase labor onset to be at 6cm in mixed-weight women (Zhang 
et al, 2010), UCH providers in this study who performed births between 2008-2012 
treated 4 cm as the onset of active phase labor even after 2010.  In the revised 
biobehavioral model, the use of unrealistic timelines is therefore shown precipitating 
the early use of AROM and synthetic oxytocin.   
 This study also provides evidence of biological determinants in the outcome of 
unplanned cesarean delivery for labor dystocia in obese, nulliparous women.  Women 
in this study showed evidence of decreased response to synthetic oxytocin.  
Augmentation of labor with synthetic oxytocin required significantly greater hourly 
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doses among women with higher levels of obesity (Aim 3, H2 analysis), even when 
controlling for infant birthweight and gestational age.  
 
 
Figure 30: Revised theoretical model of Cesarean delivery for indication of labor 
dystocia in obese, nulliparous women 
 
 There also appeared to be decreased myometrial contractility among obese 
women in this study.  There was a trend in the Aim 2 sample for longer labor durations 
in the Obese II group of women (BMI 35.00-39.99 kg/m2, 7.27 hour median time from 
4-10 centimeters) when compared to the Obese I group of women (BMI 30.00-34.99 
kg/m2, 6.38 hour median time from 4-10 centimeters).  However, morbidly obese 
women in the Aim 2 sample had shorter labor duration than the Obese II women (BMI 
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≥ 40.00 kg/m2, 6.44 hour median time from 4-10 centimeters), leading to a non-
significant comparison of labor length across BMI groupings (p= 0.508).  It is possible 
that shorter labor duration among the morbidly obese women in this study, a finding 
which contradicts published results showing a dose-dependent slowing of labor by 
maternal BMI (Kominiarek et al, 2011), is simply the result of inadequate sample size 
of morbidly obese women (only 10.5% of the total Aim 2 sample was morbidly obese).  
Perhaps if larger numbers of morbidly obese women had been included in this analysis, 
trends toward longer labor length with higher maternal obesity may have been seen.  
However, it is also possible that this study’s exclusion criteria inadvertently produced a 
group of morbidly obese women who had more efficient labors as a result of metabolic 
resilience.  
 As reviewed in Chapter 2 of this document, multiple physiologic changes in 
obese women could have contributed to their increased risk for labor slowing.  High 
levels of cholesterol, leptin, and reactive oxygen species are found in obese woman 
experiencing meta-inflammation, and these alterations are thought to alter the 
preparation, synchronization, and progression of labor.  However, these variables were 
not measured in this study.  However, not all obese women are metabolically unhealthy 
(Karelis et al, 2004).  In these women, it is possible that increased activation of PPAR 
transcription factors and other systems may up-regulate their ability to safely store 
excess free fatty acids, thereby avoiding the spiraling metabolic effects of FFA 
oxidation and lipotoxicity (Jiang et al, 2011; Mattern et al, 2007).   
 In this study, women with co-morbid conditions like chronic hypertension or 
diabetes were excluded from final samples.  Each of these conditions is known to 
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correlate with obesity in a dose-dependent manner, characterizing the group of 
conditions in metabolic syndrome.  Despite the fact that the morbidly obese women 
included in this study had high levels of maternal delivery BMI, none were diagnosed 
before or during pregnancy with co-morbid conditions.  Possibly, these women 
represent a resilient sub-sample of morbidly obese women who were better able to store 
and process excess fatty acids, thereby avoiding the high levels of cholesterol, insulin 
resistance, leptin resistance, and free fatty acid oxidation associated with co-morbidities 
in situations of obesity.  Perhaps these metabolically resilient obese women were also 
less likely to show signs of longer labor length because the factors that protected them 
from metabolic consequences also protected them from the labor dysfunction seen in 
other morbidly obese women.  This would imply a common origin of factors and 
processes involved in obesity co-morbidities and labor dysfunction, as has indeed been 
implied in bench science research linking leptin resistance and cholesterol excess, both 
associated with obesity, to myometrial contractile dysfunction.  Future studies linking 
measurement of biomarkers like leptin, cholesterol, myometrial potassium channel 
performance, PPAR transcription factors, and reactive oxygen species in late pregnancy 
with the clinical performance of women during labor (labor length, response to 
synthetic oxytocin, labor outcomes) are needed to investigate these possible links 
between metabolic dysregulation and labor dysfunction in obese women.   
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Strengths and Limitations of the Study 
Strengths 
 This study had several strengths, including the use of:  a clear theoretical model, 
propensity score random neighbor matching for group allocation, strict inclusion 
criteria, chart abstraction reliability testing, pre-tested chart abstraction tools, and 
provider type sub-groups to contrast labor interventions in obese women.  The 
biobehavioral model for labor dystocia among obese women, based upon a broader 
published theoretical model (Lowe, 2007), helped clarify decisions to include 
measurement of both provider intervention choice (Aim 2 and 4) and physiologic labor 
response (Aim 3) in this study.   
 Another strength of this study, propensity score random neighbor matching, 
allowed for the creation of CNM and OB samples that were matched on perinatal risk 
factors.  Therefore, statistically significant differences between CNM and OB patients 
in this study can be interpreted with increased confidence that these provider type 
samples were equivalent on important obstetrical variables.  The strict inclusion criteria 
used in this study necessitated a multi-step exclusion process that eliminated over 97% 
of the patients in the UCPD.  However, use of these criteria enabled me to focus 
questions about the use of labor interventions and labor outcomes on subjects who were 
essentially healthy with the exception of being obese.  Previously published work on 
labor outcomes or interventions with obese samples often includes attempts to control 
for the effect of co-morbid conditions like diabetes or hypertension in multivariate 
analyses (J. M. Crane, Murphy, Burrage & Hutchens, 2013; Gunatilake et al., 2013).  
Diabetes and hypertension are found more frequently with increased BMI (Denison et 
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al., 2014) and have multiple effects on labor including altered fetal size, increased risk 
for labor induction, and decreased fetal tolerance of labor.  For this study focusing on 
the intersection between the biology of obesity in labor and intrapartum intervention 
use, limiting the sample to a group of healthy, nulliparous obese women with 
spontaneous labor onset allowed these analyses to reflect statistically significant 
interactions without the myriad effects of co-morbidities on both subject’s biology and 
providers’ intrapartum decision-making.   
 Medical record review can be a problematic way to collect data for an 
investigation.  Two strengths of this study that addressed this problem were chart 
abstraction tool testing and repeat-rater reliability testing.  This study included pre-
testing of the chart abstraction tool on the records of ten subjects not included in final 
analyses to illuminate areas of the tool needing review and improvement for more 
accurate chart abstraction.  Also, REDcap, the system used for chart abstraction, has an 
online interface for data entry.  This feature allowed all data for this study to be directly 
entered into the online record abstraction tool, thus avoiding mistakes associated with 
the transfer of data from paper to electronic media.  Finally, the REDcap system 
includes data entry controls that were used in this study to increase data accuracy, 
including radio buttons and max/min settings on free-text boxes.  In addition, intra-rater 
reliability testing results were satisfactory by international standards, and all charts 
were abstracted by only one rater who has clinical expertise in intrapartum care, thus 
creating standardization and accuracy in the interpretation of both provider and nurse’s 
notes in the records.  This intra-rater reliability testing could not correct for observer 
bias that may have been applied to extractions of data from CNM and OB charts.   
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 A final strength of this study was the setting at the University of Colorado 
Hospital.  With nearly half of births attended by CNMs at UCH, this setting allowed for 
the comparison of different models of care among a sample of obese and overweight 
women.  In addition, both CNMs and OBs at UCH used low-technology interventions 
regularly in the labors of obese women, reflecting a unit culture and staff training 
supportive of these interventions.  Labor outcomes for obese women at UCH are better 
than national averages; the total cesarean delivery rate for all women in the UCPD was 
only 25.6%, which is much lower than the national rate of 32.7% (Martin, Hamilton, 
Osterman et al, 2015).  Although the low rate of cesarean delivery at UCH created 
difficulties in this investigation with rare event ratios for the outcome of cesarean 
delivery for labor dystocia, this study benefitted from the opportunity to describe 
components of the excellent care provided to laboring women UCH that achieved these 
low cesarean delivery rates.   
Limitations 
 There are several important limitations to this study.  The first design limitation was 
retrospective data collection.   Retrospective reviews of the UCPD and medical records were 
performed to address research questions on relationships among variables, but no causality 
conclusions are possible.  A prospective, controlled study of labor management among obese, 
nulliparous women would be necessary to establish causality.   
 Another limitation of the study design was the medical record sourcing of data for 
Aims 2-4.  Medical record data collected during retrospective chart review are a low-cost, 
useful resource for research involving vulnerable populations, such as pregnant women 
(Gregory & Radovinsky, 2012).  However, both the process of collecting data from medical 
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records and errors in the information contained within medical records can be problematic for 
analytic conclusions.  For example, the medical records reviewed for this study included 
virtually no mention of continuous labor support (doula) usage by study subjects.  
Continuous labor support has been shown in systematic reviews to increase the rate of 
spontaneous vaginal delivery and decrease the use of epidural (Hodnett et al., 2013).  
Although many subjects in this study likely had continuous labor support from family 
members or friends, these interactions were not differentiated in nurses’ notes from subjects’ 
visitors in labor who did not provide labor support.  Follow-up studies with prospective 
design could incorporate continuous labor support interventions with obese women and lend 
clarity to the effects of this powerful intervention among this population.   
 Study data extracted from the UCPD was also a limitation.  During chart abstraction, 
several errors in variables contained in the UCPD were discovered.  In several cases, these 
errors resulted in slightly different propensity scores than had been originally calculated with 
UCPD variables.  For this reason, propensity score statistics by BMI and provider type 
groupings for Aims 2-4 were calculated using chart review data.  It is possible that other 
UCPD variable fields contained errors that resulted in the inclusion of a subject who should 
have been excluded (i.e. diabetic, multiparous, etc.), exclusion of subjects who should have 
been included, or in erroneous values for variables important in study calculations (i.e. 
maternal delivery BMI, baby’s birth weight, etc.).  UCPD limitations certainly created 
difficulty in identifying CNM patients since provider type is not a variable field in the UCPD.  
This absence necessitated the comparison of UCPD records with those from the University 
Nurse Midwives’ patient lists.  Nearly 100 births had to be discarded during this process 
because medical record numbers for one of these datasets included an error and were unable 
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to be matched.  Also, failure to locate UNM data for CNM births prior to 2008 necessitated 
the exclusion of 3 years worth of CNM subjects.  Analyses for this study included the year of 
birth to evaluate how this inequity in CNM or OB births might influence study outcomes, but 
a more complete UCPD would have eliminated the need to crosscheck datasets and loose 
cases.   
 Another limitation of this study design was the small numbers of cesarean deliveries 
performed at UCH.  Among the low-risk obese women in this study, only 4.7% (Aim 1) to 
6.7% (Aims 2 and 4) had cesarean delivery for labor dystocia.  For many of this study’s 
analyses, cesarean delivery for labor dystocia was the dependent variable for logistic 
regressions.  To address this problem, techniques like rare events logistic regression were 
used to run analyses despite small outcome ratios.  However, better estimation of associations 
between predictors and this outcome would have been possible had this outcome ratio been 
higher.  Future studies would ideally include larger sample sizes or larger event ratios.   
Finally, this study was limited by the variability of BMI in final samples.  Over 68% 
of subjects in Aim 2 and 4 samples had a maternal delivery BMI between 30-35 kg/m2 
(248/361).  In the Aim 1 sample, 86.5% of subjects had BMIs between 25-35 kg/m2, and 
Aim 3’s sample had 62.5% of subjects between 30-35 kg/m2.  BMI effects on labor slowing 
are known to be dose-dependent (Carlson & Lowe, 2014; Zhang, Kendrick et al., 2007).  
Therefore, clustering of this study’s samples around low levels of maternal obesity limits 
variability and limits conclusions regarding associations of synthetic oxytocin dosing or labor 
interventions/outcomes with maternal BMI.  Future studies should include samples with 
greater ranges of maternal BMI and less clustering of subjects around one area of that range.   
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Future Directions 
Future studies focusing on the labor care and outcomes of obese women are needed.  
Analysis of this study indicates that obese women ending labor with labor dystocia are 
statistically significantly more likely to receive intrapartum interventions like synthetic 
oxytocin and AROM in early labor.  Maternal delivery BMI was not statistically significantly 
associated with these relationships in this study.  In a future study that included a larger range 
of maternal BMIs and a greater frequency of morbidly obese subjects, how might maternal 
BMI influence labor outcomes?  A multi-site clinical trial funded by the National Institutes of 
Health comparing elective induction of labor vs. expectant management on maternal and 
neonatal outcomes is ongoing at this time for low-risk, nulliparous women at 39 weeks of 
pregnancy (A Randomized Trial of Induction Versus Expectant Management (ARRIVE), 
2013).  This trial includes women of any BMI range.  Given findings in the current study that 
delivery BMI was statistically significantly correlated with the cesarean delivery for labor 
dystocia, it would be informative to perform sub-analysis of the ARRIVE trial results to 
evaluate if overall trial findings of labor outcomes and costs are different for obese women.  
Depending on racial/ethnicity group, 1/3-2/3 of childbearing women in the United States are 
obese (Flegal et al., 2012).  Given known effects of obesity on labor success, any major study 
evaluating intrapartum outcomes should be evaluated within sub-groups defined by maternal 
delivery BMI. 
Another future direction planned is analysis of data collected on these study 
participants about use of intrauterine pressure catheters (IUPC) and results of pressure 
measurements made hour-to-hour in women who had these catheters.  IUPCs are used in 
labor for a variety of reasons, but once inserted they provide precise measurements of 
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myometrial force during labor.  IUPC measurements of myometrial force were found to be 
similar between by maternal BMI in both 2nd stage labor (Buhimschi et al., 2004) and in late 
1st stage labor (Chin, Henry, Holmgren, Varner & Branch, 2012).  However, myometrial 
force measurements in obese women have never been mapped against synthetic oxytocin 
dosages.  116 subjects in the Aim 2/4 samples from this study had IUPCs placed during their 
labor (95/116 also had synthetic oxytocin augmentation), and all measurements of uterine 
force for these subjects were collected during medical record review.  Future analysis is 
planned to compare the hourly synthetic oxytocin measurements, cervical dilation results, and 
(matched) hourly uterine force measurements for these obese women.  Several important 
questions planned in this study include:   
• Is there a difference by maternal delivery BMI in hourly uterine force measurements, 
during similar phases of labor defined by cervical dilation? 
• Are hourly uterine force measurements predicted by matched hourly synthetic 
oxytocin doses in obese women? 
• Are hourly uterine force measurements predictive of cervical dilation progress in 
obese women? 
• When in labor are IUPCs inserted for indication of ‘concerns for labor progress’ with 
obese women?   
• Do higher uterine force measures predict more rapid cervical progress in obese 
women? 
 These analyses will provide new information on the physiologic response of obese 
women to synthetic oxytocin.  This future study will also provide new information on the 
correct interpretation of uterine force measurements when IUPCs are used with obese 
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women.  IUPC insertion to measure uterine force is recommended for intrapartum providers 
to assess the ‘adequacy’ of uterine contractions in women with slow labor progress  
In conclusion, I present new information in this study that maternal delivery BMI was 
significantly associated with cesarean delivery for the indication of slow labor progress, 
even when included in regression analysis with gestational age, baby’s birth weight, 
maternal age, and maternal height in a sample of healthy, nulliparous overweight and 
obese women who had spontaneous labor onset.  Obese women ending labor with 
cesarean for labor dystocia were statistically significantly more likely than women 
ending labor with vaginal delivery to receive synthetic oxytocin, have artificial rupture 
of membranes or synthetic oxytocin infusions initiated at less than 6cm cervical 
dilation, and have initiation of synthetic oxytocin during times of normal labor 
progression.  Also in this study, I found that maternal BMI explained nearly 1/5 of the 
variance in hourly synthetic oxytocin doses among obese women ending labor with 
vaginal delivery when controlling for both infant birthweight and the timing in labor of 
oxytocin augmentation initiation.  Low-technology interventions like intermittent fetal 
monitoring, ambulation in labor, and hydrotherapy were used frequently in the labors of 
obese women at UCH, but did not significantly change these obese women’s chances of 
ending labor with cesarean delivery for labor dystocia.  Labor care of obese women by 
CNMs in this study included multiple statistically significant differences from that 
provided by OBs, but these differences were not significantly related to the odds that 
their obese and overweight patients would end labor with cesarean delivery for the 
indication of slow labor progress. 
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